FHIR IG Statistics (3562 ms)

• Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
• Authority: All | hl7 | ihe | national
• Realm: All | au | be | BNW | br | ca | ch | cl | cr | cz | de | dk | ee | efss | essilux | eu | examples | fi | fr | il | in | it | jp | nl | no | nume | nz | pt | rdsuwearme | sami | se | sl | stt | test | tw | uk | us | uv | vn
• View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16260 resources

By Version

• R2: 52
• R2B: 0
• R3: 522
• R4: 15248
• R4B: 0
• R5: 438
• R6: 0

Start Prev Rows 8600 - 8800 Next http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.167

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176	Neonatal Moderate Birth Trauma with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177	Neonatal Moderate Birth Trauma with LOS	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178	Neonatal Moderate Birth Trauma with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179	Neonatal Moderate Respiratory Complications with LOS	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180	Neonatal Moderate Respiratory Complications with LOS	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181	Neonatal Moderate Respiratory Complications with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182	Moderate Neurological Complications with LOS Procedures	active	2019-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183	Neonatal Moderate Neurological Complications with LOS Procedures	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184	Neonatal Moderate Neurological Complications with LOS Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185	Neonatal Moderate Respiratory complications with LOS Procedures	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186	Neonatal Moderate Respiratory complications with LOS Procedures	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187	Neonatal Moderate Respiratory complications with LOS Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188	Single Liveborn Newborn Vaginal	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189	Single Liveborn Newborn Vaginal	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190	Single Liveborn Newborn Vaginal	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191	Single Liveborn Newborn Cesarean	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192	Single Liveborn Newborn Cesarean	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193	Single Liveborn Newborn Cesarean	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194	Birth Weight	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195	Neonatal Moderate Infection with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196	Neonatal Moderate Infection with LOS	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197	Neonatal Moderate Infection with LOS	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203	Neonatal Intensive Care Unit	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204	Intensive Care Unit	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205	Neonatal Intensive Care Unit	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206	Intensive Care Unit	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208	Blood Transfusion Administration	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209	Blood Transfusion Administration	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213	Blood Transfusion	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214	Acute Respiratory Distress Syndrome	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217	Amniotic Fluid Embolism	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219	Aortic Aneurysm	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220	Aortic Aneurysm	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221	Cardiac Arrest Ventricular Fibrillation	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223	Disseminated Intravascular Coagulation	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225	Eclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227	Heart Failure Cardiac Arrest Related to Procedure or Surgery	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228	Heart Failure Cardiac Arrest Related to Procedure or Surgery	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229	Puerperal Cerebrovascular Disorder	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231	Pulmonary Edema	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233	Acute Heart Failure	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235	Severe Anesthesia Complications	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237	Sepsis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239	Shock	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24	Blood Transfusion Administration	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241	Sickle Cell Disease with Crisis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243	Air and Thrombotic Embolism	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245	Blood Transfusion	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246	Blood Transfusion	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247	Conversion of Cardiac Rhythm	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248	Conversion of Cardiac Rhythm	active	2021-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249	Hysterectomy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250	Hysterectomy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251	Tracheostomy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252	Tracheostomy	active	2021-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253	Ventilation	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254	Ventilation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255	Severe Maternal Morbidity Diagnoses	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256	Severe Maternal Morbidity Procedures	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267	Gestational Diabetes	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269	Gestational Diabetes	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271	HIV in Pregnancy Childbirth and Puerperium	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272	HIV in Pregnancy Childbirth and Puerperium	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274	Preexisting Diabetes	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275	Preexisting Diabetes	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277	Previous Cesarean	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278	Previous Cesarean	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279	Pulmonary Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281	Pulmonary Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282	Multiple Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284	Multiple Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286	Bleeding Disorder	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287	Bleeding Disorder	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289	Morbid or Severe Obesity	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290	Morbid or Severe Obesity	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291	Economic Housing Instability	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292	Economic Housing Instability	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295	Thyrotoxicosis	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296	Thyrotoxicosis	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297	Preterm Birth	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299	Preterm Birth	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300	Placenta Accreta	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302	Placenta Accreta	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303	Placental Abruption	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305	Placental Abruption	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306	Neuromuscular Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308	Neuromuscular Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309	Autoimmune Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311	Autoimmune Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312	Mental Health Disorder	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314	Mental Health Disorder	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315	Bariatric Surgery	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317	Bariatric Surgery	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318	Substance Abuse	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320	Substance Abuse	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321	Anemia	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323	Anemia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324	Severe Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326	Mild or Moderate Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327	Severe Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329	Mild or Moderate Preeclampsia	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330	Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332	Hypertension	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333	Renal Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335	Renal Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336	Gastrointestinal Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338	Gastrointestinal Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339	Cardiac Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341	Cardiac Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344	Aortic Aneurysm	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357	Conversion of Cardiac Rhythm	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358	Hysterectomy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359	Tracheostomy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360	Ventilation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361	Venous Thromboembolism in Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363	Venous Thromboembolism in Pregnancy	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364	Long Term Anticoagulant Use	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366	Long Term Anticoagulant Use	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368	Preadmission Observation Undelivered Mother	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369	ED Visit and OB Triage	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370	Present on Admission is No or Unable To Determine	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371	COVID 19 Confirmed	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372	COVID 19 Confirmed	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373	COVID 19 Confirmed	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374	Respiratory Conditions Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375	Respiratory Conditions Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376	Respiratory Conditions Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377	Respiratory Support Procedures	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378	Respiratory Support Procedures	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379	Respiratory Support Procedures Related to COVID 19	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387	Placenta Increta or Percreta	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388	Placenta Increta or Percreta	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67	Other Health Care Facility	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10	Non essential Hypertension SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102	Suicide Attempt	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11	Cirrhosis ICD9CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12	Cirrhosis ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13	Cirrhosis SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14	Cirrhosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151	Polycystic Ovary Syndrome	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16	Low Intensity Statin Therapy/Branded	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17	Moderate Intensity Statin Therapy/Branded	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18	High Intensity Statin Therapy/Branded	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21	ALT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230	Gestational Diabetes SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231	Gestational Diabetes ICD10CM	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233	All Results of High Risk HPV Test	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234	High Risk HPV Positive Results	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248	Suicide Attempt SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26	Nonopioid pain medications	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263	High Risk Positive HPV Results Without HPV16 or HPV18	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264	CDS Pregnancy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265	CDS Pregnancy Intensional	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266	Rhabdomyolysis Intensional	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267	CDS Rhabdomyolysis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268	HPV Negative Results	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27	Non pharmacologic treatments for chronic pain ICD10PCS	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28	Urine drug screen for pain management	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29	Non pharmacologic treatments for chronic pain SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292	Non pharmacologic treatments for chronic pain NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296	SCT Findings 202209	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298	Cervical Cytology Test	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299	HPV 16 Tests	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300	HPV 18 Tests	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302	Test Cervical Excision Procedures	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303	Statin Combinations	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305	Counseling for Physical Activity CPT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306	Counseling for Physical Activity ICD10CM	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307	Counseling for Physical Activity CDS	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308	Cardiovascular disease 10Y risk	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309	SCT Findings 202309	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311	SCT Procedures 202209	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312	SCT Procedures 202309	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313	Statin Allergen Grouping	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319	Steward Transfer Test	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320	Opioids ATCPROD N02A	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322	Test 123	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34	Opioid pain medications	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36	Non pharmacologic treatments for chronic pain	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40	Suicide attempt	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42	Naloxone and Nalmefene medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43	Benzodiazepine medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44	Stool softeners and laxatives	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50	Sleep disordered breathing	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51	Sleep disordered breathing	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53	Sleep disordered breathing	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54	Adjuvant pain medications	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55	Risk assessments relevant to pain management	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6	Non essential Hypertension ICD9CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7	Non essential Hypertension ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79	Behavioral Counseling for Nutrition and Activity Referral	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85	Impaired Glucose Tolerance	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87	Fasting Plasma Glucose	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88	Waist Circumference	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9	Hypertension	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90	Gestational Diabetes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92	First Degree Family Member	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94	Glucose Tolerance Test Results	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96	Dependence on dialysis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99	Gestational Diabetes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460	Cluster Headache (ICD10CM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461	Cluster Headache (ICD9CM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464	Cluster Headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467	Medication Therapy for Cluster Headache (RXNORM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555	Patient Declines Treatment for Cluster Headache (SNOMEDCT)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558	Acute Cluster Headache Medication (RXNORM)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559	Long Term Preventive Medication for Cluster Headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561	Oral Steroid for Cluster Headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569	Migraine Preventive Medication	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601	Acute Migraine Attack Medication	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605	NSAID OTC Migraine Attack Medication	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606	NSAID Prescribable Migraine Attack Medication	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640	Neurologic Disorders	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641	Neuromodulation for migraine	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642	No pain with headache	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643	Antiplatelets	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644	Anticoagulants	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645	Statin Medications	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646	Anxiety Disorders (ICD10 and SNOMED)	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648	Depression Diagnosis (ICD10 and SNOMED)	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649	Psychosis (ICD10 and SNOMED)	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650	Cluster Headache (SNOMED)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651	Galcanezumab (RxNorm)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652	Lithium (RxNorm)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653	Verapamil	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654	Long term preventive medications for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655	Short term preventive medication for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656	Zolmitriptan	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657	Sumatriptan	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658	Dihydroergotamine	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659	Acute cluster headache medication	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660	Acute cluster headache treatment	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661	Short term preventive treatment for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662	Long term preventive treatment for cluster headache	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663	Migraine diagnosis (ICD)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664	Prescribable NSAIDs and Acute Migraine Attack Medication	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103	Abnormal Presentation	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105	Abnormal Presentation	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114	Hematocrit Lab Test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117	Potassium Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119	Sodium Lab Test	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127	Platelet Count Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129	White Blood Cells Count Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130	Respiratory Rate	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134	Glucose Lab Test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139	Bicarbonate Lab Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15	Intravenous Thrombolytic tPA Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151	Oxygen Saturation by Pulse Oximetry	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152	Body Temperature	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159	Body Weight	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16	Intraarterial Thrombolytic tPA Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163	Systolic Blood Pressure	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171	Abnormal Presentation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173	Delivery of Singleton	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21	Intravenous or Intraarterial Thrombolytic tPA Therapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26	Estimated Gestational Age at Delivery	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27	Cornual Ectopic Pregnancy	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38	General Or Neuraxial Anesthesia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39	Low Dose Unfractionated Heparin for VTE Prophylaxis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41	Glycoprotein IIb IIIa Inhibitors	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55	Oxytocin	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56	Dinoprostone	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58	Delivery Procedures	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59	Delivery Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66	PCI	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67	PCI	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68	Endotracheal Intubation	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69	Endotracheal Intubation	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98	Delivery of Singleton	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99	Delivery of Singleton	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225	Opioid Medication Assisted Treatment (MAT) SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241	Schedule II, III and IV Opioid Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242	Opioid Use Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243	Opioid Use Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265	Inpatient, Emergency, and Observation Locations	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269	Medications for Opioid Use Disorder (MOUD)	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274	NHSN Inpatient Encounter Class Codes	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277	Emergency Department Location	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278	Emergency Department Treatment Location	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279	Triage	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283	Emergency Department Location	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284	Emergency Department Location	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285	Mental Health Diagnosis without Substance Use Disorders	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286	Decision to Transfer	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35	Healthcare Agent or Proxy Choices	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10	Breastfeeding	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100	Familial Hypercholesterolemia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102	Rhabdomyolysis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107	Low Intensity Statin Therapy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12	Liver Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13	Rhabdomyolysis	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19	Atherosclerosis and Peripheral Arterial Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20	Atherosclerosis and Peripheral Arterial Disease	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21	Atherosclerosis and Peripheral Arterial Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22	Liver Disease ICD9	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37	Stable and Unstable Angina	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39	Cerebrovascular Disease Stroke or TIA	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.41	Ischemic Heart Disease or Related Diagnoses	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42	Liver Disease	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.43	Liver Disease	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44	Cerebrovascular Disease Stroke or TIA	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46	Ischemic Heart Disease or Related Diagnoses	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47	Stable and Unstable Angina	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.501	Overweight or Obese	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502	Overweight or Obese	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.512	Elevated Blood Pressure Reading	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513	Elevated Blood Pressure Reading	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514	Finding of Elevated Blood Pressure or Hypertension	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.515	Bariatric Procedures	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.517	Age related macular degeneration intermediate dry	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.518	Ophthalmologist visit	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.519	Posterior vitreous detachment (PVD)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.521	Ophthalmoscopic exam	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.523	Opthalmoscopic exams with Scleral Depression	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525	Referral (ophthalmology)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.526	Retina Ultrasound	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527	Retina visualization inadequate	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528	Refusal or Noncompliance with treatment	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.529	Vitreous hemorrhage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530	Vitreous hemorrhage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.536	Macula examination	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.539	Fluorescein angiography	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.541	Optical coherence tomography (OCT)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.542	Intravitreal injection	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543	Bevacizumab injection	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544	Ranibizumab injection	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545	Aflibercept injection	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.552	Uveitis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553	Uveitis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.554	Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.555	Macular edema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556	Corticosteroids for Injection	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557	Corticosteroids for Injection	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560	Tonometry	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.561	Intraocular pressure	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.571	Retinal Vein Occlusion Related Macular Edema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576	Vitreous hemorrhage	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580	Intravitreal and Periocular Injections	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581	Intravitreal and Periocular Injections	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582	Corticosteroids for Injection	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.583	Endophthalmitis in the Right Eye	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.584	Endophthalmitis in the Left Eye	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.585	Panophthalmitis in the Right Eye	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.586	Panophthalmitis in the Left Eye	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587	Lost to follow up	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588	Uveitis	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.610	Scleral depressed exam	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611	3 Mirror Goldmann exam	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612	Scleral depressed exam	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615	Physical Disability	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616	Financial difficulty	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.617	Vitreous exam findings	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619	Scleral depressed exam	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.629	Post operative follow up	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.67	Breastfeeding	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69	Stable and Unstable Angina	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70	Ischemic Heart Disease or Related Diagnoses	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71	Cerebrovascular Disease Stroke or TIA	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73	Breastfeeding	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85	Familial Hypercholesterolemia	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.89	Rhabdomyolysis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9	Outpatient Encounters for Preventive Care	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.91	Familial Hypercholesterolemia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.93	Hypercholesterolemia ICD 9	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97	High Intensity Statin Therapy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98	Moderate Intensity Statin Therapy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.50	HIV Lab Tests	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.51	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.71	Human Immunodeficiency Virus (HIV) Viral Load	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.10	ARBs (Angiotensin Receptor Blockers)	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1000	OIA_V2_GLP1s_RxNorms	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1001	OIA_V2_PCSK9s_RxNorms	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1002	OIA_RFs_Secondary_Prevention_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003	OIA_RFs_Secondary_Prevention_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1004	OIA_RFs_Secondary_Prevention_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005	OIA_RFs_Secondary_Prevention_ICD_SM_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1006	OIA_Asthma_COPD_Combo_Meds	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1007	OIA_Asthma_COPD_Combo_Meds_SABA_SAMA	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1008	OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009	PAE_Patient_Conditions	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012	PAE Conditions Short	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1016	OIA_TEST_VS	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1017	Triptan Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1018	NSAID Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1019	Statin Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1021	Penicillin Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1022	Macrolide Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1023	Quinolone Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1025	Beta blocker Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026	ACE inhibitor Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1027	ARB Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1028	Sulfonylurea Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1030	DPP4i Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1031	GLP1RA Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1032	Beta blocker allergy intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033	SGLT2i Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1034	MRA Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1036	Meglitinide Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1037	Alpha glucosidase inhibitor Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1038	TZD Allergy NDFRT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1041	Hemoglobin	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1042	Hematocrit	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043	Anemia for Erythropoesis Simulating Agents I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044	Anemia for Erythropoesis Simulating Agents SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045	Anemia for Erythropoesis Simulating Agents	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1046	AZT Meds	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1047	Ferritin	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1048	Knee pain I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049	Knee pain SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105	conditions_heartfailure	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050	Knee pain	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051	Knee decreased ROM SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1052	Knee effusion I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1054	Knee effusion	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055	Knee crepitus SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1056	OIA_Antiemetics	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1057	OIA_PDE5is	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1058	OIA_Vitamins	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1059	OIA_Plavix	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1061	OIA_Oral_Contraceptives	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1063	OIA_Topical_Steroids	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1064	OIA_Cough_Cold_Meds	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1065	Antiperspirant aluminum salts	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1066	Antiperspirant anticholinergics	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1067	Antieplieptic medications	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1068	Antidepressant medications	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069	Urinary incontinence SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1070	Urinary incontinence I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071	Urinary incontinence	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073	Hemifacial spasm SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1074	Hemifacial spasm I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075	Hemifacial spasm	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076	Spasmodic dysphonia SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077	Physical therapy procedure SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078	Occupational therapy SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079	Hyperhidrosis SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1080	Hyperhidrosis I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081	Hyperhidrosis	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1082	Tic disorder I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083	Tic disorder SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084	Tic disorder	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085	Esophageal achalasia SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1086	Esophageal achalasia I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087	Esophageal achalasia	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1088	ET propanolol or primidone	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1089	ET topiramate alprazolam or gabapentin	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.109	CKD stage4above I10	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090	Blephraospasm SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1091	Blepharospasm I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092	Blepharospasm	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093	Strabismus SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1094	Strabismus I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095	Strabismus	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096	Overactive bladder SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1097	Overactive bladder I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098	Overactive bladder	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099	Movement disorders SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110	CKD stage4above SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1100	Movement disorders I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101	Movement disorders	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102	Lateral epicondylitis SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1103	Lateral epicondyltisis I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104	Lateral epicondylitis	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105	Plantar fasciitis SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1106	Plantar fasciitis I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107	Plantar fasciitits	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108	Cardiac CT SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1109	Cardiac CT CPT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111	CKD stage4above	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111	Cardiac CT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112	Cardiac MRI SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1113	Cardiac MRI CPT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114	Cardiac MRI	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115	CT Angiography of Coronary Artery SCT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1116	CT Angiography of Coronary Artery CPT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117	CT Angiography of Coronary Artery	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.112	Chronic kidney disease I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113	Chronic kidney disease SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.116	DigTx Cognitive Impairment I10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117	DigTx Cognitive Impairment SCT	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120	Diabetic ketoacidosis SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121	Diabetic ketoacidosis	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124	DKD	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147	HFrEF SCT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.148	HFrEF I10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.15	Kidney tansplant	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.150	History of Hypoglycemia I10	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151	History of Hypoglycemia SCD	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.153	Hyperlipidemia	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.159	conditions_COPD I10	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168	medications_COPD	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17	Atrial fibrillation	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.173	Asthma I10	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175	Asthma	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186	Beta blockers GDMT for heart failure	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.188	medications_heart failure	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189	SGLT2i	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.193	relatedconditions_COPD I10	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.197	Blood (Serum and Plasma) Potassium	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.202	Serum Creatinine	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21	Thoracic aorta disease	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214	Type 1 Diabetes Mellitus SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.224	Systolic Heart Failure I10	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226	Systolic Heart Failure	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238	MRA mineralocorticoid receptor antagonists	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.252	relatedconditions_Heart failure I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260	UACR SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.263	Pregnancy I10	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281	Statins Allergy SCT	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282	Statin Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.292	Metabolic syndrome I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.3	Delivery I10	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.314	relatedconditions_hyperlipidemia I10	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.322	Angina I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.325	Tachyarrhythmia I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.337	Migraine I10	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.34	Blood pressure panel	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.35	Systolic Blood Pressure	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.350	Coronary artery disease I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.367	Trandolapril	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369	Candesartan	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37	relatedconditions_hypertension SCT	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377	Valsartan	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.38	relatedconditions_hypertension I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.397	eGFR	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.409	Hypertension I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412	Statin Moderate Intensity	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.415	LDL Cholesterol	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.43	Urinalysis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.434	Insulin	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.437	TZD Thiazolidinediones	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438	medications_T2DM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.439	relatedconditions_T2DM I10	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440	relatedconditions_T2DM SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.442	Blood Glucose	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45	ACE inhibitor allergy RXNORM	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.455	Metabolic acidosis I10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459	Liver cancer	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47	ACE inhibitor allergy SCT	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473	Tetanus toxoid, diphtheria (Td) Vaccine	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474	Allergy to Tdap Vaccine	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475	Allergy to Td Vaccine	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476	Allergy To Vaccine Component	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478	Allergy to HPV Vaccine	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.481	medications_hypertension	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492	Inhaled Corticosteroids Allergy	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498	Metformin AllergyIntolerance SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5	Delivery - Procedure	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.508	Abdominal aortic imaging CPT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516	Allergy to Herpes Zoster Vaccine SCT	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.517	Hemoglobin A1c	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.518	Drug hypersensitivity I10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519	Drug hypersensitivity SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520	Drug hypersensitivity	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.521	Diabetic Kidney Disease I10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.523	Diabetic kidney disease	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524	Chronic Hepatitis SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525	Chronic Hepatitis	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527	OCS_Prednisone	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528	High Dose Non Combo ICS Adult	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529	Medium Dose Non Combo Asthma ICS Adult	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530	Low Dose Non Combo ICS	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531	Anti IgE Medications	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532	IL5 Antagonists	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533	Mast cell stabilizers for asthma	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.534	Vasospastic disease I10	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535	Vasospastic disease SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536	Vasospastic disease	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.537	Hemiplegic and basilar migraine I10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538	Hemiplegic and basilar migraine SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539	Hemiplegic and basilar migraine	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.540	Peptic ulcer disease I10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541	Peptic ulcer disease SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542	Peptic ulcer disease	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.544	Bleeding disorder I10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545	Bleeding disorder SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548	Electronic cigarettes or Vaping	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549	Bleeding disorder	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.551	Heart Rate	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552	Triptans	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553	CGRP receptor antagonists	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554	Ditans	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555	Ergots	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556	Migraine specific NSAIDs	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557	OTC migraine analgesics	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558	Butalbital analgesics	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559	medications_migraine_acute	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.560	relatedconditions_migraine I10	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561	conditions_migraine	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562	relatedconditions_migraine SCT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563	relatedconditions_migraine	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564	Triptan Allergy Intolerance SCT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565	Triptan Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566	Ischemic bowel disease SCT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.567	Ischemic bowel disease I10	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568	Ischemic bowel disease	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569	Allergen Immunotherapy	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570	Allergy to house dust mites SCT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.571	Allergy to house dust mites I10	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572	Allergy to house dust mites	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.573	conditions_hyperlipidemia I10	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574	conditions_hyperlipidemia SCT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575	conditions_hyperlipidemia	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578	PIM_Schedule V	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580	PIM_Acarbose	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581	PIM_Avandamet	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582	PIM_Dulaglutide	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583	PIM_Glimepiride	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585	PIM_Glucophage	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587	PIM_Glucovance	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588	Glyburide PIM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590	Alpha glucosidase inhibitors	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.592	Azotemia	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594	Intolerance to ARB SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595	ICS Low	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596	ICS Medium	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597	ICS High	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598	Low Dose ICS Formoterol	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.599	PIM_Vitamin B12 Level_LOINC_CPT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.600	PIM_Vitamin B12 Level_LOINC	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.601	PIM_Vitamin B12 Level_CPT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604	PIM_Glyburide	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605	PIM_Pioglitazone	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606	PIM_Semaglutide	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607	PIM_Linagliptin	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609	Macrolide_Azithromycin	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61	Secondary antihypertensives	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610	Long Acting Beta Agonists (LABA) Non_Formoterol	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.611	relatedconditions_Asthma I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612	Wolff Parkinson White SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.613	Wolff Parkinson White I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614	Wolff Parkinson White	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615	medications_Asthma	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617	HighICS_LABA_NonFormoterol	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618	relatedconditions_Asthma SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619	ICS_LABA_LAMA	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620	Low Dose ICS_LABA_Non Formoterol	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621	Medium ICS_LABA Non Formoterol	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622	relatedconditions_Asthma	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623	LAMA Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624	LABA Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625	BetaBlock NonCS Secondary Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626	Eplerenone Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627	Spironolactone Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628	SGLT2 Inhibitors Allergy SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.629	PIM_Refill_Request_Antilipemics_LFTs	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631	Pneumococcal Vaccine Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632	Meglitinides Allergy SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633	DPP4i Allergy SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635	Alpha_glucosidase inhibitors allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636	Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637	Insulins Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638	TZD Allergy SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639	T2DM_Medications Allergy SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642	T2DM_Medications Allergy RXNORM	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643	T2DM_Medications Allergy SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646	T2DM_Medication Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647	Statins Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649	ACE Inhibitors Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650	ARB Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652	Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653	Long Acting Beta Agonists (LABA) Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654	BetaBlocker NonCS Secondary Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656	MRA Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657	Eplerenone Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658	Spironolactone Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659	SGLT2i Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661	Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665	Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666	Human Papillomavirus (HPV) vaccine Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667	Herpes Zoster Vaccine Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670	Pneumococcal Vaccine Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671	Inhaled Corticosteroids(ICS) Allergy Intolerance	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672	LABA(Formoterol only)	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674	PIM_Tirzepatide	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675	GLP1RA Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.676	PIM_Diabetes_Testing_Supplies	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677	PIM_H2_Antagonists	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678	SGLT2i DM CKD	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679	SGLT2i DM ASCVD	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680	GLP1RA DM ASCVD	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683	OIA_Gout_Medications	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684	GlumetzaSubstitution	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685	MetforminER500mg	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686	PIM_Metformin	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687	PIM_Glipizide	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689	PIM_Glipizide_Glyburide_Glimepiride	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690	PIM_Insulin_Meglitinides	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691	PIM_Glyxambi	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692	PIM_Farxiga	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693	PIM_Invokana	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694	PIM_Jardiance	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695	PIM_Invokana_Jardiance	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696	Reclast	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697	LAMA_LABA Combination 1 Inhaler	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698	PIM_Contraceptives	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699	Selected Oral Antiemetics for Migraine	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.700	PIM_DEXA_Scan	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.701	PIM_DEXA_Scan_CPT_LOINC	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702	PIM_SSRIs	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703	PIM_SNRIs	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704	PIM_NRIs	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705	PIM_TCAs	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706	PIM_Citalopram	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707	PIM_Hydroxyzine	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708	PIM_Buspirone	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709	PIM_Bupropion	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710	PIM_Mirtazapine	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711	PIM_Trazodone	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.712	PIM_IHD_CHD_CAD_ICD10	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713	PIM_IHD_CHD_CAD_SNOMED	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714	PIM_Gabapentin	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715	PIM_Allergy_Nasal_Sprays	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716	PIM_Allergy_Oral_Meds	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717	PIM_Allergy_Nasal_Oral	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719	OCS_Prednisolone	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72	Inhaled corticosteroids (IC)	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720	COPD_Ofloxacin	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721	COPD_Ciprofloxacin	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722	COPD_Doxycycline	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723	Macrolide Allergy SCT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724	Macrolide Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725	Prednisone Allergy SCT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727	Tetracycline Allergy SCT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728	Tetracycline Allergy Intolerance	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729	Fluoroquinolones Allergy SCT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730	Fluoroquinolone Allergy Intolerance	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731	Penicillin Allergy RXNORM	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732	Penicillin Allergy SCT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733	Penicillin Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734	PIM_Metformin_Single_Ingredient_Only	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735	PIM_Metformin_Combo_Ingredient_Only	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.736	Pneumonia I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737	Pneumonia SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738	Pneumonia	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.739	Pulmonary Embolism I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742	Pulmonary Embolism SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743	Pulmonary Embolism	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.744	Influenza I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745	Influenza SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.746	Influenza (Tests for influenza A or B virus Antigen)	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747	Influenza	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.748	COVID 19 I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749	COVID19 SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750	COVID19	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.752	RSV I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753	RSV SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754	RSV	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755	Respiratory Rate SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.756	Respiratory Rate LOINC	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757	Respiratory Rate	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.758	Acute Respiratory Failure I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759	Acute Respiratory Failure SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760	Acute Respiratory Failure	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761	Dyspnea SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.762	Dyspnea I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763	Dyspnea	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.764	Confusion I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765	Confusion SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766	Confusion	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767	Drowsiness SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.768	Drowsiness I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769	Drowsiness	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.770	Cyanosis I10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771	Cyanosis SCT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772	Cyanosis	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.775	Arterial oxygen saturation LOINC	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776	Arterial oxygen saturation SCT	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777	Arterial oxygen saturation	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.779	PIM_Potassium_Supplements	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.780	PIM_PPIs	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.781	PIM_Migraine_Medications_Abortive	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.782	PIM_Migraine_Medications_Preventive	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.783	PIM_Bisphosphonates	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.784	PIM_BPH_Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.785	PIM_Thyroid_Replacement_Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.786	PIM_Overactive_Bladder_Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.787	PIM_Topical_Acne_Medications	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.788	PIM_Antidepressant_Anxiolytic_Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.789	Simple Knee Pain I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790	Simple Knee Pain SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791	Simple Knee Pain	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792	Simple Left Knee Pain SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793	Simple Right Knee Pain SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.794	Simple Right Knee Pain I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.795	Simple Left Knee Pain I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796	Simple Right Knee Pain	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797	Simple Left Knee pain	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.798	Knee joint surgery CPT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799	Knee joint surgery SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800	Knee joint surgery	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.801	Knee Osteoarthritis I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802	Knee Osteoarthritis SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803	Knee Osteoarthritis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804	Osteoarthritis of right knee SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805	Osteoarthritis of left knee SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.806	Osteoarthritis of right knee I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.807	Osteoarthritis of left knee I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808	Osteoarthritis of right knee	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809	Osteoarthritis of left knee	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810	Hip Osteoarthritis SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.811	Hip Osteoarthritis I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812	Hip Osteoarthritis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.813	Hip joint surgery CPT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814	Hip joint surgery SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815	Hip joint surgery	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.816	Osteoarthritis of right hip I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.817	Osteoarthritis of left hip I10	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818	Osteoarthritis of right hip SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819	Osteoarthritis of left hip SCT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820	Osteoarthritis of right hip	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821	Osteoarthritis of left hip	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.822	DigTx RelieVR inclusions I10	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.823	Aminoglycosides	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.824	Carbapenems	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.826	Monobactams	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.827	Penicillins	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.828	Antimycobacterials	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.829	Beta_lactamase	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.830	Cyclic lipopeptides	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.831	Lincosamides	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.832	Macrolides	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.833	Amphenicol	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.834	Oxazolidinones	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.835	Fluoroquinolones	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.836	Sulfonamides	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.837	Tetracyclines	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.838	Phosphonics	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.839	Pleuromutilin	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.840	Streptogramins	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841	Lipoglycopeptides	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.842	Nitroimidazoles	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.843	PIM_Hyd_Bus_Mir_Tra	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.844	Nitrofurans	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.845	Rifamycins	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.846	Glycylcycline	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.847	Pyrimidines	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.849	Antibiotics oral and parenteral	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.85	PCSK9i	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.850	Medications_hyperkalemia	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.852	Hyperkalemia_ICD10	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853	Hyperkalemia_SCT	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854	Hyperkalemia Conditions	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.855	Medications_Chronic Hyperkalemia	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.858	PIM_Alpha_Blockers_2	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.860	PIM_Ambulatory_Visits_CPTs	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862	PIM_Ambulatory_Visits_SNOMED	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.863	PIM_Thyroid_Stimulating_Hormone_(TSH)	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.864	PIM_Triiodothyronine_(T3)	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.865	PIM_Thyroxine_(T4)	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.866	PIM_Magnesium_LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.867	PIM_BMP_CMP_LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.868	PIM_URIC_ACID_LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.869	PIM_Migraine_Medications	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.870	PIM_Triptans	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.871	ICS_SABA Reliever	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.873	PIM_Asthma_COPD_Meds	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.874	PIM_Lipid_Panel_CPTs	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.875	PIM_Hepatic_Function_Panel_CPTs	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876	Alpha Glucosidase Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.877	Inflammatory bowel disease I10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878	Inflammatory bowel disease SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879	Inflammatory bowel disease	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88	DEPRECATED Diabetes	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880	Gastrointestinal obstruction SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.881	Gastrointestinal obstruction I10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882	Gastrointestinal obstruction	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883	DPP4i Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884	Multiple endocrine neoplasia type 2 (MEN II) SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.885	Multiple endocrine neoplasia type 2 (MEN II) I10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886	Multiple endocrine neoplasia type 2 (MEN II)	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887	Gastroparesis SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.888	Gastroparesis I10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889	Gastroparesis	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890	Meglitinide Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891	Sulfonylurea Allergy Intolerance	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.892	Peripheral edema I10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893	Peripheral edema SCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894	Peripheral edema	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895	TZD Allergy Intolerance	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.896	PIM_Beta_Blockers	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.897	PIM_CCB_DHPs	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.898	PIM_Loop_Diuretics	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.899	PIM_Inhaled_Corticosteroids_(ICS)	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.9	ACE inhibitors	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.90	ASCVD I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.900	PIM_Leukotrienes	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.901	OIA_Asthma_COPD_Meds_Inhalers	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.902	OIA_Asthma_COPD_Meds_Nebulizers	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.903	OIA_Asthma_COPD_Meds_Oral	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.904	OIA_GLP1_Injectables	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.905	OIA_Insulin_Injectables	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.906	OIA_Oral_Hypoglycemics	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.907	OIA_DM1_DM2_Meds	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.908	Medium Dose ICS Formoterol	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.909	High Dose ICS Formoterol	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.910	CKD stage5OrESRD I10	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911	CKD stage5OrESRD SCT	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912	CKD stage5OrESRD	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.914	Anxiety_I10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915	Anxiety_SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918	Stress_SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.919	Stress_I10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92	ASCVD	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920	Stress	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921	PBH_Anxiety_SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922	PBH_Depression_SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923	PBH_Stress_SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924	PBH_Insomnia_SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.925	PIM_CMP_CPTs	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.926	Canagliflozin meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.927	Empagliflozin meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.928	Dapagliflozin meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.929	Ertugliflozin meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.93	Albuminuria I10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.930	Dulaglutide meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931	Liraglutide meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.932	Semaglutide SC meds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933	T2DM meds benefitting ASCVD	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934	T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935	T2DM meds benefitting CKD stage 5	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.936	T2DM meds benefitting HF with eGFR >= 20 mL/min	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938	Crohn disease SCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.939	Crohn disease I10	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94	Albuminuria SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940	Crohn disease	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941	Celiac disease SCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.942	Celiac disease I10	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943	Celiac disease	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.944	OIA_Bisoprolol	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.945	OIA_PVD_ICD10	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.946	Vibration Controlled Transient Elastography (VCTE)	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.947	OIA_Antihypertensive_Medications	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95	Albuminuria	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.950	OIA_CAD_ICD10	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.951	OIA_DM_ICD10	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.952	OIA_Creatinine_Levels_LOINC	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953	OIA_DM_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954	OIA_CAD_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955	OIA_PVD_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956	OIA_DM_ICD10_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957	OIA_CAD_ICD10_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958	OIA_PVD_ICD10_SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.959	ACEi for HFrEF	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.96	AlcoholicLiverDisease I10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.960	ARB for HFrEF	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.961	OIA_AntiHTN_Meds_Inclusion_List	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.962	OIA_Thiazide_Diuretics	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.963	OIA_RFs_ACS_ICD10	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.964	OIA_RFs_ACS_SNOMED	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.965	OIA_RFs_ACS__ICD10_SNOMED	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.966	OIA_Aortic_Calcifications_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.967	OIA_Aortic_Calcifications_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.968	OIA_Aortic_Calcifications_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.969	OIA_Microalbumin	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97	Sulfonylurea AllergyIntolerance SCT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.970	OIA_LDL_Cholesterol	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.971	Pioglitazone	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.972	MASLD I10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.973	MASLD SCT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.974	MASLD	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.975	OIA_Sulfonylureas	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.976	Ensifentrine	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.977	Dupilumab	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.978	OIA_RFs_ASCVD_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.979	OIA_RFs_ASCVD_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.98	BMI LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.980	OIA_RFs_ASCVD_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.981	OIA_TIA_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.982	OIA_TIA_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.983	OIA_TIA_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.984	OIA_Angina_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.985	OIA_Angina_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.987	OIA_Angina_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.988	OIA_Ischemic_Hemorrhagic_Stroke_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.989	OIA_Ischemic_Hemorrhagic_Stroke_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99	BMI SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.990	OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.991	OIA_Myocardial_Infarction_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.992	OIA_Myocardial_Infarction_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.993	OIA_Myocardial_Infarction_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.995	OIA_PAD_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.996	OIA_PAD_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.997	OIA_PAD_ICD10_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.998	OIA_Coronary_Arterial_Revascularization	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.5	Contact or Office Visit	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.6	Contact or Office Visit	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.7	Contact or Office Visit	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10	Nutrition Diagnosis SNOMED CT	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101	Hospice Status	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11	Nutrition Focused Physical Findings SNOMED CT	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14	Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17	Pediatric Enteral Formulas SNOMED CT	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18	Modified Amino Acid Formulas SNOMED CT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19	Nutrition Counseling Approach and Strategies SNOMED CT	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2	Food and Nutrient Delivery SNOMED CT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20	Enteral Nutrition Management SNOMED CT	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.21	Nutrition Assessment	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24	Malnutrition Assessment	active	2015-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.25	Nutritional Status Severely Malnourished	active	2016-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29	Malnutrition Assessment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30	Malnutrition Risk Screening	active	2015-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.31	Malnutrition At Risk	active	2015-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.32	Malnutrition Risk Screening	active	2016-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33	Nutrition Assessment Procedure	active	2015-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.34	Malnutrition Screening Finding of Not At Risk Result	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.35	Malnutrition Screening Not at Risk	active	2015-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38	Malnutrition Screening Finding of At Risk Result	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.39	Malnutrition Risk Screening	active	2016-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40	Malnutrition Risk Screening	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.41	Nutritional Status Severely Malnourished	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42	Nutrition Assessment Status Finding of Severely Malnourished	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43	Nutrition Assessment Status Finding of Severely Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44	Nutrition Assessment Status Finding of Moderately Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.45	Nutritional Status Moderately Malnourished	active	2015-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.46	Nutritional Status Moderately Malnourished	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47	Nutrition Assessment Status Finding of Moderately Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48	Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49	Nutrition Focused Physical Findings Grouping	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5	Adult Enteral Formulas SNOMED CT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50	Enteral Nutrition Composition SNOMED CT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51	Enteral Nutrition Composition Grouping	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52	Parenteral Nutrition Management SNOMED CT	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53	Malnutrition Diagnosis	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.54	Malnutrition Diagnosis	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55	Malnutrition Diagnosis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.56	Malnutrition Diagnosis	active	2016-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58	Nutrition Order Item Grouping	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59	Diet Item Grouping	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60	Edible Substances	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61	Feeding Device SNOMED CT	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65	Nutrition Recommendation Grouping	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7	Modular Nutrition Formulas SNOMED CT	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70	Nutrition Education SNOMED CT	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71	Coordination of Care by a Nutrition Professional SNOMED CT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73	Nutrition Anthropometric Measurement SNOMED CT	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.74	Nutrition Anthropometric Measure Panel LOINC	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75	Nutrition Anthropometric Measurements Grouping	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76	Manage Feeding Environment	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77	Special Food Items and Regime/Therapy for Special Food Items SNOMED CT	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.78	Food and Nutrition Related History LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.79	Nutrition Encounter Individual and Group CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.80	Nutrition Encounters HCPCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.81	Nutrition Encounter Codes Grouping	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82	Food and Nutrition Related History Grouping	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84	Food and Nutrition Related History SNOMED CT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85	Nutrition Diagnosis Grouping	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87	Feeding Device Grouping	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88	Nutrition Intervention Care Planning	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89	Malnutrition Screening Finding of At Risk Result	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.90	Medical Nutrition Therapy Procedures	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91	Dietitian Referral	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.92	Malnutrition Risk Screening	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93	Nutrition Care Plan	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.94	Malnutrition Screening Finding of At Risk Result	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.95	Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96	Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.97	Nutrition Assessment Status Finding of Severely Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.98	Nutrition Assessment Status Finding of Moderately Malnourished	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99	Nutrition Diagnosis SNOMED CT (2)	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1	Findings Related to Medication Management, Referral Source	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100	Recommendations Related to Medication Regimen	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101	Interventions Related to Medication Regimen, Initiate Medication	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102	Interventions Related to Medication Regimen, Change Medication	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103	Interventions Related to Medication Regimen, Change Medication Dose	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104	Interventions Related to Medication Regimen, Change Medication Dosage Form	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105	Interventions Related to Medication Regimen, Change Medication Course	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106	Interventions Related to Medication Regimen, Change Medication Dosing Interval	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107	Interventions Related to Medication Regimen, Discontinue Medication	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109	Interventions Related to Medication Regimen	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11	Interventions Related to Medication Management, Medication Reconciliation	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110	Interventions Related to Education, Medications	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111	Interventions Related to Education, Medical Equiptment and Devices	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112	Interventions Related to Medication Management, Notifications	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113	Interventions Related to Medication Management, Refill Synchronization	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114	Status of Patient Condition	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115	Interventions Related to Education, Diseases and Disorders	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116	Interventions Related to Education	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118	Interventions Related to Medication Management	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119	Interventions Related to Medication Management, Targeted Medication Review	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120	Interventions Related to Medication Management, Discussion	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121	Reasons for Interventions Related to Medication Management, Cost	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122	Interventions Related to Education, Immunizations	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123	Status of Recommendations	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124	Interventions Related to Medication Management, Provision of Documents	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125	Status of Compliance Ability	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126	Status of Interventions	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127	Status of Disease Control	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128	Status of Compliance	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129	Occupations of Providers	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130	Environments of Care	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131	Findings Related to Medication Management, Body Mass Index	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132	Findings Related to Medication Management, Alcohol Use	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133	Findings Related to Medication Management, Caffeine Use	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134	Interventions Related to Education, Diet	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136	Findings Related to Medication Management, Exercise	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137	Interventions Related to Education, Behavior	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138	Findings Related to Medication Management, Diet	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139	Status of Care Goal	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140	Findings Related to Medication Management, Illicit Drug Use	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141	Interventions Related to Administration, Immunizations	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142	Interventions Related to Care Coordination, Communication Needs	active	2020-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144	Findings Related to Medication Management, Life Event	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145	Interventions Related to Medication Management, Device or Equipment Fitting	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146	Findings Related to Medication Management, Immunizations	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148	Findings Related to Medication Management, Cultural Beliefs	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149	Findings Related to Medication Management, Tobacco Use	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150	Interventions Related to Medication Regimen, Continue Medication	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151	Encounter Type	active	2020-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152	Encounter Class	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156	Allergy/Intolerance Severity	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16	Reasons for Interventions Related to Medication Management	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160	Allergy/Intolerance Manifestation	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162	Allergy/Intolerance Substance & Negation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163	Allergy/Intolerance Negation	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165	Interventions Related to Care Coordination, Benefit Management	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166	Interventions Related to Administration	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167	Interventions Related to Administration, Medications	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168	Findings Related to Medication Management, Eating Habits	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169	Findings Related to Medication Management, Tobacco Exposure	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170	Interventions Related to Care Coordination	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176	Interventions Related to Medication Management, Information Gathering	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177	Interventions Related to Medication Management, Care Planning	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178	Interventions Related to Medication Management, Documentation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179	Allergy/Intolerance Substance, Food	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180	Allergy/Intolerance Substance, Environmental	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181	PharmacyEncounterReason	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182	Encounter Reason	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183	Findings Related to Medication Management, Medication related	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197	PharmacyAllergies	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198	PharmacyInterventions	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200	PharmacyReasonsForInterventions	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201	PharmacyInterventionStatus	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202	PharmacyCareCoordination	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203	PharmacyReferralsTo	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204	PharmacyGoalStatusOutcome	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205	PharmacyTypeOfProfession	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207	PharmacyEnvironmentsOfCare	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208	PharmacyEncounterType	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209	PharmacytEncounterClass	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.211	PharmacyAllergyIntoleranceType	active	2018-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212	PharmacyAllergyIntoleranceManifestation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213	PharmacyReasonForMedicationChange	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214	PharmacyEducation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215	PharmacyEducationStatus	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216	PharmacyReferralsFrom	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218	Reasons for Interventions Related to Medication Management, Discontinue Medication	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224	Social Determinants of Health Problem Observation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.225	Laboratory results that are used in medication management	active	2020-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227	Findings Related to Medication Management, Infectious Disease Symptoms	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229	COVID19 Related Disease, Test, or Exposure	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230	Maternity Health Interventions Value Set	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231	Social Determinants of Health Interventions	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232	Maternity Health Findings	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233	Reason Medication Discontinued Lack of Indication	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234	Reason Medication Discontinued Lack of Effectiveness	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235	Reason Medication Discontinued Safety Issue Occurred	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236	Reason Medication Discontinued Compliance Issue other than cost	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237	Recommendation to Resolve Medication Therapy Problem	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239	Reason Medication Discontinued Patient Unable to Afford	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.240	Medication Lists	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3	Findings Related to Medication Management, Transitions Between Health Care Settings	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35	Interventions Related to Medication Management, Comprehensive Medication Review	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5	Reasons for Interventions Related to Medication Management, Unnecessary Therapy	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53	Reasons for Interventions Related to Medication Management, Adverse Events	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55	Reasons for Interventions Related to Medication Management, Adherence	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56	Findings Related to Medication Management, Multiple Providers	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58	Findings Related to Medication Management, Chronic Disease Present	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59	Findings Related to Medication Management, Taking Medication for Chronic Disease	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6	Reasons for Interventions Related to Medication Management, New or Additional Therapy Required	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60	Findings Related to Medication Management, Health Literacy	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61	Findings Related to Medication Management	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7	Reasons for Interventions Related to Medication Management, Ineffective Therapy	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8	Reasons for Interventions Related to Medication Management, Dose Too Low	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83	Assessments Related to Medication Management, General Assessments	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84	Assessments Related to Medication Management	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85	Assessments Related to Medication Management, Assessments Using Assessment Scales	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86	Interventions Related to Medication Regimen, Monitoring	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87	Interventions Related to Care Coordination, Consultations	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88	Interventions Related to Care Coordination, Referrals to Other Providers	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89	Interventions Related to Care Coordination, Referrals for Specific Services	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9	Reasons for Interventions Related to Medication Management, Dose Too High	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90	Recommendations Related to Medication Regimen, Continue Medication	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91	Recommendations Related to Medication Regimen, Initiate Medication	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92	Recommendations Related to Medication Regimen, Change Medication	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93	Recommendations Related to Medication Regimen, Change Medication Dose	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94	Recommendations Related to Medication Regimen, Change Medication Dosage Form	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95	Recommendations Related to Medication Regimen, Change Medication Course	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97	Recommendations Related to Medication Regimen, Change Medication Dosing Interval	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98	Recommendations Related to Medication Regimen, Discontinue Medication	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99	Recommendations Related to Medication Regimen, Monitoring	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.10	Care Plan Document Type	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.11	Medication Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12	Medication Route	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24	Extended Pregnancy Status	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27	Care Team Member Function (SNOMEDCT)	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.28	Problem Type (LOINC)	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29	Allergy Clinical Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30	Care Team Member Function	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.33	External Cause of Injury/Morbidity	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35	Arthritis Feedback Types (SNOMED)	active	2019-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.36	Arthritis Feedback Types (LOINC)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.4	DIRSectionTypeCodes LOINC	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45	Bidirectional Services eReferral Type	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46	Bidirectional Services eReferral Reason	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.49	Disability Status Assessment	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50	Transport vehicle type	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53	Sex	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54	Specimen type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.55	At Home In Vitro Patient Questions	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57	Advance Directives Content Type	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58	Acute COVID 19 Diagnosis	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59	Medication Adherence SCT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.1	Case Management for Behavioral Health	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.63	Case Management for Behavioral Health	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.64	Case Management for Behavioral Health	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.10	Medicare FFS Payer	active	2023-02
us.nlm.vsac	R4	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1216	Tests for carbapenemase resistance mechanism	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1217	Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem]	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1218	Tests for carbapenem susceptibility [Ertapenem]	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1219	Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1220	NU_Tests for Enterobacteriaceae species by Culture and Identification Method	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224	Therapeutic Response to Medication [Improved]	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225	Altered Mental Status (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230	Eschar (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231	Hypotension (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233	Localized Edema (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1234	Localized Edema (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237	Tachycardia (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1238	Tachycardia (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239	RCKMS Conditions (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124	Poliomyelitis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240	Maternal Condition Puerperium (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242	Non pestis Yersiniosis Infection (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244	Blastomycosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246	Blastomycosis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1249	Blastomycosis (Tests for Blastomyces species by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1250	Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1251	Blastomycosis (Tests for Blastomyces species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1252	Blastomycosis (Tests for Blastomyces species Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1253	Blastomycosis (Tests for Blastomyces species Antigen)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1265	Fatigue (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269	Tuberculosis [Latent Infection] (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274	Histoplasmosis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1275	Histoplasmosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1281	Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295	Seizure [Unspecified Cause] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1298	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1299	Seizure [Unspecified Cause] (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130	Influenza (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1304	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1305	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1306	Body Temperature (Vital Sign)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1307	Respiratory Rate (Vital Sign)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309	RSV (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1310	RSV (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1312	RSV (Tests for RSV Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314	Wheezing (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1317	Bronchiolitis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325	Tobacco Use and Exposure (Social History)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1330	Tobacco Smoking Status [Current] (Social History) (LOINC)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335	Hospitalized [Inpatient] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336	Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337	Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1340	Prion Disease (Tests for 14_3_3 Protein)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1341	Prion Disease (Tests for Abnormal Prion Protein)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349	Cerebrospinal Fluid (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135	Chronic Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350	Endocervical (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351	Tissue (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352	Specimen from a Normally Sterile Site (Specimen Type)(SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353	Urethral Swab (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355	Wound (Specimen Type) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1359	Hepatitis E (Tests for hepatitis E virus IgM Antibody)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136	Invasive Pneumococcal Disease (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1360	Hepatitis E (Tests for hepatitis E virus Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1363	Epiglottitis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1364	Organisms (Tests by Microscopic Observation by Gram Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369	Serum (Specimen Type) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1378	Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379	Fish Poisoning (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388	Occupational Asthma (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389	Asthma (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1390	Asthma (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391	Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393	WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1400	Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative])	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1402	Cancer [Malignant Neoplasms] (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1403	Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1404	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407	Cancer [Malignant Neoplasms] (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1409	COVID_19 (Tests for SARS_CoV_2 Genomic Sequence)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418	Alpha gal syndrome (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1420	Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative])	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422	Ptosis of Eyelid [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1423	Ptosis of Eyelid [Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424	Constipation [Unspecified Cause] (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426	Intubation [Respiratory Tract] (Procedure) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430	Infant Botulism (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446	Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447	MRSA (Disorders (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449	Staphylococcus aureus infection (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145	Varicella (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1450	Staphylococcus aureus infection (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1452	MRSA (Tests by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1453	MRSA (Tests for Methicillin Resistance Gene)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1454	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1458	Tests for Cefoxitin Susceptibility [OrdQn]	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1459	Organisms (Tests in Blood by Culture and Identification)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1460	Bacteria (Tests in Blood by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1461	Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1462	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463	VRE (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464	VRE (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1465	VRE (Tests by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1466	Enterococcus species (Tests by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468	Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469	Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470	Enterococcus species (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471	Amebiasis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1473	Amebiasis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1476	Amebiasis (Tests for Entamoeba histolytica Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1482	Norovirus (Tests for Norovirus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485	Norovirus (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487	Clostridioides difficile infection (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1491	C. diff infection (Tests for C diff Toxin Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1492	C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505	Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507	Arsenic Exposure and Toxicity (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1509	Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513	Urine (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1514	Mercury Exposure and Toxicity (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1515	Cryptococcosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516	Cryptococcosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1520	Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1523	Cryptococcosis (Tests for Cryptococcus species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1524	Cryptococcosis (Tests for Cryptococcus species Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1525	Mercury Exposure and Toxicity (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1528	Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1532	Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533	Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1534	Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1538	Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154	Hepatitis C Virus Infection (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1540	Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1541	Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1542	Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1543	Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1544	Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1545	Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546	Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1551	Meningitis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552	Bacterial Meningitis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553	Fungal Meningitis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554	Parasitic Meningitis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1555	Bacterial Meningitis (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559	Photophobia (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562	Bacteria [Causing Meningitis] (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563	Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564	Viruses [Causing Meningitis] (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1565	Viruses [Causing Meningitis] (Tests for Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1566	Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1567	Bacteria [Causing Meningitis] (Tests by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1574	Invasive Group B Streptococcus (Disorders) (ICD10CM))	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1577	Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1578	Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580	Animal Bite [Dog] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581	Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582	Animal Bite [Excluding Mammals] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584	Animal Bite [Unspecified Animal] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1585	Animal Bite [Dog] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1586	Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1587	Animal Bite [Excluding Mammals] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1588	Cadmium Exposure and Toxicity (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1594	HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1595	HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1597	HIV Infection (ARV Combination Treatment for HIV) (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1598	HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600	HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1604	Vaccine Adverse Event (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605	Vaccine Adverse Event (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606	Vaccinia disease or adverse event  (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161	Vibriosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1612	Blepharitis [Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613	Keratitis [Unspecified Cause] (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1614	Keratitis [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1618	Smallpox Vaccine (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1620	Anaphylaxis [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626	Thrombocytopenic Purpura [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1634	Sofosbuvir Velpatasvir Combination (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1640	Typhus Fever (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1641	Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1642	Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1643	Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651	Chagas Disease (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1654	Chagas Disease (Tests for Trypanosoma cruzi Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661	Cervical lymphadenopathy [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662	Conjunctival injection (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663	Drying of lips (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667	Edema of hands or feet (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1676	Tests for Acinetobacter baumannii Nucleic Acid	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1677	Tests for Pseudomonas aeruginosa by Culture and Identification Method	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1678	Tests for Pseudomonas aeruginosa Nucleic Acid	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679	Pseudomonas aeruginosa (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687	NU_Gunshot Wound (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1688	NU_Gunshot Wound (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169	Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170	Chlamydia trachomatis Infection (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700	Encephalitis [Viral] (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702	Encephalitis [Parasitic] (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712	Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714	Parasites [Causing Encephalitis] (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715	Viruses [Causing Encephalitis] (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716	Drowning and Submersion (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1717	Drowning and Submersion (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718	Motor Vehicle Injury (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1719	Motor Vehicle Injury (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720	Enterovirus Infection [Non polio] (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1721	Enterovirus Infection [Non polio] (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722	Enterovirus Infection [Non polio] (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1723	Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1725	Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1726	Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1735	Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739	Head Injury (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1740	Head Injury (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1742	Brain Injury [Traumatic] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745	Rotavirus Disease (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1746	Rotavirus Disease (Tests for Rotavirus Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748	Chemical Pneumonitis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1749	Chemical Pneumonitis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1753	Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755	Vomitus (Specimen Type) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758	Asbestosis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.176	West Nile Virus Infection (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1763	Byssinosis (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1769	Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772	Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773	CLABSI (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775	Ophthalmia neonatorum (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778	Genital herpes (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1779	Genital herpes (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1781	Herpes (Tests for Herpes simplex virus Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785	Elevated liver enzyme (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1786	Elevated liver enzyme (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1788	Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789	Granuloma Inguinale (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791	Ulcer [Genital, Perineal, or Perianal Area] (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1792	Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797	Bronchial Wash (Specimen Type) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800	Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1803	Bacteria (Tests in Sputum Specimen by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181	Coccidioidomycosis (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1819	Louseborne relapsing fever (Tests for Borrelia species)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1820	Louseborne relapsing fever (Tests for Borrelia species in Blood)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823	Borrelia species (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824	Spirochetes (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829	Polyarthritis [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835	Rheumatoid nodules (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842	Ventilator associated event (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844	Leishmaniasis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1846	Leishmaniasis (Tests for Leishmania species Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1847	Leishmaniasis (Tests for Leishmania species Antibody)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1848	Leishmania species (Tests by Microscopic Observation in Tissue)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185	Brucellosis (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864	Taeniasis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866	Taeniasis (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187	Dengue Virus Infection (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1875	Cysticercosis (Tests for Taenia solium Antibody)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878	Surgical Site Infection (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1880	Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1881	NU_Tests for Enterobacteriaceae species Nucleic Acid	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882	Carbapenemase production (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892	Toxoplasmosis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1893	Toxoplasmosis (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895	Toxoplasmosis (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1897	Toxoplasmosis (Tests by Microscopic Observation)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1898	Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1901	Toxoplasmosis (Tests for Toxoplasma gondii Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1902	Orthopox (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1908	Organisms (Tests by Electron Microscopic Observation)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1912	Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1913	Penicillin G [Procaine] [Injectable] (RXNORM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1919	Fungi [Causing Meningitis] (Tests by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923	Coronary artery aneurysm (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924	Coronary artery dilatation (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925	Ectatic coronary artery (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926	Left ventricular ejection fraction [Decreased Level] (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1927	Coronary artery aneurysm (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928	Shock (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1929	Shock (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930	Troponin [Elevated Level] (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931	Oral mucosa Inflammation (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1932	Oral mucosa Inflammation (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1933	C reactive protein (Tests by Any Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1934	Lymphocytes [Concentration] (Tests by Any Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935	Strongyloidiasis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1936	Strongyloidiasis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1937	Strongyloidiasis (Tests for Strongyloides Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1938	Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1939	Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1940	Organisms (Tests by Microscopic Observation in Stool)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941	Strongyloidiasis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942	Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943	Jamestown Canyon Virus Diseases (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1944	Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1945	Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1946	Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947	Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948	Keystone Virus Diseases (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949	La Crosse Virus Diseases (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950	Snowshoe hare Virus Diseases (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951	Trivittatus Virus Diseases (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1952	La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1953	Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1954	La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1955	Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1956	La Crosse Virus Diseases (Tests for La Crosse Virus Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1957	Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1958	Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1959	Keystone Virus Diseases (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1960	La Crosse Virus Diseases (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1961	Snowshoe hare Virus Diseases (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1962	Trivittatus Virus Diseases (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1963	Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1964	Encephalomyelitis (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1965	Encephalomyelitis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1966	Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1967	Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1968	Hepatitis D Virus Infection (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1969	Hepatitis D Virus Infection (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1970	NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1971	Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1972	Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1973	Hepatitis D Virus Infection (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1974	Baylisascariasis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1975	Baylisascariasis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1976	Baylisascariasis (Tests for Baylisascaris species Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1978	Larva Migrans (Neural, Ocular, or Visceral) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1979	Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1980	California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1981	California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1982	California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1983	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1984	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1985	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1986	Pregnant (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1987	Flank Pain (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1988	Bone Pain (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1989	Abscess (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1990	Abscess (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1991	Focal Brain Lesions (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1992	Pathologic Fractures [Unspecified Cause] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1993	Pathologic Fractures [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1994	Granulomas (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1995	Granulomas (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1996	Skin Lesions (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1997	Skin Lesions (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1998	Angiostrongyliasis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999	Lymphocytic Choriomeningitis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2000	Lymphocytic Choriomeningitis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001	Lymphocytic Choriomeningitis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2002	Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2003	Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2004	Lymphocytic Choriomeningitis (Tests for LCMV Antibody)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2005	Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2006	Angiostrongyliasis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007	Eosinophilic meningitis (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2009	Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2010	Eosinophils [Concentration] (Tests in CSF by Any Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2011	Eosinophils [Percentage] (Tests in CSF by Any Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2012	Mpox (Tests for mpox virus by Genomic Sequencing)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2013	Mpox (Test Panels for mpox virus by Genomic Sequencing)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017	Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2018	Interpretation of an Observation (High)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2019	Interpretation of an Observation (Low)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202	Trichinellosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2020	Lymphadenopathy [Acute] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023	Tick Paralysis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024	Bacillary angiomatosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025	Animal Bite or Scratch [Cat] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2026	Animal Bite or Scratch [Cat] (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027	Bartonellosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2028	Bartonellosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029	Bartonellosis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030	Bartonella henselae infection (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031	Bartonella quintana infection (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032	Bartonella bacilliformis infection (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2033	Bartonella henselae infection (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2034	Bartonella quintana infection (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036	Bartonella henselae (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037	Bartonella quintana (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038	Bartonella bacilliformis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2039	Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204	Giardiasis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2040	Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2041	Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2042	Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2043	Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2044	Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2045	Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2046	Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2047	Bartonellosis (Tests for Bartonella spp. Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2048	Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2049	Bartonella spp. (Tests by Microscopic Observation)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2050	Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2051	Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052	Echinococcosis (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2053	Echinococcosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054	Cystic Echinococcosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2055	Cystic Echinococcosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056	Alveolar Echinococcosis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2057	Alveolar Echinococcosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2058	Echinococcosis (Tests for Echinococcus species Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2059	Echinococcus species (Tests by Microscopic Observation)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060	Echinococcosis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061	Genital Warts (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062	Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2063	Genital Warts (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064	Diphyllobothriasis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2065	Diphyllobothriasis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066	Diphyllobothriasis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2067	Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068	Angiostrongyliasis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069	Pelvic Inflammatory Disease (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070	Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071	Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2072	Pelvic Inflammatory Disease (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2073	Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2074	Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075	Lower Abdominal Tenderness (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2076	Lower Abdominal Tenderness (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077	Tenderness with motion of the cervix (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078	Adnexal Tenderness (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079	Uterine Tenderness (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080	Leukocytosis (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2081	Leukocytosis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082	Purulent material in the peritoneal cavity (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083	Pelvic Abscess (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2084	Pelvic Abscess (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2085	Leukocytes [Concentration] (Tests in Blood by Any Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087	Nongonococcal Urethritis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2088	Nongonococcal Urethritis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089	Urethritis (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2090	Urethritis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091	Urethral discharge (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2092	Urethral discharge (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093	Dysuria (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2094	Dysuria (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2095	Gonorrhea (Tests for Neisseria gonorrhoeae Antigen)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096	Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098	Rhinitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2100	Rhinitis (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101	Pleuritis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2102	Pleuritis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2103	Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105	Methemoglobinemia (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106	Methemoglobinemia [Non Congenital] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2107	Methemoglobinemia (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2108	Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2109	Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative])	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110	Anencephaly (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2111	Anencephaly (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112	Fetal Anencephaly (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2113	Fetal Anencephaly (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114	Cleft Lip Alone (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2115	Cleft Lip Alone (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116	Fetal Cleft Lip (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117	Cleft Palate Alone (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2118	Cleft Palate Alone (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119	Cleft Lip with Cleft Palate (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2120	Cleft Lip with Cleft Palate (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121	Fetal Spina Bifida (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122	Spina Bifida (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2123	Spina Bifida (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124	Down Syndrome (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2125	Down Syndrome (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126	Fetal Down Syndrome (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2127	Fetal Down Syndrome (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2128	Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129	Bacteremia (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2130	Bacteremia (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131	Gastroschisis (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2132	Gastroschisis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133	Fatal Familial Insomnia (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2134	Fatal Familial Insomnia (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135	Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2136	Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137	Prion Disease (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2138	Prion Disease (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2139	Prion Disease (Tests for Abnormal PRNP Gene Variant)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140	Phenylketonuria (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2141	Phenylketonuria (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2142	Linezolid (RXNORM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2143	Tuberculosis (Pretomanid) (RXNORM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2144	Tuberculosis (Bedaquiline) (RXNORM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145	Tuberculosis [Suspected] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146	Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147	Limb Reduction (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2148	Limb Reduction (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2149	NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150	Congenital Hearing Loss (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2151	Congenital Hearing Loss (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2152	Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153	Primary Congenital Hypothyroidism (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154	Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2155	Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2156	Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2157	Mpox (Combination Tests that include mpox virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2158	Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2159	Mpox (Test Panels for mpox virus Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.216	Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody])	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2160	Orthopox (Test Panels for orthopoxvirus Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2161	COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163	Dengue Virus Infection [Suspected] (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164	Mumps [Suspected] (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165	Pertussis [Suspected] (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2166	Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2167	Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2168	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2169	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2170	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2171	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2172	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2173	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2174	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2175	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2176	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2177	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2178	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2179	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.218	Listeriosis (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2180	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2181	Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2183	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2187	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2188	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2189	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2190	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2192	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2193	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2194	Organisms (Combination Tests by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2195	Organisms (Combination Tests for Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196	Lung Tissue (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197	Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2198	Anaplasmosis (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2199	NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2200	Organisms (Tests by Animal Inoculation Method)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2201	Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202	Abnormal Lung Sounds (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2203	Abnormal Lung Sounds (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204	Anemia [Unspecified Cause] (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2205	Anemia [Unspecified Cause] (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2206	Creatinine (Tests in Serum by Any Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2207	Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2208	Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209	Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2210	Histopathology or Cytopathology Tests by Microscopic Observation	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2211	Ehrlichiosis (Tests for Ehrlichia species IgG Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212	Invasive Cronobacter Infection (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2213	Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214	Necrotizing Enterocolitis (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2215	Necrotizing Enterocolitis (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216	Abscess [Brain] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2217	Abscess [Brain] (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218	Urinary Tract Infection (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2219	Urinary Tract Infection (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220	Amniotic Fluid (Specimen Type) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221	Congenital Cytomegalovirus (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2222	Organisms (Tests in Amniotic Fluid by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2223	Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2224	Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2225	Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2226	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2227	Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2228	Congenital Cytomegalovirus (Tests for CMV Antigen)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2229	Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2230	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231	Congenital Cytomegalovirus Infection (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2232	Congenital Cytomegalovirus Infection (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233	Cytomegalovirus Disease (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2234	Cytomegalovirus Disease (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2235	Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2236	Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2237	Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2238	Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2239	Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2240	Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241	Stillbirth (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2242	Stillbirth (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2243	Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2244	Candida species (Tests by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2245	Organisms (Tests in Extrapulmonary Specimen by Culture and Identification)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2246	Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247	Extrapulmonary [NTM] (Specimen Type) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2248	Plasmodium species (Tests by Microscopic Observation)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2249	Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250	Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2251	Organisms (Tests in Sputum Specimen by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2252	Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2253	Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] )	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2254	Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255	Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256	CP_CRE (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2257	Organisms (Tests in Stool by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2258	Loss of Consciousness (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259	Neonatal Abstinence Syndrome (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226	Lyme Disease (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2260	Neonatal Abstinence Syndrome (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261	High Pitched Cry (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262	Inability to Console (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2263	Inability to Console (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264	Hypertonia (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2265	Hypertonia (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266	Tremors (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2267	Tremors (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268	Myoclonus (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2269	Myoclonus (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.227	Lyme Disease (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270	Poor Sleep (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2271	Poor Sleep (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272	Alterations in Feeding (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2273	Alterations in Feeding (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274	Excoriation (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2275	Excoriation (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276	Sneezing (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2277	Sneezing (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278	Nasal Congestion (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2279	Nasal Congestion (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280	Yawning (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281	Cutaneous Mottling (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282	Sweating (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2283	Sweating (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284	Feeding Intolerance (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2285	Feeding Intolerance (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286	Respiratory Distress or Nasal Flaring (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2287	Respiratory Distress or Nasal Flaring (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2288	In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289	In Utero Substance Exposure (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2290	In Utero Substance Exposure (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291	Childbirth (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2292	Childbirth (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2293	Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2294	NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295	Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296	NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297	Exposure or suspected exposure to harmful algae or algae toxins (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2298	Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2299	Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2300	Babesia species (Tests by Microscopic Observation)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2301	Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2302	Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2303	Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2304	Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305	Gram_negative Diplococcus (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2306	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307	D_Transposition of the Great Arteries (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308	L_Transposition of the Great Arteries (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309	Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2310	Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311	Interrupted Aortic Arch (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2312	Interrupted Aortic Arch (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313	Coarctation of the Aorta (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2314	Coarctation of the Aorta (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315	Ebstein Anomaly (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2316	Ebstein Anomaly (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317	Pulmonary valve atresia (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2318	Pulmonary valve atresia (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319	Pulmonary valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2320	Pulmonary valve stenosis (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321	Fetal Pulmonary valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322	Double Outlet Right Ventricle (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2323	Double Outlet Right Ventricle (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324	Hypoplastic left heart syndrome (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2325	Hypoplastic left heart syndrome (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326	Single Ventricle (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2327	Single Ventricle (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328	Tetralogy of Fallot (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2329	Tetralogy of Fallot (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330	Truncus Arteriosus (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2331	Truncus Arteriosus (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332	Atrioventricular septal defect (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2333	Atrioventricular septal defect (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334	Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2335	Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336	Tricuspid valve atresia (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2337	Tricuspid valve atresia (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338	Tricuspid valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2339	Tricuspid valve stenosis (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340	Fetal Tricuspid valve stenosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341	Exposure to Measles (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342	Increased Risk for Exposure to Measles (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2343	Giardiasis (Tests by Microscopic Observation)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2344	Diphtheria (Tests for Diphtheria Toxin Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2345	Lead in Blood (Tests for Lead in Venous Blood)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2346	Lead in Blood (Tests for Lead in Capillary Blood)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2347	Opioid Overdose and Poisoning (Test Panels for Opioids)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2348	Rubella (Test Panels for rubella virus IgM Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349	Consistent with Tuberculosis (Finding in Chest Xray Imaging Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2350	Acute Viral Hepatitis (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2351	Shigellosis (Combination Tests that include Shigella species by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2352	Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2353	Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2354	Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2355	Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356	Skin (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2357	Organisms (Tests by Microscopic Observation in Skin)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358	Unspecified Tissue (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2359	Organisms (Tests by Microscopic Observation in Unspecified Tissue)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2360	S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2361	S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2362	Tuberculosis (Ethambutol) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2363	Tuberculosis (Isoniazid [INH]) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364	Tuberculosis (Pyrazinamide [PZA]) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2365	Tuberculosis (Rifabutin) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2366	Tuberculosis (Rifampin) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2367	Tuberculosis (Rifapentine) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368	Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369	Necrotizing Fasciitis (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2370	Necrotizing Fasciitis (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371	Renal Impairment [Acute or Unspecified] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2372	Renal Impairment [Acute or Unspecified] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373	Coagulopathy [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2374	Coagulopathy [Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375	Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2376	Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377	Soft Tissue Necrosis (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2378	Soft Tissue Necrosis (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2379	Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2380	Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381	Specimen from a Nonsterile Site (Specimen Type) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2382	Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2383	Absence of Skin Lesions (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2384	Neuralgia (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2385	Neuralgia (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2386	Peripheral Nerve Thickening (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2387	Nerve (Specimen Type) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2388	Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.239	Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.240	Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2403	NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2404	Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2405	Hepatitis D Virus Infection (Test for hepatitis D virus Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2406	Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2407	Firearm Injury (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2408	Firearm Injury (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2409	Babesiosis (Tests for B. microti IgG or Total Antibody [Titer])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2410	Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2411	Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2412	Babesiosis (Tests for Babesia species IgG or Total Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2413	Brucellosis (Tests for Brucella species IgG Antibody by ELISA)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2414	Cranial Nerve Involvement (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2415	Cranial Nerve Involvement (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2416	Unusual Change in Behavior (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2417	Radiculitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2418	Subarachnoid Hemorrhage (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2419	Subarachnoid Hemorrhage (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2420	Discitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2421	Discitis (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2423	Respiratory Insufficiency [Unspecified Cause] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2424	Respiratory Insufficiency [Unspecified Cause] (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2425	Conjunctival Suffusion (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2426	Leptospira species (Tests by Microscopic Observation)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2427	Leptospirosis (Tests for Leptospira Antibody by Agglutination)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2428	Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2429	Conjunctival Suffusion (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2430	Pleural effusion (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2431	Pleural effusion (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2432	Abdominal swelling (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2433	Abdominal swelling (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2434	Neck swelling (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2435	Neck swelling (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2436	Diaphoresis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2437	Diaphoresis (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2438	Edema (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2439	Edema (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.244	Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2440	Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2441	Anthrax (Tests for Bacillus species by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2442	Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2443	Influenza A (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2444	Influenza B (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2445	Influenza [Unspecified] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2446	Influenza A (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2447	Influenza [Unspecified] (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2448	Influenza (Tests for unspecified influenza virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2449	Influenza (Tests for influenza B virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2450	Influenza (Tests for unspecified influenza virus Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2451	Influenza (Tests for influenza B virus Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2452	Influenza (unspecified influenza virus in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2453	Influenza (influenza B virus in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2454	Influenza (Tests for unspecified influenza virus by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2455	Influenza (Tests for influenza B virus by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2456	Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2457	Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2458	Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2459	Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2460	Borrelia species (Tests by Microscopic Observation)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2461	Borrelia species (Tests by Microscopic Observation in Blood)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2462	Spirochetes (Tests by Microscopic Observation)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2463	Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2464	CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2465	CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2466	CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2467	CRE (Tests for Enterobacterales species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2468	CRE (Combination Tests that include Enterobacterales by Culture and Identification)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2469	Tests for Carbapenem Susceptibility [Meropenem and Doripenem]	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2470	Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2471	Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2473	Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2474	Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2475	Aortic valve stenosis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2476	Aortic valve stenosis (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2477	Anotia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2478	Microtia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2479	Microtia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2480	Anotia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2482	Anophthalmia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2483	Anophthalmia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2484	Microphthalmia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2485	Microphthalmia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2486	Atrial septal defect (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2487	Atrial septal defect (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2488	Fetal Aortic valve stenosis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2489	Congenital Posterior Urethral Valves (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2490	Congenital Posterior Urethral Valves (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2491	Bladder Exstrophy (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2492	Bladder Exstrophy (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2493	Encephalocele (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2494	Fetal Encephalocele (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2495	Encephalocele (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2496	Choanal Atresia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2497	Choanal Atresia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2498	Cloacal Exstrophy (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2499	Cloacal Exstrophy (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2500	Renal Agenesis or Hypoplasia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2501	Renal Agenesis or Hypoplasia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2502	Trisomy 13 (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2503	Trisomy 13 (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2504	Fetal Trisomy 13 (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2505	Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2506	Galactosemia (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2507	Galactosemia (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2508	Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2509	Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2510	Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2511	Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2512	Galactosemia (Tests for Galactokinase (GALK) [Quantitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2513	Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2514	Galactosemia (Tests for GALT gene allele 1)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2515	Galactosemia (Tests for GALT gene allele 2)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2516	Hypospadias (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2517	Hypospadias (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2518	Trisomy 18 (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2519	Fetal Trisomy 18 (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2520	Fetal Trisomy 18 (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2521	Trisomy 18 (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2522	Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2523	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2524	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2525	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2526	Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2527	Chlamydia species [Unspecified] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2528	Ventricular septal defect (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2529	Ventricular septal defect (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2530	Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2531	Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2532	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2533	Congenital Cytomegalovirus (Tests for CMV Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.264	Viral Hemorrhagic Fever (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.265	Viral Hemorrhagic Fever (Disorders) (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.268	Mumps (Tests for mumps virus IgM Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.272	Present or Positive Lab Result Value	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.282	Varicella (Tests for Varicella zoster virus by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.283	Varicella (Tests for Varicella zoster virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.285	Encephalitis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.287	Varicella (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.289	Carbon Monoxide Poisoning (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.293	Toxic Effects of Lead (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.297	Measles (Tests for measles virus Nucleic Acid)	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.299	Measles (Tests for measles virus IgM Antibody)	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.300	Meningococcal Disease (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.301	Shigellosis (Tests for Shigella species by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.304	Pesticide Related Illness (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.305	Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.307	Leptospirosis (Tests for Leptospira IgM Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.308	Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.310	Bacteria (Tests by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.311	Viruses (Tests by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.316	Rubella (Tests for rubella virus IgM Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.317	Shigellosis (Tests for Shigella species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.319	Fungi (Tests by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.322	Pesticide Related Illness (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.326	Arboviral Disease [Other] (Disorders) (ICD10CM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.329	Apnea (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.330	Apnea (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.333	Shigellosis (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.335	Influenza (Tests for influenza A virus by Culture and Identification Method)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.336	Influenza (Tests for influenza A or B virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.340	Influenza (influenza A or B virus in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.341	Campylobacteriosis (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.342	Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.343	Campylobacteriosis (Tests for Campylobacter species Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.344	Campylobacteriosis (Tests for Campylobacter species Antigen)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.349	Hepatitis A (Tests for hepatitis A virus IgM Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.353	Diarrhea (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.356	HIV Infection (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.359	Botulism (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.362	Hansen’s Disease (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.365	Silicosis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.366	Silicosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.371	Cryptosporidiosis (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.372	Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.375	Cyclosporiasis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.376	Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.379	Giardiasis (Tests for Giardia species Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.384	Listeriosis (Tests for Listeria monocytogenes Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.386	Vibriosis (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.388	Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.390	Trichinellosis (Tests for Trichinella species Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.395	Syphilis (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.396	Syphilis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.398	Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.399	Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.40	STEC Infection (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.400	Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.401	Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.403	Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.405	Hantavirus Infection and Diseases (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.407	Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.408	Hepatitis B Virus Infection (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.422	Tuberculosis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.427	STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.43	Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.436	Coccidioidomycosis (Tests for Coccidioides species IgM Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.437	Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.438	Coccidioidomycosis (Tests for Coccidioides species Antigen)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.44	Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.445	Legionellosis (Tests for Legionella species Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.446	Legionellosis (Tests for Legionella species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.451	Tuberculosis (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.460	HIV Infection or AIDS (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.464	Malaria (Tests for Plasmodium species Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.468	Leptospirosis (Tests for Leptospira Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.471	Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.472	Leptospirosis (Tests for Leptospira Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.476	Babesia species (Tests by Microscopic Observation in Blood)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.478	Anthrax (Tests for Bacillus anthracis by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.479	Anthrax (Tests for Bacillus anthracis Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.48	Salmonellosis (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.480	Anthrax (Tests for Bacillus anthracis Antigen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.481	Anthrax (Tests for Bacillus anthracis Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.494	Ehrlichiosis (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.496	Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen])	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.500	Q Fever (Tests for Coxiella burnetii Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.505	Toxic Shock Syndrome (TSS) (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.507	Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.512	Brucellosis (Tests for Brucella species Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.515	Brucellosis (Tests for Brucella species Antibody [Quantitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.516	Brucellosis (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.519	Dengue Virus Infection (Tests for dengue virus Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.523	Dengue Virus Infection (Tests for dengue virus Antigen)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.524	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative])	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.525	Dengue Virus Infection (Tests for dengue virus IgM Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.527	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative])	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.530	Borrelia species (Tests for Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.531	Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.532	Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.534	Smallpox (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.542	Spotted Fever Rickettsiosis (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.548	St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative])	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.550	Syphilis (Tests for Treponema pallidum Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.553	Anaplasma species (Tests by Microscopic Observation)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.555	Yellow Fever (Tests for yellow fever virus Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.557	Yellow Fever (Tests for yellow fever virus Antibody [Quantitative])	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.56	Diarrhea (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.560	West Nile Virus Infection (Tests for West Nile virus Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.569	Plague (Tests for Yersinia pestis Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.575	Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.576	Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.577	Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.578	Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.579	Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.58	Pertussis (Tests for Bordetella pertussis Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.580	Arboviral Disease [Other] (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.581	Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.584	Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.586	Viral Hemorrhagic Fever (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.595	Tularemia (Tests for Francisella tularensis Nucleic Acid)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.598	Tularemia (Tests for Francisella tularensis Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.6	Diphtheria (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.605	Organisms (Tests by Microscopic Observation by Acid Fast Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.606	Tuberculosis (Organism or Substance in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.614	Pertussis (Tests for Bordetella pertussis Toxin Antibody)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.621	Inspiratory Whoop (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.632	Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.645	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.648	Vomiting (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.650	Jaundice (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.652	Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.660	Hypertonia [Excluding Congenital Hypertonia] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.662	Chest Pain (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.663	Erythema Nodosum (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.664	Congenital Zika Syndromes (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.665	Congenital Zika Syndromes (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.666	Guillain Barré syndrome (Disorders) (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.668	Rash (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.671	Fever (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.672	Arthralgia (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.673	Arthralgia (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.674	Conjunctivitis (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.675	Conjunctivitis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.676	Pregnant (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.677	Postpartum (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.678	Postpartum (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.679	Hearing Loss (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.680	Abdominal Pain (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.681	Abdominal Pain (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.686	Erythema Multiforme (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.687	Myalgia (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.689	Periorbital Edema (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.691	Eosinophilia (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.692	Eosinophilia (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.70	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.702	Weight Loss (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.705	Syphilis (Tests for Treponemal or Non Treponemal Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.709	Cough [Non Productive] (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.71	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.711	Wound Infection (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.712	Pneumonia (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.713	Sepsis [Septicemia] [Unspecified Organism] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.714	Sepsis [Septicemia] [Unspecified Organism] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.715	Meningitis (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.717	Cellulitis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.718	Cellulitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.719	Myositis [Unspecified Cause] (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.720	Myositis [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.721	Otitis Media (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.722	Otitis Media (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.723	Otitis Externa (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.724	Otitis Externa (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.727	Acute Upper Respiratory Illness (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.728	HIV Infection (Tests for HIV Nucleic Acid [Qualitative])	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.730	HIV Infection (Tests for HIV Antibody)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.733	Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.741	Hepatitis B Immune Globulin (RXNORM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.744	Coccidioidomycosis (Tests for Coccidioides species IgG Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.746	Treponema pallidum (Tests by Microscopic Observation)	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.747	Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.750	Chest Pain (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.755	Acute Upper Respiratory Illness (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.756	Purpura (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.757	Muscle Spasms (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.758	Muscle Spasms (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.762	Mumps (Test Panels for mumps virus IgM IgG Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.763	Parotitis [Unspecified Cause] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.764	Mumps (Tests for mumps virus IgG Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.765	Aseptic Meningitis (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.766	Encephalitis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.767	Hearing Loss (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.770	Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.773	Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.777	Mastitis (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.779	Pancreatitis (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.780	Pancreatitis (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.782	Rubella (Test Panels for rubella virus IgM IgG Antibody)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.785	Opioid Overdose and Poisoning (Tests for Opioids [Qualitative])	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.789	Purpura (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.79	Campylobacteriosis (Disorders) (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.792	Novel Influenza A Virus Infection (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.793	Novel Influenza A Virus Infection (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.794	Sore Throat (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.795	Influenza (influenza A virus in Lab Results)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.796	Influenza (Novel influenza A virus in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.797	Influenza (Tests for influenza A or B virus by Culture and Identification Method)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.798	Influenza (Tests for influenza A virus Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.799	Influenza (Tests for influenza A virus Antigen)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.802	Influenza (Tests for Novel influenza A virus Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.803	Tests by Microscopic Observation in Tissue by H&E or PAS Stain	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.808	Headache (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.809	Headache (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.810	Backache (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.811	Backache (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.815	NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative])	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.816	Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.818	Measles (Tests for measles virus IgG Antibody [Ratio] in Serum)	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.820	Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.822	Pneumoconiosis (Unspecified) (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.823	Pneumoconiosis (Unspecified) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.824	Computerized Tomography of Chest (Imaging)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.830	Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.835	Lead in Blood (Disorders) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.836	Lead in Blood (Disorders) (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.839	Acid Fast Bacilli (Organism or Substance in Lab Results)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.841	Tuberculosis (Interferon Gamma Release Assays)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.842	Tests by Microscopic Observation in Tissue	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.844	Tuberculosis (Second Line Drugs for Treatment) (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.846	SARS (Tests for SARS_CoV by Culture and Identification Method)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.847	SARS (Tests for SARS_CoV Nucleic Acid)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86	Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.864	Nausea (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.865	Confusion (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.867	Dyspnea (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.869	Loss of Consciousness (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.87	Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.875	SARS (Organism or Substance in Lab Results)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.878	MERS (Tests for MERS_CoV Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.88	Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.881	Difficulty Breathing (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.884	Tests by Microscopic Observation in Blood	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.889	Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.892	Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.895	Rhinorrhea (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.896	Tests by Microscopic Observation in Blood Smear	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.897	Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.9	Xray of Chest (Imaging)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.90	Cough (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.900	Organisms (Tests by Microscopic Observation)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.902	Acute Renal Failure [Unspecified Cause] (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.907	Arthritis [Unspecified Cause] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.91	Cough (SNOMED)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.910	Epididymitis [Unspecified Cause] (SNOMED)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.911	Epididymitis [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.914	Osteomyelitis [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.915	Osteomyelitis [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.918	Spondylitis [Unspecified Cause] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.919	Arthritis [Unspecified Cause] (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.92	Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.927	Thrombocytopenia [Unspecified Cause] (ICD10CM)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.928	Bleeding [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.930	ECG Abnormalities [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.931	Hematemesis [Unspecified Cause] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.932	Hematemesis [Unspecified Cause] (ICD10CM)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.934	Hematuria [Unspecified Cause] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.935	Hemoptysis (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.937	Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.942	Petechiae [Non Traumatic] (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.952	Thrombocytopenia [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.956	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.957	Regional Lymphadenitis [Including Bubo] (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.958	Regional Lymphadenitis (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.96	Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.963	Arboviral Disease [Other] (Disorders) (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.965	Proteinuria [Unspecified Cause] (ICD10CM)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.969	Proteinuria [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.970	Bulbar Weakness (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.971	Bulbar Weakness (ICD10CM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.976	Dysphagia (SNOMED)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.978	Impaired Respiration [Unspecified Cause] (SNOMED)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.979	Botulism (Organism or Substance in Lab Results)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.98	Shigellosis (Disorders) (SNOMED)	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.989	Tests for Mycobacterium species by Culture and Identification Method	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.991	Rifampin (RXNORM)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.994	Organisms (Tests for Nucleic Acid)	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.998	Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.999	Chlamydia species (Organism or Substance in Lab Results)	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.109	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.110	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.112	Pressure Injury Deep Tissue	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.113	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.119	Inpatient Falls	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.120	Major Injuries	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.122	Inpatient Falls	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.125	Bleeding at Non Critical Site	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.130	Anticoagulants for VTE Prophylaxis	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.131	Anticoagulants for Indications Other than VTE Prophylaxis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.135	Bleeding at Critical Site	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143	Bleeding at Critical Site	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.144	Bleeding at Critical Site	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.145	Bleeding at Non Critical Site	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146	Bleeding at Non Critical Site	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.160	Abdominal or Pelvic CT Scan with Contrast	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.163	Ultrasound of Lower Extremities	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.164	Ultrasound of Lower Extremities	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.165	Ultrasound of Lower Extremities	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.171	Inpatient Falls	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.183	Anti Factor Xa Assay	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.187	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.188	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.190	Intra Aortic Balloon Pump	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.191	Intra Aortic Balloon Pump	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.193	Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.194	Pressure Injury Deep Tissue Diagnoses	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.196	Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.197	Present on Admission or Clinically Undetermined	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.198	Not Present On Admission or Documentation Insufficient to Determine	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.1	DEXA Dual Energy Xray Absorptiometry, Bone Density	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.11	Bladder Cancer Staging Ta for Urology Care	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.12	Bladder Cancer staging T1 for Urology Care	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.13	Bladder Cancer staging Tis for Urology Care	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.15	Carcinoma of urinary bladder, superficial	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.16	Injection Leuprolide Acetate	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17	High grade bladder cancer Ta for Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.18	Immunocompromised state for Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.19	Systemic chemotherapy for urology care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.2	Bladder Cancer in Situ	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.20	Corticosteroids for patients receiving Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21	Calcineurin inhibitors for patients receiving Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.23	Immunomodulators for patients undergoing Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.24	Monoclonal antibody for patient undergoing Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.28	Radiotherapy for patients undergoing Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.29	Plasmacytoid cell, morphologic abnormality for urology care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.3	Bladder Cancer in Situ	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.30	Sarcomatoid, morphologic abnormality for Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.31	Micropapillary, morphologic abnormality, for Urology Care	active	2017-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.32	Immunosuppressive Drugs for Urology Care	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.38	DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39	Mixed histology urothelial cell carcinoma for Urology Care	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4	BCG Bacillus Calmette Guerin, Tice	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.40	Cystectomy for Urology Care	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.44	Unavailability of Bacillus Calmette Guerin for urology care	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.45	Bladder Cancer for Urology Care	active	2017-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.48	Androgen deprivation therapy for Urology Care	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5	BCG Bacillus Calmette Guerin, Connaught	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.52	BCG Bacillus Calmette Guerin for Urology Care	active	2020-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.53	Cystectomy for Urology Care	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.54	Acute Tuberculosis for Urology Care	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.55	Cystectomy for Urology Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.56	Active Tuberculosis for Urology Care	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.57	Bladder Cancer Staging Tis for Urology Care	active	2019-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.58	Bladder Cancer Staging Tis for Urology Care	active	2019-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.59	Hospital Services for Urology	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.6	Peripheral DXA Scan	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.60	Chemotherapy Agents for Advanced Cancer	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.8	Tuberculosis Diagnosis Prior to Urology Care	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.9	Leukemia Diagnosis Prior to Urology Care	active	2016-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.13	Preventative Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.14	Intensive Lifestyle Interventions	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.15	Intensive Lifestyle Interventions	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.16	Intensive Lifestyle Interventions	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.17	Intensive lifestyle interventions	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.21	Outpatient Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.22	Outpatient Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.23	Outpatient Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.24	Outpatient Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.25	Reason for No Intensive Lifestyle Intervention	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.27	Type 2 Diabetes Diagnoses	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.28	Type 2 Diabetes Diagnoses	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.29	Type 2 Diabetes Diagnoses	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.30	Prediabetes HbA1c Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.31	Prediabetes HbA1c Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.32	Prediabetes HbA1c Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.33	Prediabetes Oral Glucose Tolerance Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.34	Prediabetes Oral Glucose Tolerance Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.35	Prediabetes Oral Glucose Tolerance Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.36	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.37	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.38	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.4	Glycemic Screening Tests	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.40	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.41	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.42	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.43	Analgesics for Acute Pain	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.49	Medication Therapy Management Services for Essential Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.5	Glycemic Screening Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.52	Remote Physiologic Blood Pressure Monitoring	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57	Aldosterone Receptor Blocker for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58	Alpha Blocker for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.59	Angiotensin Converting Enzyme Inhibitor for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.6	Glycemic Screening Tests	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.60	Angiotensin II Receptor Blocker for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.61	Beta Blocker for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.62	Calcium Channel Blocker Dihydropyridine for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.63	Calcium Channel Blocker Non Dihydropyridine for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.64	Central Acting for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65	Direct Renin Inhibitor for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.66	Loop Diuretic for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.67	Neuronal Blocking Agent for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68	Potassium Sparing Diuretic for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.69	Thiazide Diuretic for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.7	Preventative Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70	Vasodilator for Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.73	Analgesics for Acute Pain (Non Parenteral Route)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.74	Analgesics for Acute Pain (Parenteral Route)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.75	Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.77	Antihypertensive Medication Classes	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.78	Medication Therapy Management Services for Essential Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.79	Medication Therapy Management Services for Essential Hypertension	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.8	Preventative Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.84	Renal Colic	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.85	Renal Colic	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.86	Renal Colic	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.88	Direct LDL Cholesterol	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.89	Calculated LDL Cholesterol	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.9	Preventative Clinical Encounters	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.50	Urinary retention	active	2017-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.51	Urinary retention	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.52	Urinary retention	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.65	Morbid Obesity	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.66	Morbid Obesity	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.67	Morbid Obesity	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.68	BMI greater than 40	active	2019-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.69	Morbid Obesity	active	2019-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.1	Pregnancy Status	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.10	Pap Smear Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.103	Female Sterilization HCPCS Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.105	Female Sterilization ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.109	Sterilization SNOMED Findings	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.11	HIV Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.110	Pregnancy Bundle Visits	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.111	Prenatal Care Specific Visits CPT	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.112	Prenatal Care Specific Visits HCPCS	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.113	Prenatal Care Specific Visits SNOMED	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.114	Prenatal Care Specific Visits	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.115	Self Identified Need for Contraception (SINC)	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.117	Syphilis Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.118	Infecund Not for Contraceptive Reasons CPT Procedures	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.119	Infecund Not for Contraceptive Reasons HCPCS Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.12	Human Papilloma Virus Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.120	Prenatal Care Visits CPT	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.121	Prenatal Care Visits HCPCS	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.122	Prenatal Care Visits SNOMED	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.123	Pregnancy Related Diagnoses ICD10CM	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.124	Pregnancy Related Diagnoses SNOMED	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.125	Non Live Birth Diagnoses ICD10CM	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.126	Non Live Birth Diagnoses SNOMED	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.127	Non Live Birth CPT Procedures	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.128	Non Live Birth ICD10PCS Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.129	Contraceptive Ring RXNORM Medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.13	Chlamydia Trachomatis Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.130	Contraceptive Implants RXNORM Medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.131	Injectable Contraceptive RXNORM Medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.132	Oral Contraceptive Pills RXNORM Medications	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.133	Pregnancy Related Diagnoses	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.134	Female Sterilization SNOMED Provision Procedures	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.135	General Prenatal Care Visits	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.136	Non Live Birth Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.137	Non Live Birth Diagnoses	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.138	IUD Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.139	IUD Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.14	Neisseria Gonorrhoeae Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.140	IUD Devices	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.141	Contraceptive Patch SNOMED Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.142	Female Sterilization Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.143	Live Birth Delivery CPT Procedures	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.144	Contraceptive Patch SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.145	Contraceptive Patch SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.146	Contraceptive Patch ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.147	Contraceptive Patch ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.148	Live Birth Delivery ICD10PCS Procedures	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.149	Contraceptive Patch HCPCS Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.15	Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.150	Contraceptive Patch LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.151	Infecund Not for Contraceptive Reasons Procedures	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.152	Live Birth Delivery Procedures SNOMED CT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.153	Contraceptive Ring SNOMED Surveillance Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.154	Contraceptive Ring SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.155	Contraceptive Ring SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.156	Contraceptive Ring ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.157	Contraceptive Ring ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.159	Contraceptive Ring HCPCS Devices	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.160	Contraceptive Ring LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.161	Contraceptive Implant SNOMED Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.162	Contraceptive Implant ICD10PCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.163	Contraceptive Implant SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.164	Contraceptive Implant SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.165	Infecund Not for Contraceptive Reasons SNOMED Procedures	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.167	Contraceptive Implant LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.168	Pregnancy Bundle CPT	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.169	Pregnancy Bundle HCPCS	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.17	Contraceptive Type	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.170	Contraceptive Implant ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.171	Contraceptive Implant ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.173	Contraceptive Implant HCPCS Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.174	Contraceptive Patch Devices	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.177	Live Birth Delivery Procedures	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.178	Contraceptive Ring Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.18	Contraception Not Used Reason	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.180	Contraceptive Implant CPT Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.181	Injectable Contraceptive SNOMED Surveillance Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.182	Injectable Contraceptive SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.183	Injectable Contraceptive SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.185	Injectable Contraceptive ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.186	Injectable Contraceptive ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.187	Injectable Contraceptive HCPCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.188	Injectable Contraceptive LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.189	Oral Contraceptive Pill SNOMED Surveillance Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.190	Oral Contraceptive Pill SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.191	Oral Contraceptive Pill SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.192	Contraceptive Implant SNOMED Surveillance Procedures	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.193	Oral Contraceptive Pill ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.194	Oral Contraceptive Pill ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.195	Oral Contraceptive Pill HCPCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.196	Oral Contraceptive Pill LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197	Injectable Contraceptive Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198	Injectable Contraceptive Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199	Oral Contraceptive Pill Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200	Oral Contraceptive Pill Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201	Contraceptive Implant Devices	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202	Contraceptive Implant Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203	Contraceptive Implant Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.204	Prenatal Care Bundle CPT	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.205	Prenatal Care Bundle Visits	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.206	Infecund Not for Contraceptive Reasons ICD10PCS Procedures	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209	Yes and No Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21	Contraceptive Provision Method	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210	Pap Smear Results	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.211	Contraceptive discussion	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22	Pregnancy Intention	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24	Clinical Provider Role	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.29	Insurance Coverage Type	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3	Organism Detection	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31	English Proficiency	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.76	Contraceptive Patch RXNORM Medications	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.78	Intrauterine Devices CPT Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.79	Intrauterine Devices HCPCS Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.80	Intrauterine Devices LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.81	Intrauterine Devices HCPCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.83	Intrauterine Devices ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.84	Intrauterine Devices ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.85	Intrauterine Devices RXNORM Medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86	Intrauterine Devices SNOMED Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87	Intrauterine Devices SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88	Intrauterine Device SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89	Intrauterine Devices SNOMED Surveillance Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.91	Intrauterine Devices ICD10PCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.93	Female Sterilization CPT Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96	Infecund Not for Contraceptive Reasons SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.97	Infecund Not for Contraceptive Reasons ICD10CM	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.98	Female Sterilization LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.99	Female Sterilization ICD10PCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10	ASN Screening Declined	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.11	Transportation Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.12	Food Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.13	Homelessness Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.14	Housing Instability Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16	Intervention for Positive Food Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.17	Intervention for Positive Food Insecurity Screen	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.18	Intervention for Positive Food Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19	Intervention for Positive Food Insecurity Screen	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2	Intracranial or Intraspinal surgery	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20	Intervention for Positive Homelessness Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21	Intervention for Positive Housing Instability Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.22	Emergency Department Observation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27	Mental Health Diagnosis without Substance Use Disorders	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.28	Mental Health Diagnosis without Substance Use Disorders	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29	Bed Assigned	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3	Malignant Intracranial Neoplasm Group	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31	Healthcare Agent & Power of Attorney Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.32	Healthcare Agent and Power of Attorney Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.33	Advance Directive Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34	Advance Directive Documentation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.35	Advance Directive Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.36	Portable Medical Order(s) Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37	Portable Medical Order(s) Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38	Advance Care Planning Discussion Documentation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4	Thrombolytic medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.40	Advance Care Planning Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.41	Advance Care Planning Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42	Healthcare Agent & Power of Attorney Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43	Advance Directive Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45	Advance Care Planning Documentation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.46	Advance Care Planning Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47	Portable Medical Order(s) Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48	Portable Medical Order(s) Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.49	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5	Allergy to thrombolytics	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.51	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.53	Intervention for Positive Housing Instability Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54	Intervention for Positive Housing Instability Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.55	Intervention for Positive Homelessness Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56	Intervention for Positive Homelessness Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.57	Non Invasive Oxygen Therapy Device Codes	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.58	Goals, preferences, and priorities for medical treatment	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6	Thrombolytics Adverse Event	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.7	Intraspinal surgery	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.9	Utility Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58	Food Insecurity Screening Positive	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.1	Ezetimibe Therapy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.10	Antihypertensive Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100	Allergy or Intolerance to ACE Medication	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101	Allergy or Intolerance to ARB Medication	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102	Chronic Kidney Disease Stage 1	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103	Chronic Kidney Disease Stage 2	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104	Chronic Kidney Disease Stage 3	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105	Chronic Kidney Disease Stage 4	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106	Chronic Kidney Disease Stage 5	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.107	ICD10 CM Chronic Kidney Disease Stage 1	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.108	ICD10 CM Chronic Kidney Disease Stage 2	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111	AHA GWTG Chronic Kidney Disease Stage 2	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.112	ICD10 CM Chronic Kidney Disease Stage 3	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.113	ICD10 CM Chronic Kidney Disease Stage 4	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.114	ICD10 CM Chronic Kidney Disease Stage 5	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115	AHA GWTG Chronic Kidney Disease Stage 1	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116	AHA GWTG Chronic Kidney Disease Stage 3	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117	AHA GWTG Chronic Kidney Disease Stage 4	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.118	SNOMED CT Atrial Fibrillation	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.119	ICD10 CM Atrial Fibrillation	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.121	AHA GWTG Atrial Fibrillation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.123	SNOMED CT Hyperlipidemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.124	ICD10 CM Hyperlipidemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.125	AHA GWTG Hyperlipidemia	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.126	SNOMED CT Hypertriglyceridemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.127	ICD10 CM Hypertriglyceridemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.129	AHA GWTG Hypertriglyceridemia	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.130	SNOMED CT Gestational Diabetes	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.131	ICD10 CM Gestational Diabetes	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.132	AHA GWTG Gestational Diabetes	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.133	SNOMED CT Hyperglycemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.134	ICD10 CM Hyperglycemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.135	AHA GWTG Hyperglycemia	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.136	SNOMED CT Nonobstructive CAD	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.137	ICD10 CM Nonobstructive Coronary Artery Disease	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.138	AHA GWTG Nonobstructive coronary artery disease	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.139	AHA GWTG Anti Obesity Pharmacotherapy	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15	Non Tobacco Smoking Product User	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.16	Antihypertensive Fixed Dose Combination Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2	PCSK9 Inhibitors	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.20	CCB and Thiazide and Thiazide Like Diuretics	active	2021-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21	Referral to cardiac rehab	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22	Cardiac Rehabilitation	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.25	2 Hour Blood Glucose Test	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.26	NYHA Functional Classification	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27	ARNI Therapy	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29	MRA Therapy	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.3	Cholesterol non HDL Laboratory Test	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.30	SGLT2 Inhibitors	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.31	Heart Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32	Heart Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33	Heart Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34	Allergy to MRA Therapy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.35	Aspirin or Clopidogrel	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.39	Cardiac Rehabilitation	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.4	Hypothyroidism	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40	Cardiac Rehabilitation	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43	SGLT2 Ingredients	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.44	MRA Ingredients	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.49	Minnesota Living with Heart Failure Questionnaire	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5	Hypothyroidism	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.50	Kansas City Cardiomyopathy Questionnaire	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.51	Cardiac Pacer	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52	Cardiac Pacer	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53	Cardiac Pacer	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.54	Heart Transplant Complications	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55	Heart Transplant Complications	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56	Heart Transplant Complications	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57	Left Ventricular Assist Device Complications	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58	Left Ventricular Assist Device Complications	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.59	Left Ventricular Assist Device Placement	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6	Hypothyroidism	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60	Left Ventricular Assist Device Placement	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61	Left Ventricular Assist Device Placement	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.62	Left Ventricular Assist Device Placement	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.63	Heart Transplant	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.65	Cardiac Pacer	active	2022-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.66	Diastolic Heart Failure	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67	Diastolic Heart Failure	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68	Diastolic Heart Failure	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69	Allergy to SGLT2 Inhibitors	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.7	Anorexia Nervosa	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70	Intolerance to SGLT2 Inhibitors	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71	Intolerance to MRA Therapy	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.72	ARNI Ingredient	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.73	Mitral Stenosis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74	Mitral Stenosis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75	Mitral Stenosis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.76	Mechanical Prosthetic Heart Valve	active	2022-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77	Mechanical Prosthetic Heart Valve	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78	Mechanical Prosthetic Heart Valve	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.79	Mechanical Prosthetic Heart Valve in Situ	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8	Anorexia Nervosa	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.82	Systolic Heart Failure	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83	Systolic Heart Failure	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84	Systolic Heart Failure	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.85	Carotid Intervention	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.86	Serum Creatinine	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.87	Urine Creatinine	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.88	Urine Albumin	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9	Anorexia Nervosa	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.90	Non Steroidal Mineralcorticoid Receptor Antagonist	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.91	Glucagon like peptide 1 medications	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96	AHA GWTG Long COVID19	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97	AHA GWTG Long COVID19 SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.98	AHA GWTG Long COVID19 ICD10CM	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1	Wound internal item and/or body structure visible value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11	Wound exudate appearance value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12	Wound exudate color value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13	Exudate odor value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14	Wound anatomic location value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16	Skin temperature value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17	Skin color enumerated value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18	Skin turgor value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19	Skin and mucous membrane integrity value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2	Periwound condition value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20	Skin moisture value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3	Wound Type Etiology value set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4	Wound episode value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	Abortion, Surgical Management	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.168	Abortion, Surgical Management	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.169	Abortion, Spontaneous / Miscarriage	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.170	Abortion, Spontaneous / Miscarriage	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.171	Abortion, Spontaneous / Miscarriage	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.172	Contraception, Counseling	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.173	Contraception, Counseling	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.174	Contraception, Counseling	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.175	Contraception, Counseling	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.176	Methotrexate Injection	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.177	Mifepristone	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.178	Misoprostol	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.179	Abortion Medications	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.180	Contraception, Surveillance	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.181	Contraception, Surveillance	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.182	Contraception, Surveillance	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.183	Clomiphene (Selective Estrogen Receptor Modulator / SERM)	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.184	Letrozole (Aromatase inhibitor)	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.185	Infertility, Female Medications	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.186	Infertility, Female	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.187	Infertility, Female	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.188	Infertility, Female	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.189	Infertility, Male	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.190	Infertility, Male	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.191	Infertility, Male	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.192	Infertility, All	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.193	Gender Dysphoria	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.194	Gender Identity	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.195	Intersex Surgery, History	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.196	Intersex Surgery, Non specific	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.197	Intersex Surgery, Female to Male	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.198	Intersex Surgery, Female to Male	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.199	Intersex Surgery, Female to Male	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.200	Intersex Surgery, Male to Female Sex	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.201	Intersex Surgery, Male to Female Sex	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.202	Intersex Surgery, Male to Female Sex	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.203	Intersex Surgery, All	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.204	Pregnancy Labs, Blood/Serum/Plasma/Urine	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.205	Stillbirth	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.206	Stillbirth	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.208	Sexual Orientation	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.209	Transfeminine Regimens, Antiandrogens	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.210	Transfeminine Regimens, Estrogens	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.211	Transfeminine Regimens, GnRH Agonists	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.212	Transfeminine Regimens, All	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.213	Transmasculine Regimens, Testosterone, Transdermal	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.214	Transmasculine Regimens, Testosterone, Parenteral	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.215	Transmasculine Regimens, All	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.216	Abortion, 1st Trimester	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.100	Sleep Apnea Disorders SCT	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1005	Sexual Satisfaction	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.101	Sleep Apnea Disorders ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1015	Substance Use	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1016	Tobacco Use	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.102	Sleep Apnea Disorders	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1020	Screen Time	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1022	Fluid Management	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1023	Fat Intake	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1024	Unsaturated Fat Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1025	Saturated Fat Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1026	Carbohydrate Intake	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1027	Salt Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1028	Vegetable Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1029	Fruit Intake	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103	PostTraumatic Stress Disorder PTSD	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1030	English Proficiency	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.104	PostTraumatic Stress Disorder PTSD ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1042	Neglect	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1048	Current or Former Occupation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105	PostTraumatic Stress Disorder PTSD SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1050	Work Productivity	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1053	Income Level	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1057	Caregiver Characteristics	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1058	Caregiver Availability	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1060	Living Situation	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1064	Marital or Spousal Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1065	Dependents in Home	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1068	Physical Activity Level	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1069	Leisure Activity Engagement	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1075	Exposure to Environmental Hazards	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1076	Neighborhood Safety	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1080	Experiences of Discrimination	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1082	Criminal Justice Involvement or Incarceration	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1083	Immigration Status	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.111	Creatinine in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.113	Blood Urea Nitrogen	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.114	Hemoglobin	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.118	Iron Saturation (Transferrin Saturation/TSAT)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.119	Hemoglobin A1C	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1197	Sleep Behavior	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.120	Potassium in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203	Medication Literacy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213	Elder and Child Abuse SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.122	Corrected Calcium	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229	Education Level SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.123	Phosphorus in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.126	Vitamin D Levels	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.128	KT/V Hemodialysis Ratio	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281	Elder and Child Abuse	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.129	Intact Parathyroid Hormone	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.130	Bicarbonate in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.131	Sodium in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.132	Chloride in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1336	Elder and Child Abuse ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.135	High Density Lipoprotein	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.137	Triglyceride in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1375	Tinnitus	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1377	Brain Fog	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1378	Depression Symptoms	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1379	Mood Swings	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.138	Cystatin C	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1380	Anxiety	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1381	Lightheadedness	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1382	Stress	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1383	Grief and Suffering	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1384	Insomnia and Other Sleep Difficulties	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1385	Impaired Sense of Taste	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1386	Pink Eye Diagnosis SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1387	Pink Eye Diagnosis ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1388	Pink Eye Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.139	Total Cholesterol	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1392	Lymphadenopathy Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1393	Lymphadenopathy Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1394	Lymphadenopathy Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1395	Visual Changes	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1396	Impaired Sense of Smell	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1398	Fatigue	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1399	Chills	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.140	Ferritin	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1400	Fever	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1401	Functional and Mobility Impairment	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1403	Orthostatic Intolerance	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1405	Cough	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1406	Dyspnea	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1409	Wheezing	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.141	Red Blood Cell Count (Erythrocytes)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1413	Sinonasal Congestion	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1414	Respiratory Distress	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1415	Edema	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1419	Weight Changes	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.142	White Blood Cell (Leukocytes) Count	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1422	Immunologic Changes	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1424	Pain	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1425	Arthralgia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1426	Chest Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1427	Headache	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1428	Myalgia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1429	Back Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.143	Hematocrit	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1430	Pain in Extremities	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1431	Pain in Throat	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1432	Palpitations	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1433	Tachycardia	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1434	Bleeding	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1435	Abdominal Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1436	Diarrhea	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1437	Gastroesophageal Reflux	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1438	Nausea	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1439	Vomiting	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.144	Mean Corpuscular Volume	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1440	Constipation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1441	Difficulty Swallowing	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1442	Bronchiectasis Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1443	Loss of Appetite	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1444	Paresthesia	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1445	Rash	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1446	Covid Toes (Toes and/or Fingers)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1447	Itching	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1448	Menstrual Cycle Irregularities	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1449	Lower Urinary Tract Symptoms	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.145	Mean Corpuscular Hemoglobin Concentration	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1450	Urinary Incontinence	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1451	Dizziness	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1453	Hair Loss	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1455	Disability Severity	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1456	Hypercoagulability	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1457	Post Exertional Malaise	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1458	Chronic Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1459	Neurogenic Pain	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.146	Platelet Count	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1460	Impaired Hearing	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1461	Parkinsonia Like Symptoms	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1462	Bronchiectasis Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1463	Bronchiectasis Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1464	Chronic obstructive pulmonary disease (COPD) Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1465	Chronic obstructive pulmonary disease (COPD) Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1466	Chronic obstructive pulmonary disease (COPD) Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1467	Interstitial lung disease Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1468	Interstitial lung disease Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1469	Interstitial lung disease Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.147	Erythrocyte Distribution Width	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1470	Asthma Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1471	Asthma Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1472	Asthma Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1473	Fibromyalgia Diagnosis SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1474	Fibromyalgia Diagnosis ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1475	Fibromyalgia Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1476	Herpes zoster Diagnosis ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1477	Herpes zoster Diagnosis SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1478	Herpes zoster	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1479	Pulmonary embolism Diagnosis SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.148	Platelet Distribution Width	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1480	Pulmonary embolism Diagnosis ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1481	Pulmonary embolism Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1482	Hypertension, Pulmonary Hypertension SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1483	Hypertension, Pulmonary Hypertension Diagnosis ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1484	Hypertension, Pulmonary Hypertension	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1485	Language and Speech Problems	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1486	Postural tachycardia syndrome (POTS) Diagnosis SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1487	Postural tachycardia syndrome (POTS) Diagnosis ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1488	Postural tachycardia syndrome (POTS) Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1489	Functional disorder of gastrointestinal tract Diagnosis SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.149	Platelet Mean Volume	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1490	Functional disorder of gastrointestinal tract Diagnosis ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1491	Functional disorder of gastrointestinal tract Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1492	Autonomic dysfunction	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1496	Mast Cell Activation Syndrome (MCAS) Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1497	Mast Cell Activation Syndrome (MCAS) Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1498	Mast Cell Activation Syndrome (MCAS) Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.150	Estimated Average Glucose	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1500	Debility or Frailty SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1501	Debility or Frailty ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1502	Debility or Frailty	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1503	Ehlers Danlos syndrome (EDS) Diagnosis SCT	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1504	Ehlers Danlos syndrome (EDS) Diagnosis ICD10	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1505	Ehlers Danlos syndrome (EDS) Diagnosis	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1506	Malnutrition Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1507	Malnutrition Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1508	Narcolepsy Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1509	Narcolepsy Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.151	Albumin in Blood, Plasma, or Serum	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1510	Narcolepsy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1514	Small Fiber Neuropathy Diagnosis SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1515	Small Fiber Neuropathy Diagnosis ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1516	Small Fiber Neuropathy Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1517	Malnutrition Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1518	Neuropathy Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1519	Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1520	Multisystem Inflammatory Syndrome in Adults (MIS A) ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1521	Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1522	Congestive heart failure Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1523	Congestive heart failure Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1524	Congestive heart failure Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1525	Cognitive disorder Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1526	Cognitive disorder SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1527	Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1529	Post Acute Sequelae of Sars Cov 2 infection (PASC) ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.153	Anion Gap	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1530	Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1531	Hypertension, Persistent SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1532	Acute Renal Failure Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1533	Acute Renal Failure Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1534	Acute Renal Failure Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1535	Complication due to Diabetes Mellitus Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1536	Complication due to Diabetes Mellitus Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1537	Complication due to Diabetes Mellitus Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1538	Coronary Revascularization History SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1539	Coronary Revascularization History ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.154	Urine Urea Nitrogen	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1540	Coronary Revascularization History	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1541	Heart Failure Diagnosis SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1542	Heart Failure Diagnosis ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1543	Heart Failure Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1547	Hypertension, Primary and Secondary Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1548	Cerebrovascular Disease Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1549	Cerebrovascular Disease Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.155	Bone Density	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1550	Migraine Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1551	Migraine Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1552	Migraine Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1553	Chronic Tension type Headache Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1554	Chronic Tension type Headache Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1555	Chronic Tension type Headache Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1556	Low Back Pain SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1557	Low Back Pain ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1558	Low Back Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1559	Metabolic Syndrome Diagnosis SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.156	Bone Survey X Rays	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1560	Metabolic Syndrome Diagnosis ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1561	Metabolic Syndrome Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1562	Hypertension, Persistent ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1563	Hypertension, Persistent	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1564	Pregnancy SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1565	Pregnancy ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1566	Pregnancy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1568	Low Density Lipoprotein	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1569	Physical findings of the abdomen	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.157	Chronic Kidney Disease All Stages (1 through 5) SNOMED	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1571	Chest US	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1572	Sleep Disorder Assessment	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1573	Cerebral Spinal Fluid (CSF) Analysis	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1574	Comprehensive Metabolic Panel (CMP)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1575	Arterial Blood Gas (ABG)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1576	Coagulation Assay (PT, aPTT, Fibrinogen)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1577	D Dimer Test	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1578	Procalcitonin in Blood, Serum, or Plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1579	Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.158	Chronic Kidney Disease All Stages (1 through 5) ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1580	COVID 19 (SARS CoV 2), SARS CoV, Influenza virus A and B Tests	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1581	Microorganisms Detection by Blood Culture	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1582	Microorganisms Detection by Sputum Culture	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1583	Cystography	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1584	Cognitive Health Related Questionnaire Panel Codes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1585	Alcohol Use Related Questionnaire Panel Codes	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1586	Functional Status Related Questionnaire Panel Codes	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1587	Kidney Disease Related Questionnaire Panel Codes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1588	Long Covid Related Questionnaire Panel Codes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1589	Nutrition Status Related Questionnaire Panel Codes	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.159	Chronic Kidney Disease All Stages (1 through 5)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1590	Pain Perception Related Questionnaire Panel Codes	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1591	Patient Goal Related Questionnaire Panel Codes	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1592	Social Determinant of Health Related Questionnaire Panel Codes	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1593	Covid 19 Related Health Questionnaire Panel Codes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1594	Caregiver Considerations Related Questionnaire Panel Codes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1595	Acute COVID 19 Diagnosis SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1597	Drugs of Abuse Screen	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1598	Criminal Justice Involvement or Incarceration History	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1599	Cardiomyopathy Diagnosis SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1600	Cardiomyopathy Diagnosis ICD10	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1601	Atherosclerotic Cardiovascular Disease SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1602	Neuropathy Diagnosis ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1603	Neuropathy Diagnosis SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1605	Left Ventricular Hypertrophy ICD10	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1606	Left Ventricular Hypertrophy	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1607	Alanine Aminotransferase (ALT) in Blood, Plasma, or Serum	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1608	Aspartate Aminotransferase (AST) in Blood, Plasma, or Serum	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1609	Erythrocyte Sedimentation Rate (ESR) in Blood	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1610	Oxygen Saturation in Blood	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.176	Urine Sediment	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.179	Estimated Glomerular Filtration Rate (eGFR)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.22	Alcohol Use Disorder SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.23	Alcohol Use Disorder ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24	Alcohol Use Disorder	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.25	Peripheral Vascular Disease SCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.26	Peripheral Vascular Disease ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.27	Peripheral Vascular Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.28	Hepatitis C Condition SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.30	Hepatitis C Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.31	Diabetic Neuropathy SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.32	Diabetic Neuropathy ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.33	Diabetic Neuropathy Conditions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.35	Obesity ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.36	Obesity Conditions	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.37	Obesity SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.4	Chronic Kidney Disease Type or Cause SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.41	Tuberculosis (Disorders) SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.417	Prediabetes (Borderline Diabetes)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.418	Prediabetes (Borderline Diabetes)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.419	Prediabetes (Borderline Diabetes)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.420	Maturity Onset Diabetes of the Young (MODY)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.43	Tuberculosis Disorders	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.44	Tuberculosis (Disorders) Ext	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.45	Hypoalbuminemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.450	CKD Progression Risk	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.46	Hypoalbuminemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.47	Hypoalbuminemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.48	Hyperkalemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.480	Diabetic Coma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.481	Diabetic Coma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.482	Diabetic Coma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.49	Hyperkalemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.490	Diabetic Peripheral Angiopathy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.491	Diabetic Peripheral Angiopathy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.492	Diabetic Peripheral Angiopathy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.496	Cataract of the Eye	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.497	Cataract of the Eye	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.498	Cataract of the Eye	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.499	Rubeosis Iridis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.5	Chronic Kidney Disease Type or Cause ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.50	Hyperkalemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.500	Rubeosis Iridis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.501	Rubeosis Iridis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.502	Rubeosis Iridis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.506	Emotional Distress caused by Chronic Condition	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.507	Emotional Distress caused by Chronic Condition	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.508	Emotional Distress caused by Chronic Condition	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.51	Anemia Conditions SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.510	Hypoglycemic Event	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.512	Hypoglycemic Event	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.513	Hypoglycemic Event	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.514	Hypoglycemia Unawareness	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.515	Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.516	Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.517	Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.518	Ketoacidosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.519	Ketoacidosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.52	Anemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.520	Ketoacidosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.521	Diabetic Foot	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.522	Diabetic Foot	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.523	Diabetic Foot	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.524	Diabetic Foot Ulcer	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.525	Diabetic Foot Ulcer	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.526	Diabetic Foot Ulcer	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.529	Charcot Foot	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.53	Anemia Conditions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.530	Charcot Foot	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.531	Charcot Foot	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.533	Cellulitis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.535	Diabetic Hand or Diabetic Cheiroarthropathy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.538	Necrobiosis Lipoidica (Skin Lesions)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.539	Necrobiosis Lipoidica (Skin Lesions)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.540	Necrobiosis Lipoidica (Skin Lesions)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.541	Gangrene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.542	Gangrene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.543	Gangrene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.544	Dupuytren's Contracture	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.545	Dupuytren's Contracture	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.546	Dupuytren's Contracture	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.547	Scleroderma or Thick Skin Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.548	Scleroderma or Thick Skin Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.549	Scleroderma or Thick Skin Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.554	Acanthosis Nigricans	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.555	Acanthosis Nigricans	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.556	Acanthosis Nigricans	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.557	Eruptive Xanthomatosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.558	Periodontitis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.559	Periodontitis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.560	Periodontitis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.561	Amputated Limb (Not Traumatic)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.562	Amputated Limb (Not Traumatic)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.563	Amputated Limb (Not Traumatic)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.564	Hypertension, Essential or Primary ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.565	Hypertension, Essential or Primary SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.567	Hypertension, Secondary ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.568	Hypertension, Secondary SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.571	Hypertension Stage	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.579	Cardiomyopathy	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.58	Hypercalcemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.580	NYHA Heart Failure Functional Classifications	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.581	American Heart Association Heart Failure Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.582	Framingham Risk Assessments	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.583	American College of Cardiology or American Heart Association Ascvd Risk Score (acc/aha Ascvd Risk)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.584	Atherosclerotic Cardiovascular Disease	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.586	Gout	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.587	Psoriatic Arthritis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.588	Reactive Arthritis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.59	Hypercalcemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.590	Experience of Traumatic Events	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.591	Cannabis Use	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.592	Hearing Impairment	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.6	Chronic Kidney Disease Type or Cause	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.60	Hypercalcemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.606	Angina	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.607	Angina	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.608	Angina	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.609	Unstable Angina	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.61	Hypocalcemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.610	Unstable Angina	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.611	Unstable Angina	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.613	Ischemic Heart Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.614	Ischemic Heart Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.615	Left Ventricular Hypertrophy SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.616	Stroke History	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.618	Stroke	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.619	Transient Ischemic Attack	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.62	Hypocalcemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.620	Transient Ischemic Attack	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.621	Transient Ischemic Attack	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.625	Aneurysm	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.626	Aneurysm	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.627	Aneurysm	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.63	Hypocalcemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.634	Aortic Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.635	Aortic Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.636	Aortic Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.637	Carotid Stenosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.638	Carotid Stenosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.639	Carotid Stenosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.64	Hyperphosphatemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.640	Intracranial Stenosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.641	Intracranial Stenosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.642	Intracranial Stenosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.643	Pulmonary Edema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.644	Pulmonary Edema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.645	Pulmonary Edema	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.646	Osteoarthritis (Oa)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.647	Osteoarthritis (Oa)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.648	Osteoarthritis (Oa)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.649	Rheumatoid Arthritis (Ra)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.65	Hyperphosphatemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.650	Rheumatoid Arthritis (Ra)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.651	Rheumatoid Arthritis (Ra)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.652	Infectious Arthritis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.653	Infectious Arthritis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.654	Infectious Arthritis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.656	Temporomandibular Disorder Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.658	Irritable Bowel Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.659	Irritable Bowel Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.66	Hyperphosphatemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.660	Irritable Bowel Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.661	Neuropathic Pain (Neuralgia)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.662	Neuropathic Pain (Neuralgia)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.663	Neuropathic Pain (Neuralgia)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.664	Neuromas	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.665	Neuromas	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.666	Neuromas	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.667	Phantom Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.668	Phantom Pain	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.669	Phantom Pain	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.67	Hematuria Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.670	Entrapment Neuropathy	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.671	Entrapment Neuropathy	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.672	Entrapment Neuropathy	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.673	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.674	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.675	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.676	Psychotic Depression	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.677	Psychotic Depression	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.678	Psychotic Depression	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.679	Post Partum Depression	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.68	Hematuria Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.680	Post Partum Depression	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.681	Post Partum Depression	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.682	Seasonal Affective Disorder	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.683	Seasonal Affective Disorder	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.684	Seasonal Affective Disorder	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.685	Psychological Trauma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.686	Psychological Trauma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.687	Psychological Trauma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.688	Grief or Loss	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.689	Grief or Loss	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.69	Hematuria Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.690	Grief or Loss	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.691	Suicide Risk	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.692	Suicide Risk	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.693	Suicide Risk	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.694	Vaping	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.695	Vaping	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.696	Vaping	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.697	Tobacco Use or Exposure	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.699	Tobacco Use or Exposure	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.70	Metabolic Acidosis Conditions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.701	Binge Drinking	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.702	Binge Drinking	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.703	Binge Drinking	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.704	Drug Misuse	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.705	Drug Misuse	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.706	Drug Misuse	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.707	Drug Misuse	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.708	Sensory Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.709	Sensory Status	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.71	Metabolic Acidosis Conditions ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.711	Fall Risk	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.713	Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.714	Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.715	Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.716	Urinary Incontinence	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.717	Urinary Incontinence	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.718	Urinary Incontinence	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.719	Urinary Urgency	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.72	Metabolic Acidosis Conditions SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.720	Urinary Urgency	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.721	Urinary Urgency	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.722	Urinary Frequency	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.723	Urinary Frequency	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.724	Urinary Frequency	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.725	Nocturia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.726	Nocturia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.727	Nocturia	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.728	Pelvic Organ Prolapse	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.729	Pelvic Organ Prolapse	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.73	Hyperlipidemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.730	Pelvic Organ Prolapse	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.731	Erectile Dysfunction	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.732	Erectile Dysfunction	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.733	Erectile Dysfunction	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.734	Interstitial Cystitis or Bladder Pain Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.735	Interstitial Cystitis or Bladder Pain Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.736	Interstitial Cystitis or Bladder Pain Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.737	Recurrent Urinary Tract Infections	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.738	Recurrent Urinary Tract Infections	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.739	Recurrent Urinary Tract Infections	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.74	Hyperlipidemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.740	Hypertriglyceridemia	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.741	Hypertriglyceridemia	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.742	Hypertriglyceridemia	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.743	Hypothyroidism	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.744	Hypothyroidism	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.745	Hypothyroidism	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.746	Menopause	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.747	Menopause	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.748	Menopause	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.749	Testicular Hypofunction	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.75	Hyperlipidemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.750	Testicular Hypofunction	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.751	Testicular Hypofunction	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.752	Primary Aldosteronism	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.753	Primary Aldosteronism	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.754	Primary Aldosteronism	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.755	Restless Leg Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.756	Restless Leg Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.757	Restless Leg Syndrome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.759	Claudication	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.76	Chronic Pain Conditions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.760	Claudication	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.761	Claudication	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.762	Angioedema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.763	Angioedema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.764	Angioedema	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.768	Nonalcoholic Fatty Liver Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.769	Nonalcoholic Fatty Liver Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.77	Chronic Pain ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.770	Nonalcoholic Fatty Liver Disease	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.771	Thalassemia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.772	Thalassemia	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.773	Thalassemia	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.78	Chronic Pain SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.79	Arthritis Disorders SCT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.790	Urine Protein to Creatinine Ratio (UPCR)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.791	24 Hour Urine Volume	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.792	24 Hour Urine Protein Excretion	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.793	Total Carbon Dioxide or Bicarbonate in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.794	Calcium (Not Corrected for Serum Albumin) in Blood, Plasms, or Serum	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.795	B Type Natriuretic Peptide [Bnp] in Blood, Serum or Plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.797	N Terminal Pro_B_Type Natriuretic Peptide [Nt_Probnp] in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.799	Temporomandibular Disorder Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.80	Arthritis Disorders ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.800	Temporomandibular Disorder Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.801	High Sensitivity Troponin	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.804	Aspartate Transaminase or Alanine Aminotransferase Ratio	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.805	Alkaline Phosphatase (Alp) in Blood, Serum or Plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.806	Gamma Glutamyl Transpeptidase (Ggt) in blood, serum or plasma	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.807	Triiodothyronine in serum or plasma	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.808	Fasting Blood Glucose	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.809	Random Blood Glucose Test	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.81	Arthritis Disorders	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.810	Uric Acid (Urate) in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.811	Aldosterone/Renin Ratio	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.812	Serum Rheumatoid Factor	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.813	Blood Ethanol Level	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.814	Drugs of Abuse Screen in Hair	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.815	Drugs of Abuse Screen in Urine	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.816	Drugs of Abuse Screen in Blood	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.817	Drugs of Abuse Screen in Tissue	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.818	Drugs of Abuse Screen in Body Fluid	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.819	Urea Reduction Ratio	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.82	Preeclampsia Disorders SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.822	Bowel Sounds	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.823	Uroflowmetry	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.826	Gait Quality	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.828	Balance Assessments	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.83	Preeclampsia Disorders ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.836	Sit to Stand Ability	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.84	Preeclampsia Disorders	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.840	Spinal Cord Compression	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.841	Spinal Cord Compression	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.842	Alcohol Use (Revised 2021)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.843	Alcohol Use (Revised 2021)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.844	Alcohol Use (Revised 2021)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.845	Alcohol Use	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.85	Hyperuricemia Conditions	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.86	Hyperuricemia Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.864	Kidney Biopsy Report	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.867	Skin Biopsy Report	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.868	Muscle Biopsy Report	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.869	Gastric Tissue Biopsy Report	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.87	Hyperuricemia Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.870	Bone Biopsy Report	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.873	Echocardiogram	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.88	Vitamin D Deficiency Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.880	Spinal or Back CT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.881	Chest CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.882	Abdominal or Pelvic CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.883	Limb CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.884	Heart Calcium Score	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.885	Coronary CT Angiogram	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.886	Limb CT Angiogram	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.888	Chest CT Angiogram	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.889	Head and Neck CT Angiogram	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.89	Vitamin D Deficiency Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.891	Gastrointestinal Tract X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.892	Gallbladder X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.893	Kidney X Ray	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.894	Abdomen X Ray	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.895	Pelvis X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.896	Hand X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.897	Wrist X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.898	Forearm X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.899	Elbow X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.90	Vitamin D Deficiency Conditions	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.900	Upper Arm X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.901	Shoulder X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.902	Upper Extremity X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.903	Foot X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.904	Ankle X Ray	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.905	Shin X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.906	Knee X Ray	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.907	Thigh X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.908	Hip X Ray	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.909	Lower Extremity X Ray	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.91	Alkaline Phosphatase Deficiency Conditions SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.910	Abdominal MRI	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.911	Adrenal Gland MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.912	Kidney MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.913	Pancreas MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.915	Kidney MRA	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.916	Chest Region MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.917	Pulmonary MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.918	Cardiac MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.92	Alkaline Phosphatase Deficiency Conditions ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.920	Spine MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.921	Head and Neck MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.922	Brain MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.923	Pelvic Region MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.924	Knee MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.925	Foot MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.927	Shoulder MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.928	Lower Extremity MRA	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.93	Alkaline Phosphatase Deficiency Conditions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.930	Spine X Ray	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.933	Hip MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.934	Thigh or Femur MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.935	Ankle MRI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.936	Lower Extremity MRI	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.937	Forearm MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.938	Elbow MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.939	Wrist MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.94	Uremic Pruritus Conditions ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.940	Hand MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.942	Upper Extremity MRI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.943	Abdominal MRA	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.944	Chest MRA	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.945	Upper Extremity MRA	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.947	Head and Neck MRA	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.948	Pelvic Region MRA	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.949	Functional MRI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.95	Uremic Pruritus Conditions SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.951	Optical Coherence Tomography	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.954	Bathing or grooming/hygiene (ADL/IADL)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.955	Dressing (ADL or IADL)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.956	Toileting (ADL or IADL)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.957	Transferring (ADL or IADL)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.958	Walking or ambulation/locomotion (ADL/IADL)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.96	Uremic Pruritus Conditions	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.960	Domestic Duties or Household Tasks (ADL/IADL)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.961	Telephone Use (ADL or IADL)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.962	Bed Mobility (ADL or IADL)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.963	Stair Use (ADL or IADL)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.964	Medication Management (ADL or IADL)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.967	Electromyography	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.968	Electroencephalogram	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.969	Exercise Stress Test	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.97	Insomnia Disorders	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.976	Sleep Duration, Device	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.977	Steps Per Time, Device	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.978	Physical Activity Level, Device	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.979	Cognitive Function Clinician Interpretation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.98	Insomnia Disorders ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.987	Psychosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.99	Insomnia Disorders SCT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.991	Suicidal Ideation and Behaviors	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.994	Sleep Duration	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.996	Pain Intensity or Severity	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.997	Pain Quality	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.4	Glaucoma ICD10	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.5	Glaucoma SNOMED	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.1	Scleritis	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.2	Scleritis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.3	Scleritis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.1	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.2	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Non Diagnostic or Non CT	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.3	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Nuclear Medicine With CT	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.4	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography CT Without Specified Body Region	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.6	Outpatient Encounter Locations	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.7	Outpatient Activity Codes	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.6	Anaphylaxis, ICD10CM codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.60	Guillain Barre Syndrome, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.61	Febrile seizure, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.62	Encephalomyelitis and encephalitis, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.63	Disseminated Intravascular Coagulation, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.64	Deep Vein Thrombosis, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.65	Bells Palsy, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.66	Appendicitis, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.67	Anaphylaxis, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.68	Acute Myocardial Infarction, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.69	Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.7	Anaphylaxis, SNOMED codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.70	Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.71	Transfusion CPT codes for exposure identification	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.72	Transfusion ICD9 codes for exposure identification	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.73	Transfusion ICD10PCS codes for exposure identification	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.74	Transfusion CPT, ICD9, ICD10PCS codes for exposure identification	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75	COVID19 vaccine ICD10PCS codes for exposure identification	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.8	Appendicitis, SNOMED codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.9	Appendicitis, ICD10CM codes for AE reporting	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.1	Test Diabetes codes	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.100	Cardiomyopathy Hypertrophic Condition	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.12	Metabolic Syndrome LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.15	MetabolicSyndromeCondition	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.16	Annual Physical ICD9 CN5	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.164	Diabetic Retinal Screening HD CPT for Tax Pair	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.165	Optometrist and Ophthalmologist Taxonomy HD Taxonomy	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.167	End Stage Renal Disease (ESRD)_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.168	End Stage Renal Disease (ESRD)_HD_ICD9	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.169	End Stage Renal Disease (ESRD)_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.17	Annual Physical ICD10 CN5	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.170	End Stage Renal Disease (ESRD)_HD_HCPCS	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.171	End Stage Renal Disease (ESRD)_HD_LOINC	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.172	End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.173	Systolic Blood Pressure_HD_SNOMED	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.174	Systolic Blood Pressure_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.175	Systolic Blood Pressure_HD_LOINC	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.176	Systolic Blood Pressure_HD	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.177	Diastolic Blood Pressure_HD_SNOMED	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.178	Diastolic Blood Pressure_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.179	Diastolic Blood Pressure_HD_LOINC	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.18	Annual Physical SNOMED CN5	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.180	Diastolic Blood Pressure_HD	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.181	Remote Blood Pressure_HD_SNOMED	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.182	Remote Blood Pressure_HD	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.183	Remote Blood Pressure_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.184	Acute Inpatient_CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.185	Acute Inpatient_CN_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.186	Acute Inpatient_HD_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.187	ED Visit_CN_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.188	ED Visit_CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.19	Annual Physical Taxonomy CN5	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.190	Pregnancy_HD_Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.191	Pregnancy_CN_HD_SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.192	Pregnancy_CN_HD_ICD10	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.193	ED Visit_HD_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.194	Lipid Panel_Event_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.195	Lipid Panel_Event_HCPCS	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.196	Lipid Panel_Event_LOINC	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.197	Lipid Panel_Event_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.198	Lipid Panel_Event_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.199	Unknown Glucose_Event_ICD9	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.20	Annual Physical CN5	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.200	Unknown Glucose_Event_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.201	Unknown Glucose_Event_LOINC	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.202	Unknown Glucose_Event_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.203	Unknown Glucose_Event_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.204	Unknown Glucose_Lab_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.205	Bone Marrow Transplant CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.206	Bone Marrow Transplant CN_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.207	Bone Marrow Transplant_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.208	Immunocompromising Conditions CN_HD_ICD9	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.209	Immunocompromising Conditions CN_HD_ICD10PCS	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.21	Annual Physical CPT CN5	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.210	Immunocompromising Conditions CN_HD_ICD10CM	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.211	Immunocompromising Conditions_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.212	Immunocompromising Conditions CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.213	Cerebrospinal Fluid Leak CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.214	Cerebrospinal Fluid Leak CN_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.215	Cerebrospinal Fluid Leak_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.216	Anatomic or Functional Asplenia CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.217	Anatomic or Functional Asplenia CN_HD_ICD9	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.218	Anatomic or Functional Asplenia CN_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.219	Anatomic or Functional Asplenia_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.22	Annual Physical HCPCS CN5	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.220	Sickle cell Anemia and HB S Disease CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.221	Sickle cell Anemia and HB S Disease CN_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.222	Sickle cell Anemia and HB S Disease_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.223	Pneumococcal Vaccine CN_HD_SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.224	Pneumococcal Vaccine CN_HD_HCPCS	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.225	Pneumococcal Vaccine CN_HD_CVX	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.226	Pneumococcal Vaccine CN_HD_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.227	Pneumococcal Vaccine_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228	Influenza Vaccine CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.229	Influenza Vaccine CN_HD_HCPCS	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.23	Annual Physical CPT for Tax Pair CN5	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.230	Influenza Vaccine CN_HD_CVX	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231	Influenza Vaccine CN_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232	Influenza Vaccine_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.233	Cochlear Implant CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.234	Cochlear Implant CN_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.235	Cochlear Implant CN_HD_HCPCS	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.236	Cochlear Implant CN_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.237	Cochlear Implant_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.238	Chemotherapy CN_HD_SNOMED	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.239	Chemotherapy CN_HD_ICD10	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.24	Annual Physical ICD9 for Tax Pair CN5	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.240	Chemotherapy CN_HD_CPT	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.241	Chemotherapy_HD_CN_Grouping	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.244	Fasting Blood Glucose_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.245	Chronic Heart Failure (CHF)_ICD9	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.246	Chronic Heart Failure (CHF)_ICD10	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.251	Asthma_LOINC	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.253	Asthma_Clinical Condition Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.254	Pregnancy Loss_HD_SNOMED	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.255	Pregnancy Loss_HD_ICD10	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.257	Pregnancy Loss_HD_Clinical Condition Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.258	Heart Failure (CHF)_ICD9	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.259	Heart Failure (CHF)_ICD10	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.260	Heart Failure (CHF)_SNOMED	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.261	Heart Failure (CHF)_HCPCS	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.262	Heart Failure (CHF)_LOINC	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.263	Heart Failure (CHF)_CPT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.264	Heart Failure (CHF)_RxNorm	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265	Heart Failure (CHF)_Clinical Condition Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.270	Triglyceride_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.274	Total Cholesterol_CPT	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.275	Total Cholesterol_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.276	LDL_SNOMED	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.280	LDL_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.284	HDL_LOINC	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.285	HDL_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.286	Colectomy_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.288	Colectomy_ICD9	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.29	Hospice Exclusions Grouping	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.290	Colectomy_Event_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.291	CT Colonography_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.292	CT Colonography_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.294	CT Colonography_Event_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.295	FIT DNA_LOINC	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.296	FIT DNA_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.297	FIT DNA_HCPCS	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.298	FIT DNA_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.299	FIT DNA Test_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.30	Annual Physical Codes for Tax Pair CN5	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.300	Sigmoidoscopy_CPT	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.302	Sigmoidoscopy_ICD9	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.303	Sigmoidoscopy_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.304	Sigmoidoscopy_Event_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.305	Colonoscopy_CPT	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.306	Colonoscopy_HCPCS	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.307	Colonoscopy_ICD9	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.308	Colonoscopy_SNOMED	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.309	Colonoscopy_Event_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.310	FOBT Lab_CPT	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.311	FOBT Lab_HCPCS	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.312	FOBT Lab_LOINC	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.313	FOBT Lab_SNOMED	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.314	FOBT Lab Test_Lab_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.315	Colorectal Cancer_HD_ICD10	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.316	Colorectal Cancer_HD_ICD9	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.317	Colorectal Cancer_HD_SNOMED	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.318	Colorectal Cancer_HD_Grouping	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.319	Absence of Cervix Diagnosis_HD_ICD10	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.320	Absence of Cervix Diagnosis_HD_ICD9	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.321	Absence of Cervix Diagnosis_HD_SNOMED	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.322	Absence of Cervix Diagnosis_HD_Grouping	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.323	Hysterectomy With No Residual Cervix_HD_CPT	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.324	Hysterectomy With No Residual Cervix_HD_ICD10	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.325	Hysterectomy With No Residual Cervix_HD_ICD9	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.326	Hysterectomy With No Residual Cervix_HD_SNOMED	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.327	Hysterectomy With No Residual Cervix_HD_Grouping	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328	High Risk HPV Test_HD_CPT	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329	High Risk HPV Test_HD_HCPCS	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330	High Risk HPV Test_HD_LOINC	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331	High Risk HPV Test_HD_SNOMED	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332	High Risk HPV Test_HD_Grouping	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.333	Cervical Cytology_HD_CPT	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.334	Cervical Cytology_HD_HCPCS	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.335	Cervical Cytology_HD_LOINC	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.336	Cervical Cytology_HD_SNOMED	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.337	Cervical Cytology_HD_Grouping	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.338	AFib (Atrial Fibrillation)_ICD9	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.339	AFib (Atrial Fibrillation)_ICD10	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.340	AFib (Atrial Fibrillation)_SNOMED	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.341	AFib (Atrial Fibrillation)_LOINC	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342	AFib (Atrial Fibrillation)_RxNORM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.343	AFib (Atrial Fibrillation)_CPT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.344	AFib (Atrial Fibrillation)_Clinical Condition Grouping	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.345	COVID19 Vaccine_CPT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.346	COVID19 Vaccine_HCPCS	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348	COVID19 Vaccine_RxNorm	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.349	COVID19 Vaccine_CVX	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350	COVID19 Vaccine_Event Clinical Grouping	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.351	Coronary Artery Disease (CAD)_ICD9	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.352	Coronary Artery Disease (CAD)_ICD10PCS	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.353	Coronary Artery Disease (CAD)_ICD10CM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.354	Coronary Artery Disease (CAD)_CPT	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.355	Coronary Artery Disease (CAD)_HCPCS	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.356	Coronary Artery Disease (CAD)_LOINC	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.357	Coronary Artery Disease (CAD)_SNOMED	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.358	Coronary Artery Disease (CAD)_CUI_UMLS	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.359	Coronary Artery Disease (CAD)_Clinical Condition Grouping	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.360	Allergy List_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.361	Allergy List_ICD10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.362	Allergy List_Clinical Grouping Event	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.363	Statin Use_RxNorm	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.364	Other Revascularization_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.365	Other Revascularization_CPT	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.366	Other Revascularization_Grouping	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.367	Ischemic Vascular Disease (IVD)_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.368	Ischemic Vascular Disease (IVD)_ICD10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.369	Ischemic Vascular Disease (IVD)_Grouping	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.370	Muscular Pain and Disease_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.371	Muscular Pain and Disease_ICD10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.372	Muscular Pain and Disease_Grouping	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.373	Cirrhosis_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.374	Cirrhosis_ICD10	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.375	Cirrhosis_Grouping	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.376	IVF_SNOMED	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.377	IVF_HCPCS	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.378	IVF_Grouping	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.379	Estrogen Agonists Medications_RXNORM	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.382	Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.384	Family History Hypertension (HTN)_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.385	Family History Hypertension (HTN)_Clinical Condition Grouping	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.386	Obesity_Condition_UMLS	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.387	Podiatry_Taxonomy	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.388	Cardiology _Taxonomy	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.393	BMI >=40_Event_Clinical Condition Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.400	Smoker Status_Event_Clinical Condition Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.401	First Trimester_ICD10	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.402	First Trimester_SNOMED	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.403	First Trimester_LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.404	First Trimester_CPT	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.405	First Trimester_UMLS CUI	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.406	First Trimester_Clinical Grouping Event	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.408	Birth Event_ICD10	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.409	Birth Event_SNOMED	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.413	Birth Event_Clinical Grouping Event	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.414	Obesity_Condition_SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.415	Obesity_Condition_ICD10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.416	Obesity_Condition_ICD9	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.417	Obesity_Clinical Grouping Condition	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.418	Pre_Hypertension (Pre_HTN)_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.419	Pre_Hypertension (Pre_HTN)_ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.420	Pre_Hypertension (Pre_HTN)_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.424	BMI >=30_Event_Clinical Condition Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.427	Obesity_Condition_LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.428	Vitals Body Height LOINC	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.429	Vitals Body Height SnoMed	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.430	Vitals Body Height	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.431	bwell_Vital_Blood Glucose_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.432	Anxiety_Clinical Grouping Condition_ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.433	Anxiety_Clinical Grouping Condition_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.434	Anxiety_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.435	Anxiety_Clinical Grouping Condition_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.436	Anxiety_Clinical Grouping Condition	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.437	bwell_Vital_Blood Oxygen_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.438	bwell_Vital_Systolic Blood Pressure_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.439	bwell_Vital_Diastolic Blood Pressure_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.440	bwell_Vital_Heart Rate_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.441	bwell_Vital_BMI_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.442	bwell_Vital_Body Fat_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.443	bwell_Vital_Body Temperature_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.444	bwell_Vital_Body Height_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.445	bwell_Vital_Body Weight_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.446	bwell_Vital_Respiratory Rate_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.447	bwell_Vital_Waist Circumference_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.448	bwell_Vital_Blood Glucose_Clinical Grouping Lab	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.449	bwell_Vital_Blood Oxygen_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.450	bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.451	bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.452	bwell_Vital_Heart Rate_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.453	bwell_Vital_BMI_Clinical Grouping Event	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.454	bwell_Vital_Body Fat_Clinical Grouping Event	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.455	bwell_Vital_Body Temperature_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.456	bwell_Vital_Body Height_Clinical Grouping Event	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.457	bwell_Vital_Body Weight_Clinical Grouping Event	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.458	bwell_Vital_Respiratory Rate_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.459	bwell_Vital_Waist Circumference_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.460	Pregnancy_CN_HD_LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.461	Pregnancy_CN_HD_CPT	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.462	Pregnancy_CN_HD_UMLS	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.463	Second Trimester_ICD10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.464	Second Trimester_SNOMED	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.465	Second Trimester_Clinical Grouping Event	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.466	Third Trimester_SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.467	Third Trimester_ICD10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.468	Third Trimester_Clinical Grouping Event	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.469	Pregnancy Due Date_LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.470	Second Trimester_LOINC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.472	OGTT_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.473	OGTT_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475	OGTT_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476	OGTT_Grouping	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.477	Second Trimester_CPT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.479	Prostate Cancer Screening_HD_ICD9	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.482	Prostate Cancer Screening_HD_Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.484	Prostate Dysplasia_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.486	Prostate Dysplasia_Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.487	Prostectomy_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.488	Prostectomy_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.490	Prostectomy_Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.494	PSA Testing _LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.495	PSA Testing_Grouping	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.496	Active Pregnancy_CPT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.497	Active Pregnancy_ICD10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.498	Active Pregnancy_LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.499	Active Pregnancy_SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.5	ADD/ADHD Condition	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.500	Active Pregnancy_Clinical Grouping Event	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.501	Abnormal PSA Testing _SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.502	Prediabetes_Clinical Grouping Condition_ICD10	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.503	Prediabetes_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.504	Prediabetes_Clinical Grouping Condition	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.505	Third Trimester_CPT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.506	Third Trimester_LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.508	bwell_Vital_Waist Circumference_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.509	bwell_Vital_Blood Oxygen_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.510	bwell_Vital_Body Temperature_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.511	bwell_Vital_Diastolic Blood Pressure_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.512	bwell_Vital_Systolic Blood Pressure_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.513	bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.514	bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.515	bwell_Vital_Heart Rate_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.516	bwell_Vital_Respiratory Rate_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.517	Lupus_Clinical_Condition_ICD10	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.519	Lupus_Clinical_Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.520	Lupus_Clinical Condition Grouping	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.523	UTI_Clinical_Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.524	UTI_Clinical Condition Grouping	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.525	Postpartum_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.526	Postpartum_HCPCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.527	Postpartum_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.528	Postpartum_ICD9CM	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.529	Postpartum_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.530	Postpartum_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.531	Postpartum_Clinical Grouping Event	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.532	bwell_Vital_Head Circumference_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.533	bwell_Vital_Head Circumference_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.534	bwell_Vital_Head Circumference_Clinical Grouping Event	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.535	bwell_Vital_Body Surface Area_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.536	bwell_Vital_Body Surface Area_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.537	bwell_Vital_Body Surface Area_Clinical Grouping Event	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.538	bwell_Vital_Vital Signs Panel_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.539	bwell_Vital_Vital Signs Panel_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.540	bwell_Vital_Vital Signs Panel_Clinical Grouping Event	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.541	bwell_Vital_Blood Pressure Panel_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.542	bwell_Vital_Blood Pressure Panel_Clinical Grouping Event	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.543	Depression_Clinical Grouping Condition_CPT	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.544	Depression_Clinical Grouping Condition_HCPCS	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.545	Depression_Clinical Grouping Condition_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.546	Depression_Clinical Grouping Condition_ICD9	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.547	Depression_Clinical Grouping Condition_LOINC	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.548	Depression_Clinical Grouping Condition_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.549	Depression_Clinical Grouping Condition	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.550	MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.551	MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.552	MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.553	MI (Myocardial Infarction)_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.554	CABG_Clinical Grouping Condition_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.555	CABG_Clinical Grouping Condition_HCPCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.556	CABG_Clinical Grouping Condition_ICD10PCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.557	CABG_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.558	CABG_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.559	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.56	Diabetic Retinal Screening HD CPT	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.560	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.561	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.562	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.563	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.564	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.565	Essential HTN_HD_Clinical Grouping Condition_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.566	Essential HTN_HD_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.567	Essential HTN_HD_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.568	Total and Partial Neph_HD_Clinical Grouping Condition_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.569	Total and Partial Neph_HD_Clinical Grouping Condition_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.570	Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.571	Total and Partial Neph_HD_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.572	Kid Trans and Hx_HD_Clinical Grouping Condition_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.573	Kid Trans and Hx_HD_Clinical Grouping Condition_HCPCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.574	Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10CM	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.575	Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCS	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.576	Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.577	Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.578	Kid Trans and Hx_HD_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.579	HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.580	HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.581	Systolic Less than 140_HD_Clinical Grouping Event_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.582	Diastolic Less than 90_HD_Clinical Grouping Event_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.583	Systolic Less than 140_HD_Clinical Grouping Event	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.584	Diastolic Less than 90_HD_Clinical Grouping Event	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.585	COPD_Clinical_Grouping_Condition_ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.586	COPD_Clinical_Grouping_Condition_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.587	COPD_Clinical_Grouping_Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.588	COPD_Clinical Condition Grouping	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.589	Polypharmacy_Clinical_Grouping_Condition_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.590	Polypharmacy_Clinical_Grouping_Condition_ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.591	Polypharmacy_Clinical_Grouping_Condition_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.592	Polypharmacy_Clinical_Grouping_Condition_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.593	Polypharmacy_Clinical Condition Grouping	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.595	Thyroid Cancer_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.596	Thyroid Cancer_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.597	Thyroid Cancer_Grouping	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.598	Allergy Iodine_SNOMED	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.599	Allergy to contrast_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.600	Allergy to contrast_ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.601	Allergy to contrast_Grouping	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.602	Contrast induced nephropathy_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.603	Contrast induced nephropathy_ICD10	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.604	Contrast induced nephropathy_Grouping	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.605	Systolic Blood Pressure_Compliant	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.606	Diastolic Blood Pressure_Compliant	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.607	Diastolic Blood Pressure_Compliant_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.608	Systolic Blood Pressure_Compliant_CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.609	bwell Systolic Blood Pressure Vitals_UI_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.610	bwell Systolic Blood Pressure Vitals_UI_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.611	bwell Diastolic Blood Pressure Vitals_UI_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.612	bwell Diastolic Blood Pressure Vitals_UI_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.613	bwell Combo Blood Pressure Vitals_UI_LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.614	bwell Combo Blood Pressure Vitals_UI_SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.615	bwell Systolic Blood Pressure_UI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.616	bwell Diastolic Blood Pressure_UI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.617	bwell Combo Blood Pressure_UI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.618	b.well Herpes Zoster Vaccine CN_HD	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.619	b.well Herpes Zoster Vaccine CN_HD_SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.620	b.well Herpes Zoster Vaccine CN_HD_CVX	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.621	b.well Herpes Zoster Vaccine CN_HD_CPT	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.622	b.well Herpes Zoster Vaccine CN_HD_2dose	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.623	b.well Herpes Zoster Vaccine CN_HD_2dose_CPT	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.624	b.well Herpes Zoster Vaccine CN_HD_2dose_CVX	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.625	b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.626	b.well Herpes Zoster Vaccine CN_HD_Exclusions	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.627	b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.628	b.well Adult RSV Vaccine CN_CVX	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.629	b.well Adult RSV Vaccine CN_CPT	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.630	b.well Adult RSV Vaccine CN_HCPCS	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.631	b.well Adult RSV Vaccine CN_SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.633	Lp(a) Test_SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.634	Lp(a) Test_LOINC	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.635	LP(a) Test_ICD	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.636	Lp(a) Test_CPT	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.637	LP(a) Test	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.638	b.well Adult Tetanus Vaccine CN	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.639	BWellAdultTetanusVaccineCN_SNOMED	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.640	b.well Adult Tetanus Vaccine CN_CPT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.641	b.well Adult Tetanus Vaccine CN_CVX	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.642	b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.643	b.well Adult Tetanus Vaccine CN_Exclusions	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.644	BWellAdultTetanusVaccineCN_RxNorm	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.645	Pneumococcal Vaccine HD_CN_ Allergy	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.646	bwell COVID Vaccine CN_Allergy	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.647	bwell Covid Vaccine CN_Allergy_SNOMED	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.648	bwell COVID Vaccine CN_Met	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.9	Metabolic Syndrome ICD10	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.91	Cardiomyopathy Dilated ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.92	Cardiomyopathy Dilated ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.93	Cardiomyopathy Dilated SNOMED	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.94	Cardiomyopathy Dilated Condition	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.95	Cardiomyopathy Dilated LOINC	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.96	Cardiomyopathy Hypertrophic ICD9	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.97	Cardiomyopathy Hypertrophic ICD10	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.98	Cardiomyopathy Hypertrophic SNOMED	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.99	Cardiomyopathy Hypertrophic LOINC	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.12	SNOMEDFindingValuesQualifierValue	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.13	SNOMED Organism from LOINC Answer List	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.18	Medication Prescribable Brand Name	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.2	SNOMED Organisms	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.22	Medicinal Ingredients RXNORM	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.1	Mental Status Observation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.10	Other Unknown Nulls	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.11	Sexual Orientation Including nulls and Data Absent Reason	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.12	Pregnancy Status Observation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.2	No Healthcare Agent Included Reason	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.3	Sex	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.4	Asked Declined Data Absent Reason	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.5	Act Encounter Codes	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.6	Completed or Nullified Act Status	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.7	Data Absent Reason Types of Unknown	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.8	Medication Adherence	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.2	Sickle Cell Disease	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.4	Depression	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.1	Food Insecurity Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.100	Intimate Partner Violence Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.101	Less Than High School Education Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.102	Less Than High School Education Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.103	Less Than High School Education Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.106	Transportation Insecurity Interventions SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.107	Financial Insecurity Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.108	Financial Insecurity Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.109	Financial Insecurity Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.11	Food Insecurity Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.110	Medical Cost Burden Goals SNOMED CT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.111	Health Insurance Coverage Status Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.112	Health Literacy Diagnoses SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.113	Health Literacy Diagnoses ICD10CM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.114	Health Literacy Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.115	Health Literacy Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.116	Health Literacy Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.117	Health Literacy Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.118	Health Literacy Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.119	Health Literacy Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.120	Medical Cost Burden Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.121	Health Insurance Coverage Status Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.122	Medical Cost Burden Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.123	Medical Cost Burden Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.124	Health Insurance Coverage Status Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.125	Health Insurance Coverage Status Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.126	Social Determinants of Health Screening Assessments	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.127	Food Insecurity Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.128	Transportation Insecurity Screening Assessments	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.129	Homelessness Screening Assessments	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.13	Homelessness Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.130	Housing Instability Screening Assessments	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.131	Inadequate Housing Screening Assessments	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.132	Less Than High School Education Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.133	Unemployment Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.134	Veteran Status Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.135	Social Connection Screening Assessments	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.136	Stress Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.137	Cognitive disorder Diagnosis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.138	Financial Insecurity Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.139	Material Hardship Screening Assessments	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.14	Homelessness Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.140	Intimate Partner Violence Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.141	Health Literacy Screening Assessments	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.142	Medical Cost Burden Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.143	Health Insurance Coverage Status Screening Assessments	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.144	Elder Abuse Screening Assessments	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.145	Less Than High School Education Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.146	Financial Insecurity Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.147	Health Insurance Coverage Status Diagnoses ICD10CM	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.148	Health Insurance Coverage Status Diagnoses	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.149	Health Insurance Coverage Status Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.15	Food Insecurity Interventions CPT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.150	Material Hardship Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.151	Medical Cost Burden Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.152	Medical Cost Burden Diagnoses SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.153	Medical Cost Burden Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.154	Medical Cost Burden Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.157	Transportation Insecurity Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.158	Homelessness Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.159	Homelessness Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.16	Food Insecurity Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.160	Housing Instability Goals SNOMED CT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.161	Housing Instability Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.162	Transportation Insecurity Goals SNOMED CT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.163	Transportation Insecurity Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.164	Veteran Status Interventions SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.167	Inadequate Housing Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.168	Material Hardship Screening Assessments Questions	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.169	Stress Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.17	Food Insecurity Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.170	Transportation Insecurity Screening Assessments Questions	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.171	Unemployment Screening Assessments Questions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.172	Veteran Status Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.173	Financial Insecurity Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.174	Food Insecurity Screening Assessments Answers	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.175	Health Literacy Screening Assessments Answers	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.176	Homelessness Screening Assessments Answers	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.177	Housing Instability Screening Assessments Answers	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.178	Inadequate Housing Screening Assessments Answers	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.179	Less Than High School Education Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.18	Homelessness Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.180	Material Hardship Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.181	Stress Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.182	Transportation Insecurity Screening Assessments Answers	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.183	Unemployment Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.184	Veteran Status Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.185	Health Insurance Coverage Status Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.186	Health Insurance Coverage Status Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.187	Medical Cost Burden Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.188	Medical Cost Burden Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.189	Elder Abuse Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.19	Homelessness Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.190	Elder Abuse Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.191	Elder Abuse Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.192	Veteran Status Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.193	Financial Insecurity Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.194	Food Insecurity Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.195	Health Literacy Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.196	Homelessness Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.197	Housing Instability Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.198	Intimate Partner Violence Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.199	Less Than High School Education Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.20	Homelessness Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.200	Material Hardship Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.201	Medical Cost Burden Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.202	Social Connection Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.203	Stress Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.204	Transportation Insecurity Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.205	Unemployment Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.206	Social Determinants of Health Screening Assessments And Questions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.207	Social Determinants of Health Screening Assessments Questions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.208	Social Determinants of Health Screening Assessments Answers	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.209	Intimate Partner Violence Screening Assessments Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.21	Homelessness Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.210	Social Connection Screening Assessments Answers	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.211	Intimate Partner Violence Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.212	Social Connection Screening Assessments Questions	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.213	Health Insurance Coverage Status Diagnoses SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.214	Veteran Status Goals	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.215	Veteran Status Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.217	Digital Literacy Diagnoses SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.218	Digital Literacy Diagnoses ICD10CM	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.219	Digital Literacy Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.22	Housing Instability Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.220	Digital Literacy Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.224	Digital Literacy Diagnoses	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.225	Digital Literacy Goals	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.226	Digital Literacy Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.227	Digital Literacy Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.229	Digital Access Diagnoses SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.23	Housing Instability Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.230	Digital Access Diagnoses ICD10CM	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.231	Digital Access Diagnoses	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.232	Digital Access Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.233	Digital Access Goals	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.234	Digital Access Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.235	Digital Access Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.236	Digital Access Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.237	Digital Access Screening Assessments	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.238	Digital Access Screening Assessments Questions	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.239	Digital Access Screening Assessments Answers	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.24	Housing Instability Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.240	Digital Access Screening Assessments And Questions	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.241	Utility Insecurity Diagnoses SNOMED CT	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.242	Utility Insecurity Diagnoses ICD10CM	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.243	Utility Insecurity Diagnoses	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.244	Utility Insecurity Goals SNOMED CT	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.245	Utility Insecurity Goals	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.246	Utility Insecurity Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.247	Utility Insecurity Procedures	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.248	Utility Insecurity Screening Assessments	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.249	Utility Insecurity Screening Assessments Questions	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.25	Transportation Insecurity Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.250	Utility Insecurity Screening Assessments Answers	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.251	Utility Insecurity Screening Assessments And Questions	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.252	Utility Insecurity Service Requests	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.253	Social Determinants of Health General Interventions HCPCS	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.254	Incarceration Status Diagnoses ICD10CM	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.255	Incarceration Status Diagnoses SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.256	Incarceration Status Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.257	Incarceration Status Goals	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.258	Incarceration Status Diagnoses	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.259	Incarceration Status Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.26	Transportation Insecurity Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.260	Incarceration Status Procedures	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.261	Incarceration Status Service Requests	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.262	Language Access Diagnoses	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.263	Language Access Diagnoses ICD10CM	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.264	Language Access Diagnoses SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.265	Language Access Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.266	Language Access Goals	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.267	Language Access Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.268	Language Access Procedures	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.269	Language Access Service Requests	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.27	Transportation Insecurity Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.270	Language Access Screening Assessments	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.271	Language Access Screening Assessments Answers	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.272	Language Access Screening Assessments Questions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.273	Language Access Screening Assessments And Questions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.28	Transportation Insecurity Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.29	Financial Insecurity Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.3	Food Insecurity Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.30	Financial Insecurity Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.31	Financial Insecurity Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.32	Financial Insecurity Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.33	Material Hardship Diagnoses ICD10CM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.34	Material Hardship Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.35	Material Hardship Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.36	Material Hardship Goals SNOMED CT	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.37	Material Hardship Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.38	Material Hardship Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.39	Material Hardship Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.4	Food Insecurity Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.40	Unemployment Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.41	Unemployment Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.42	Unemployment Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.43	Housing Instability Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.44	Housing Instability Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.45	Housing Instability Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.46	Inadequate Housing Diagnoses SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.47	Inadequate Housing Diagnoses ICD10CM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.48	Inadequate Housing Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.49	Inadequate Housing Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.5	Social Determinants of Health General Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.50	Inadequate Housing Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.51	Inadequate Housing Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.52	Inadequate Housing Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.53	Inadequate Housing Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.54	Less Than High School Education Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.55	Less Than High School Education Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.56	Less Than High School Education Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.57	Less Than High School Education Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.58	Unemployment Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.59	Unemployment Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.6	Food Insecurity Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.60	Unemployment Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.61	Elder Abuse Diagnoses ICD10CM	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.62	Elder Abuse Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.63	Elder Abuse Diagnoses	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.64	Elder Abuse Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.65	Elder Abuse Goals	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.66	Elder Abuse Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.67	Elder Abuse Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.68	Elder Abuse Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.69	Unemployment Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.7	Food Insecurity Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.70	Unemployment Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.71	Social Determinants of Health Goals	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.72	Stress Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.73	Stress Interventions SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.74	Stress Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.75	Stress Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.76	Veteran Status Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.77	Veteran Status Diagnoses ICD10CM	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.78	Veteran Status Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.79	Social Connection Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.8	Social Determinants of Health General Interventions CPT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.80	Social Connection Diagnoses ICD10CM	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.81	Social Connection Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.82	Intimate Partner Violence Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.83	Intimate Partner Violence Diagnoses ICD10CM	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.84	Intimate Partner Violence Diagnoses	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.85	Stress Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.86	Stress Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.87	Stress Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.88	Social Connection Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.89	Social Connection Goals	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.9	Food Insecurity Interventions HCPCS	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.90	Veteran Status Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.91	Veteran Status Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.92	Stress Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.93	Social Connection Interventions SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.94	Social Connection Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.95	Social Connection Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.96	Intimate Partner Violence Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.97	Intimate Partner Violence Procedures	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.98	Intimate Partner Violence Service Requests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.99	Intimate Partner Violence Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.105	Mechanical Ventilation Procedures	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.106	Mechanical Ventilation	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.107	Mechanical Ventilation	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.109	aPTT Tests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119	Opioid Antagonist	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.12	High Risk Diagnosis for AKI	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.120	Opioids	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.124	Immune Modulators	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.130	Suicide Attempt	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.134	Central Nervous System Depressants	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.136	Leukemia or Lymphoma	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.137	Liver Disease Moderate to Severe	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.138	COVID19	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.139	COVID 19	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.14	Hemolytic Uremic Syndrome (HUS)	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.140	COVID 19	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.162	Obesity	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.163	Antidepressants	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.164	Antihypertensives	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.165	Delirium	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.166	Dementia	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.167	Psychosis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.168	Delirium or Dementia and Other Psychoses	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.169	Depression	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.170	Diuretics	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.171	Epilepsy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.172	Neurologic Movement Disorders	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.173	Neurologic Disorders, Other	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.174	Neurologic Movement and Related Disorders	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.175	Peripheral Neuropathy	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.176	Stroke	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.177	Abnormal Weight Loss and Malnutrition	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.178	Intubation	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.179	Intubation	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.180	Tracheostomy Procedures	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.181	Tracheostomy Procedures	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.182	Head and Neck Surgeries with High Risk Airway Compromise	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.185	Spinal Surgery	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187	Routes of Administration for Opioid Antagonists	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.19	High Risk Procedures for AKI	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.197	Hospital Based Dialysis Services	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.198	Hospital Based Dialysis Services	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.199	Hospital Based Dialysis Services	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.200	Nephrectomy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.201	Thrombotic Thrombocytopenic Purpura	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204	VTE Prophylaxis	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.205	Moderate Injuries	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.206	General and Neuraxial Anesthesia	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.207	General and Neuraxial Anesthesia	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.208	General and Neuraxial Anesthesia	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.209	Non Invasive Oxygen Therapy by Nasal Cannula or Mask	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.21	Creatinine Mass Per Volume	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.210	Continuous and Bilevel Positive Airway Pressure	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.211	Continuous and Bilevel Positive Airway Pressure	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.213	Non Invasive Oxygen Therapy	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.214	Non Invasive Oxygen Therapy Devices	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.216	Procedural Hospital Locations	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.217	ASA physical status class	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.218	Blood urea nitrogen lab test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.219	Hemoglobin lab test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.22	Anticoagulants for All Indications	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.220	Smoking status	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.221	Albumin lab test	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.222	Leukocyte count lab test	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.223	Bilirubin lab test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.224	Aspartate transaminase lab test	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.226	Cardiac Arrest	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.23	Coagulation Disorders	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.230	PO Antibacterials	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.231	Injectable Antifungals	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.238	Neuromuscular Disorder	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.239	Neuromuscular Disorder	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.24	Malignant Bone Disease	active	2022-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.240	Degenerative Neurological Disorder	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.241	Degenerative Neurological Disorder	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.242	Heart and Lung Transplants	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.243	Heart and Lung Transplants	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.245	Lung Resections and Excisions	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.246	Lung Resections and Excisions	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.247	Chest Wall Procedures	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.248	Chest Wall Procedures	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.249	Maxillary Procedures	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.250	Maxillary Procedures	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.251	Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.252	Anesthesia Requiring Monitored Care	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.253	Anesthesia Requiring Monitored Care	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.255	Anesthesia Requiring Monitored Care	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.256	Osteoporosis	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.260	Rivaroxaban Anticoagulant	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.262	Fondaparinux Anticoagulant	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.263	Dalteparin Anticoagulant	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.264	Heparin	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.268	Enoxaparin Anticoagulant	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.271	Undetectable Lab Result Value	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.272	Undetectable Lab Result Value	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.274	Dietary Recommendations	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.275	Bariatric Procedures	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.276	Telemedicine Services	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.277	Prostate Cancer Treatment	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.28	Traumatic Avulsion of Kidney	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.29	Rapidly Progressive Nephritic Syndrome	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.301	LDL Cholesterol	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.33	Obstetrics and VTE Obstetrics	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.34	Glucose Lab Test Mass Per Volume	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.349	Tuberculosis for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.350	Tuberculosis for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351	Tuberculosis for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.352	Androgen Deprivation Therapy for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353	Bacillus Calmette Guerin for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354	Bladder Cancer for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355	Chemotherapy Agents for Advanced Cancer	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.356	Cystectomy for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.357	Cystectomy for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358	Cystectomy for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.359	DEXA Bone Density for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360	Hospital Services for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.361	Immunocompromised Conditions	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.362	Immunocompromised Conditions	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363	Immunocompromised Conditions	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364	Immunosuppressive Drugs for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365	Mixed Histology Urothelial Cell Carcinoma for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.366	Morbid Obesity	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.367	Morbid Obesity	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368	Morbid Obesity	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.369	Unavailability of Bacillus Calmette Guerin for Urology Care	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.370	Urinary Retention	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.371	Urinary Retention	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372	Urinary Retention	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.374	Face to Face Interaction	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.375	Face to Face Interaction	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.376	HIV Viral Load Tests	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.377	HIV Viral Load Tests	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.389	Syphilis Tests	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.4	Nephrectomy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.79	Acute Brain or Spinal Injury or Hemorrhage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.8	Large Body Surface Area (BSA) Burns	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.80	Pulmonary Arterial Thrombectomy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.81	Extracorporeal Membrane Oxygenation	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.85	Elective Inpatient Encounter	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.86	Intubation	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.88	Acute Respiratory Failure	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.89	Tracheostomy Diagnoses	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.90	Tracheostomy Procedures	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.91	Neuromuscular Disorder	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.92	Degenerative Neurological Disorder	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.93	Head and Neck Surgeries with High Risk Airway Compromise	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.94	Oxygen Partial Pressure in Arterial Blood	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.95	Carbon Dioxide Partial Pressure in Arterial Blood	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.96	Arterial Blood pH	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.2	Psychological Neuropsychological or Neurobehavioral Testing	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.3	Psychological or Neuropsychological Testing	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.10	Tricuspid Valve Regurgitation	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.12	Hypertension	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.2	Valvular Heart Disease	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.22	Acute Kidney Injury	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.23	Anemia	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.24	Cardiac Arrhythmias	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.25	Attention Deficit and Hyperactivity Disorder	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.26	Cerebrovascular Disease	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.27	Seizure Disorder	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.28	Proteinuria	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.29	Thyroid Hormone Disorder	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.30	Thromboembolic Disease	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.31	Parkinson's Disease and Parkinsonism	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.32	Upper GI Diseases	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.33	Failure to Thrive	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.34	Osteoporosis	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.35	Mood Disorders	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.36	Dyslipidemia	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.37	Heart Failure	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.38	Coronary Artery Disease	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.39	Chronic Kidney Disease	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.40	Chronic Obstructive Pulmonary Disease	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.41	Diabetes Mellitus	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.1	EventTiming-TimingEvent	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.2	EventTiming-EventTiming	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.1	Gonorrhea Screening	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.2	Abnormal Weight Loss	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.2	Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.3	Prescribable brand and generic insulins and analogues	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.4	eGFR Using 2021 Race Free Formulas	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.5	Fructosamine in Serum or Plasma	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.6	Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.7	Creatinine in serum/plasma	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.9	IgE Agonists, prescribable	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.10	Estrogen Receptor Testing for Orserdu	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.100	MMR Proficient	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.101	Systemic Cancer Directed Therapy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.102	Face To Face Interaction	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.104	Erdafitinib	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.107	Chemotherapy Encounter	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.108	Urothelial Cancers ICD9	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.109	Urothelial Cancer ICD10	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.11	Estrogen Receptor Test for Orserdu	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.110	Urothelial Cancers	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.111	Prior Therapies for Erdafitinib	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.112	Urothelial Cancer Histologies	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.113	Malignant Tumor Behavior	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.114	Localized Bladder Cancer Stage SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.116	Localized Bladder Cancer Staging	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.117	Advanced Bladder Cancer Stage	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.118	Localized Bladder Cancer T Stage	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.119	Localized Bladder Cancer T Stage	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.12	Negative	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.120	Localized Bladder Cancer N Stage	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.121	Localized Bladder Cancer M Stage	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.122	Advanced Bladder Cancer M Stage	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.124	Locoregional Urothelial Cancer ICD9	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.125	Locoregional Urothelial Cancer ICD10	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.126	Locoregional Urothelial Cancer SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.127	Locoregional Urothelial Cancer	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.128	FGFR3 Gene	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.129	FGFR3 Gene Interpretation Positive SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.13	HER2 Negative	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.130	FGFR3 Gene Interpretation Positive LOINC	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.131	FGFR3 Gene Interpretation Positive NCI	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.133	FGFR3 Gene Interpretation Positive	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.134	FGFR3 Gene Interpretation Negative SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.135	FGFR3 Gene Interpretation Negative NCI	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.137	FGFR3 Gene Interpretation Negative	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.138	FGFR3 Molecular Variants	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.139	Tumor Behavior	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.14	Endocrine Therapy	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.140	Physcological Support for Cancer	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.141	Referral For Pain From Cancer	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.142	Cancer Pain Education	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.143	Telehealth Encounters	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.144	Pain Assessment Score	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.146	Telehealth Encounters SNOMEDCT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.147	Telehealth Encounters CPT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.148	Telehealth Encounters HCPCS	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.149	Telehealth Encounters All	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.15	All Metastatic Sites	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.150	Chemo Admin SNOMEDCT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.151	Chemo Admin CPT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.152	Chemo Admin HCPCS	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.153	Chemotherapy Administration All	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.154	Radiation Treatment CPT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.155	Radiation Treatment HCPCS	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.156	Radiation Treatment SNOMEDCT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.157	Radiation Treatment All	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.158	Bipolar Diagnosis Codes	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.159	Telephone Visits SNOMED	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.16	All Metastatic Sites	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.160	Telephone Visit CPT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.161	Telephone Visits All	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.162	Adolescent depression screening assessment	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.163	Adult depression screening assessment LOINC	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.165	Referral for Depression Adult	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.166	Referrals for Adolescent Depression	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.167	Follow Ups for Adolescent Depression	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.168	FollowUps for Adult Depression	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.169	Depression Screen Declined for Medical Reason	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.17	Metastatic Breast Cancer	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.170	Physical Therapy Evaluations SNOMEDCT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.171	Physical Therapy Evaluation CPT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.172	Physical Therapies Evaluations	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.173	Non Opioid Analgesics	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.174	Adjuvant Analgesics	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.176	Lung Cancer ICD9	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.177	Lung Cancer ICD10	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.178	Lung Cancer	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.179	Prior Therapies for Osimertinib	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.18	Stage IA	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.181	Plan of Care for Pain	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.182	All Antineoplastic Agents	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.183	Locally Advanced NSCLC Stage Group	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.185	Localized NSCLC Stage Group SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.186	Radiation Treatment Management	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.187	Plan of Care	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.188	Documentation of Plan of Care	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.189	Pain Present	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.19	Stage IB	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.190	Localized NSCLC Stage Group NCIM	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.192	Localized NSCLC Stage Group	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.193	Advanced NSCLC Stage Group	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.194	NSCLC M Stage (metastatic)	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.195	NSCLC T Stage	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.196	NSCLC N Stage	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.197	SCLC and rarer lung cancer histology	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.198	EGFR Gene	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.199	EGFR Gene Interpretation Positive SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.20	Stage IIA	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.200	EGFR Gene Interpretation Positive LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.201	EGFR Gene Interpretation Positive	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.202	EGFR Osimertinib Molecular Variants	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.203	EGFR Generic Molecular Variant NCIM	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.204	EGFR Generic Molecular Variant SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.205	EGFR Generic Molecular Variant LOINC	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.206	EGFR Molecular Variants Osimertinib PM	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.207	Osimertinib	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.208	Pemetrexed	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.209	Radiation Treatment Management SNOMEDCT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.21	Stage IIB	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.210	Radiation Treatment Management Codes	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.211	Radiation Treatment Delivery CPT	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.212	77427 Management Code	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.213	Radiation Treatment Delivery HCPCS	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.214	Radiation Treatment Delivery NCIM	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.215	Radiation Treatment Delivery SNOMED	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.216	Radiation Treatment Delivery	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.217	MET Gene Test	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.219	Tepotinib	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.22	Stage IIIA	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.220	MET Positive gene interpretation	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.227	MET Exon 14 skipping molecular variant	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.23	Stage IIIB	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.230	All Cancer Directed therapies	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.231	EGFR Amivantamab Molecular Variants	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.232	EGFR Molecular Variants Amivantamab PM	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.233	test43	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.234	ROS1 Molecular Variants Repotrectinib PM	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.235	ROS1 Repotrectinib Molecular Variants	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.236	ROS1 Negative (geneinterpretation) SNOMEDCT	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.237	ROS1 Negative (geneinterpretation) NCI	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.238	ROS1 Negative (geneinterpretation) SNOMEDCT,NCI	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.239	ROS1 Positive (geneinterpretation)	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.24	Stage IIIC	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.240	ROS1 results (HGNC)	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.241	ROS1 Gene Rearrangement	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.242	RET Test (HGNC)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.243	RET Positive (Genei interpretation )	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.244	RET Gene Rearrangement	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.245	RET Negative (geneinterpretaion) SNOMED	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.246	RET Negative (geneinterpretaion) NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.247	RET Negative (geneinterpretaion) SNOMEDCT,NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.248	RET Fusion Molecular Variants	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.249	pralsetinib	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.25	ESR1 Gene Test	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.250	Repotrectinib Value set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.251	Amivantamab	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.252	Alectinib Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.253	Gemcitabine Drug Value set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.254	vinorelbine Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.255	NSCLC_Tumor_resection SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.256	NSCLC_Tumor_resection CPT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.257	NSCLC_Tumor_resection SNOMEDCT CPT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.258	ALK results (HGNC)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.259	ALK Positive (geneinterpretation) SNOMED	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.26	ESR1 Genetic Mutation	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.260	ALK Positive (geneinterpretation) NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.261	ALK Positive (geneinterpretation) SNOMEDCT NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.262	ALK Negative (geneinterpretation) SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.263	ALK Negative (geneinterpretation) NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.264	ALK Negative (geneinterpretation) SNOMEDCT NCI	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.265	Locoregional Sites	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.266	NSCLC N2 Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.267	NSCLC N1 Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.268	NSCLC N0 Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.269	NSCLC T3_T4 Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.27	Genetic Test Finding	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.270	NSCLC T2 Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.271	NSCLC T1 Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.272	Locally_Advanced_Metastatic_NSCLC Stage Group	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.273	Localized_Inclusion_NSCLC Stage Group	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.274	Localized_Exclusion_NSCLC Stage Group	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.275	tarlatamab dlle	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.276	Extensive SCLC Stage Group SNOMEDCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.277	Extensive SCLC Stage Group NCIM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.278	Extensive SCLC Stage Group	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.279	Localized SCLC Stage Group	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.28	Her2 Negative	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.280	SCLC M Stage (metastatic)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.281	SCLC T Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.282	SCLC N Stage	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.283	SCLC histology (to include those patients)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.284	Binimetinib	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.285	Encorafenib	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.286	Encorafenib PM Molecular variant	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.288	BRAF Positive (geneinterpretation)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.289	BRAF test (HGNC)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.29	HER2 Positive	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.292	Prior therapy for Amivantamab	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.293	ENHERTU Drug	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.294	Metastatic_Solid_Cancer_Stage Group SNOMED CT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.295	Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.296	Localized_Solid_Cancer_Stage Group SNOMED CT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.297	Solid cancer M Stage (metastatic)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.298	Solid Cancer T Stage	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.299	Solid Cancer N Stage	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.30	HER2 Positive	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.302	HER2_IHC_Positive	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.303	HER2 Negative (geneinterpretation/Labtestvalue) SNOMED	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.304	HER2 Negative (geneinterpretation/Labtestvalue) LOINC	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.305	HER2 Negative (geneinterpretation/Labtestvalue) NCI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.307	HER2 Negative (geneinterpretation/Labtestvalue)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.308	Solid Cancer Diagnosis ICD 9	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.309	Solid Cancer Diagnosis SNOMED CT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.31	HER2 Positive	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.310	Solid Cancer Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.311	Localized_Solid_Cancer_Stage Group NCIM	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.313	Localized_Solid_Cancer_Stage Group	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.314	Locally_Advanced_Solid_Cancer_Stage Group NCIM	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.315	Locally_Advanced_Solid_Cancer_Stage Group	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.316	Metastatic_Solid_Cancer_Stage Group NCIM	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.317	Metastatic_Solid_Cancer_Stage Group	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.318	Solid Cancer T Stage LOINC	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.319	Solid Cancer T Stage NCI	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.32	HER2 Positive	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.320	Solid Cancer T Stage codes	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.321	Prior_Systemic_therapy_Enhertu	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.322	RET test_Solid_cancer (HGNC)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.323	RET Positive_Solid_Cancer (geneinterpretation)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.324	RET Negative_Solid_Cancer (geneinterpretation)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.325	RET fusion Molecular Variants_Solid_Cancer	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.326	Prior_systemic_therapy_Retevmo	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.327	Selpercatinib (Retevmo) Drug	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.328	Breast Cancer Diagnosis ICD9	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.329	Breast Cancer Diagnosis ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.33	Metastatic Breast Cancer	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.330	Breast Cancer Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.331	Metastatic_Breast_Cancer_Stage Group	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.332	Locally_Advanced_Breast_Cancer_Stage Group	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.333	Localized_Breast_Cancer_Stage Group	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.334	Breast cancer M Stage (metastatic)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.335	Breast Cancer T Stage	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.336	Breast Cancer N Stage	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.337	Metastatic Sites All Breast SNOMEDCT	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.338	Metastatic Sites All Breast ICD9	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.339	Metastatic Sites All Breast ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.340	Metastatic Sites All Breast (grouped, SNOMEDCT/ICD9/ICD10)	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.341	Aromatase_Inhibitor therapy	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.342	Capivasertib_therapy	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.343	Fulvestrant_therapy	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.344	PTEN_gene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.345	PTEN_geneinterpretation	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.346	PIK3CA_gene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.347	PI3KCA_geneinterpretation	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.348	AKTI_gene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.349	AKTI_geneinterpretation	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.35	All Metastatic Sites	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.350	Progesterone_receptor_gene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.351	Progesterone_receptor_geneinterpretation	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.352	Estrogen_receptor_gene	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.353	Estrogen_receptor_geneinterpretation	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.354	Progesterone_receptor_labtest	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.355	Progesterone_receptor_labinterpretation	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.356	Estrogen_receptor_labtest	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.357	Estrogen_receptor_labinterpretation	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.358	NSCLC M0 Stage	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.359	HER2_IHC_test_Gene	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.36	All Metastatic Sites	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.360	HER2_IHC_test_Lab	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.361	HER2_Fish_test	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.362	HER2_IHC_Negative	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.363	Trodelvy	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.364	Chemotherapy_breast_cancer	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.365	Cyclin_dependent_kinase	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.366	Taxane_Trodelvy	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.367	Endocrine_therapy	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.368	HER2_Fish_test_Negative	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.369	HER2_IHC_Equivocal	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.37	Locoregional Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.370	HER2 Positive_PM_results	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.371	HER2 test_Lab	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.372	HER2 test_gene	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.374	Thyroid Cancer Diagnosis	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.375	Metastatic_Thyroid_Stage Group	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.376	RET mutation_Molecular Variants	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.377	RET Gene mutation	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.378	Locally_Advanced_Localized_Thyroid_Cancer_Stage Group	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.379	Thyroid cancer M1_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.38	Locoregional Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.380	Thyroid_cancer_M0_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.381	Thyroid_cancer_T_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.382	Thyroid_cancer_T1_T2_T3_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.383	Thyroid_cancer_T4_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.384	Thyroid_cancer_N1b_Stage&Above	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.385	Thyroid_cancer_N_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.386	Medullary_thyroid_histology	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.387	RET test_Thyroid_cancer (HGNC)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.388	RET Positive	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.389	NSCLC N3 Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.39	Locoregional Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.390	CRC Cancer Diagnosis ICD9	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.391	CRC Cancer Diagnosis ICD10	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.392	CRC Cancer Diagnosis ICD9/ICD10	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.393	Metastatic_CRC_Cancer_Stage Group	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.394	Locally_Advanced_Localized_CRC_Stage Group	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.395	CRC cancer M Stage (metastatic)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.396	CRC Cancer T Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.397	CRC Cancer N Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.398	KRAS_gene	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.399	KRAS_negative	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.40	Locoregional Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.400	Fluoropyrimidine_CRC	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.401	Oxaliplatin	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.402	Irinotecan_based_therapy	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.403	anti_VEGF_therapy_CRC	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.404	anti_EGFR_therapy_CRC	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.405	fruquitinib	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.406	Locally_Advanced_CRC_Stage Group	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.407	Localized_CRC_Stage Group	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.408	CRC cancer M0_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.409	CRC_Cancer_T1_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.41	All Metastatic Sites ICD910	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.410	CRC_Cancer_T2_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.411	CRC_Cancer_T3_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.412	CRC_Cancer_T4_Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.413	CRC Cancer N1 Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.414	CRC Cancer N2 Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.415	CRC Cancer N2b Stage	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.416	KRAS_G12C_MV	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.417	KRAS_G12C_PM	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.418	KRAS_positive	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.419	Adagrasib	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.42	Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.420	cetuximab_therapy	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.421	Tamoxifen_therapy	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.423	Endometrial Cancer Diagnosis ICD 10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.425	Endometrial Cancer Diagnosis ICD9CM	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.426	Endometrial Cancer Diagnosis	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.428	Localized_Endometerial_Stage Group SNOMED	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.429	Localized_Endometerial_Stage Group NCIM	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.43	Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.431	Endometrial_Sarcoma_Tumor_Histology_exc	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.432	Endometrial cancer M Stage (metastatic)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.433	Endometrial_M0_Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.436	Prior_therapy_Endometrial	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.437	Paclitaxel_therapy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.44	Breast Cancer	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.441	Carboplatin_therapy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.442	Durvalumab_therapy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.444	MMR_Gene_Lab_LOINC	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.447	MMR_Gene_HGNC	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.449	Endometrial_ Cancer N Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.45	Endometrial Cancer ICD9	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.451	Endometrial_N0_Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.453	Endometrial_N1_N2_Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.455	Endometrial_T1_T3_Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.456	Endometrial_T3_Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.458	Endometrial_T4_Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.459	Endometrial Cancer T Stage	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.46	Endometrial Cancer ICD10	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.460	Localized_Endometerial_Stage Group_SNOMED/NCIM	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.461	Metastatic Sites All CRC	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.462	Metastatic Sites All CRC ICD 10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.463	Metastatic Sites All CRC ICD 9	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.464	Metastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.465	NTRK Repotrectinib Molecular Variants	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.466	NTRK_Gene_rearrangment	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.467	Prior_Systemic_therapy_Repotrectinib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.468	NTRK_Positive	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.469	NTRK_test_gene	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.47	Systemic treatment for endometrial cancer	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.470	Tamoxifen_Trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.471	Toremifene_trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.472	Fulvestrant_Trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.473	Elacestrant	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.474	Anastrozole_Trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.475	Leuprolide_Trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.476	Abemaciclib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.477	Palbociclib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.478	Ribociclib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.479	Carboplatin_Trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.48	Endometrial Cancers	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.480	Cisplatin_Trodelvy	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.481	Cyclophosphamide	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.482	Methotrexate	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.483	Gemcitabine	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.484	Capecitabine	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.485	Eribulin	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.486	Doxorubicin	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.487	Vinorelbine	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.488	Epirubicin	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.489	Ixabepilone	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.49	MSI Testing	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.490	Olaparib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.491	Talazoparib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.492	Entrectinib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.493	larotrectinib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.494	Alpelisib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.495	Capivasertib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.496	Pembrolizumab	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.497	Dostarlimab	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.498	Selpercatinib	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.499	Everolimus	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.50	MSI High	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.500	Trastuzumab_deruxtecan	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.501	Test 23	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.502	All Metastatic sites Endometrial SNOMED	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.503	All Metastatic sites Endometrial ICD9	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.504	All Metastatic sites Endometrial ICD10	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.505	All Metastatic sites Endometrial	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.506	Create CRC_Cancer_T4a_Stage	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.507	Create CRC_Cancer_T4b_Stage	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.508	High Emetogenic Risk Chemotherapy	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.510	InactiveFollowup	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.53	MMR Gene Testing	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.54	MSI High	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.55	MSI High	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.56	Early and Limited Stage	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.57	Early Stage IIB or lower	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.58	MMR Deficient	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.59	MMR Deficient	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.6	Orserdu	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.60	MMR Deficient	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.61	Stage IIB or lower and limited	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.62	Stage III or higher	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.63	Stage III or higher	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.64	Stage III or higher	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.65	Staging Unknown	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.66	Staging Unknown	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.67	Staging Unknown	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.68	Jemperli	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.69	Uterine Sarcoma	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.7	Her2 Test For Orserdu	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.70	Tumor Histology	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.71	Platinum based therapy	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.72	Prior Therapies for Tucatinib	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.73	Tucatinib	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.74	Colorectal Cancer ICD10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.75	Colorectal Cancer ICD9	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.76	Colorectal Cancer ICD9 and ICD10	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.78	Advanced or Unresectable Colorectal Cancer Staging	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.79	0 to IIIB Colorectal Cancer Staging	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.80	Colorectal Cancer M1 Stage	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.81	RAS Genes	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.82	RAS Gene Interpretation Negative LOINC	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.83	RAS Gene Interpretation Negative SNOMED	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.84	RAS Gene Interpretation Negative NCM	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.85	RAS Gene Negative	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.86	RAS Gene Interpretation Positive SNOMED	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.87	RAS Gene Interpretation Positive LOINC	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.88	RAS Gene Positive	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.89	Her2 Testing	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.9	ER Test for Orserdu	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.90	Patient Reason	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.91	MSI High NCI	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.92	MSI Low SNOMED	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.93	MSI Low LOINC	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.94	MSI Low NCI	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.95	MSI Low	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.96	MMR Deficient NCI	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.97	MMR Proficient SNOMED	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.98	MMR Proficient LOINC	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.99	MMR Proficient NCI	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1262.3	ICD9 Codes for HIV Diagnosis	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.1	Inpatient Pneumonia Diagnosis	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.11	Chest Imaging for Pneumonia, HCPCS	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.12	Chest Imaging for Pneumonia Grouping Definition	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.18	ICD9 Abnormal Finding on Chest Imaging	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.19	ICD10 Abnormal Finding on Chest Imaging	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.2	ICD9 Pneumonia Definition	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.20	SNOMEDCT Abnormal Finding on Chest Imaging	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.21	Abnormal Finding on Chest Imaging	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.22	SNOMEDCT Pneumonia Definition	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.23	CAP Concurrent Infections	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.24	CAP Pneumonia Diagnostic	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.25	Antibiotic Usage for CAP Diagnosis	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.27	Legionella Presence by Urine Antigen or DNA	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.29	Broad Spectrum Antibiotics for MDRO	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.3	ICD10 Pneumonia Definition	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.32	CPT Transplants, Stem Cell and Solid	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.33	HCPCS Transplant, Stem Cell and Solid	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.34	ICD10CM Transplant, Stem Cell and Solid	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.35	ICD10PCS Transplant, Stem Cell and Solid	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.37	SNOMEDCT Transplant, Stem Cell and Solid	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.38	Transplant, Stem Cell and Solid	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.39	Antibiotic Usage for CAP Duration	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.40	CAP Sepsis Diagnostic	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.41	CAP Respiratory Failure Diagnostic	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.42	MRSA Organism or Substance in Lab Results	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.8	Systemic Antimicrobials	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.9	Chest Imaging for Pneumonia, CPT	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.1	Problem Type	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.10	Information Source for Medication Adherence HSLOC	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.11	Information Source for Medication Adherence	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.13	Screening and Assessment Survey Codes	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.14	Unknown and Asked but Unknown (DAR)	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.15	Yes or No SCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.16	Answer Set with Yes No and Unknowns	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.17	Common LOINC Lab Codes	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.18	Radiology Procedures (LOINC)	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.19	Clinical Tests	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.21	Universal Common LOINC Lab Orders	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.22	Route of Administration of Therapeutic Agents	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.23	Encounter Type	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.24	Specimen Condition SCT	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.25	Detailed race including absence reasons.	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.26	Healthcare Facility type (SCT)	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.27	Social History Type (LOINC)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.28	Social History Type	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.29	Encounter Type CPT	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.3	Smoking status comprehensive	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.31	Healthcare Service Location Type Combined	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.4	Smoking Status Type LOINC	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.5	Smoking Status Pack Years SCT	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.6	Smoking Status Type	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.7	Information Source for Medication Adherence HL7 Role Code	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.8	Information Source for Medication Adherence ParticpationFunction	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1267.9	Information Source for Medication Adherence SCT	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.1	Malnutrition	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.10	Fracture	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.11	Transplant Diagnoses	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.13	Transplant Diagnoses ICD10CM	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.14	Transplant Diagnoses SNOMED CT	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.15	Respiratory Procedures	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.2	Moderate Injuries (SNOMEDCT)	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.3	Diabetes	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.4	Diabetes	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.5	Diabetes	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.6	Immobility	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.7	Smoking status	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.8	Obesity	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1272.9	Hormone Therapy	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1282.1	Drug Intervention Not Indicated/Contraindicated	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1282.10	Endotracheal Intubation	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1282.2	Procedure Not Indicated/Contraindicated	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1282.9	Mechanical Circulatory Assist Device	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1289.1	RXNormSBD0305	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1289.2	RXNormSCD0305	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1290.4	Sequential Organ Failure Assessment SOFA	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1290.5	Septic Shock	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1290.6	Septic Shock	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.1	Administrative Gender (HL7 V3)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10267	ParticipationFunction	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10416	Financially Responsible Party Type Value Set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10612	Unknown Null	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10637	PostalAddressUse	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10901	ParticipationType	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.11610	x_ActRelationshipDocument	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12199	LanguageAbilityProficiency	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12212	Marital Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12249	LanguageAbilityMode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.14914	Race Value Set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.15913	EntityNameUse	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16926	HL7 BasicConfidentialityKind	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.18877	Coverage Role Type Value Set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19185	Religious Affiliation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19563	Personal Relationship Role Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19579	Family Member Value	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19601	x_ServiceEventPerformer	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19717	No Immunization Reason	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.12	HealthStatus	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2.3	ReferralDocumentType	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2.4	TransferDocumentType	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2.5	Wound Measurements	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2.6	Wound Type	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2.7	Nutritional Status	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2.9	Nutrition Recommendations	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2	Advance Directive Type Code	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.22	HPDocumentType	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20275	HealthcareServiceLocation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20549	Criticality Observation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.78	Observation Interpretation (HL7)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.1	Initial Case Report Trigger Code Result Status	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.12	Therapeutic Response to Medication	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.22.5.300	Transmission Based Precaution Types	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.22.5.304	Organism	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.22.5.305	Microbiology and Antimicrobial Susceptibility Tests	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.22.5.306	Infectious Disease	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.1.5.9.2	Codes for MDRO and CDI Summary Data LTCF	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.1.5.9.3	NHSNPrimaryResidentServiceType	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.1.5.9.4	Codes for Denominators for Long Term Care Locations LTCF	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.1.5.9.5	Codes for Prevention Process Measures LTCF	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.1.9.1	NHSNReportNoEventsMDROLTCF	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.10	Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Data	active	2019-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.11	Codes for Hemovigilance (HV) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.12	Codes for Intensive Care Unit (ICU) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.13	Codes for Neonatal Intensive Care Unit (NICU) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.15	Codes for Prevention Process and Outcome Measures (POM) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.16	Codes for Specialty Care Area (SCA) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.17	Codes for Vascular Access Type (Dialysis) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.18	NHSNReportNoEventsICU	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.19	NHSNReportNoEventsNICU	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.20	NHSNReportNoEventsSCA	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.21	NHSNReportNoEventsMDRO	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.22	NHSNReportNoEventsDialysis	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.24	NHSNVascularSpecimenCollectionSite	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.29	NHSNSSIDetectionMethod	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.3	NHSNLastLocationEncounterTypeCode	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.30	NHSNLOS/MENDischargeDisposition	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.31	NHSNSSIDetectionMethodType	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.32	Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.33	NHSNReportNoEventsOPCSameDayOutcomeMeasures	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.34	NHSNOPCProcedureCategoryCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.35	NHSNReportNoEventsAR	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.4	NHSNDrugSusceptibilityTestMethod	active	2020-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.40	NHSN COVID19 Case Classification	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.5	NHSN Pathogen Reduced Apheresis Platelet Usage	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.50	NHSNGenotypicTestInterpretation	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.6	HealthcarePersonnelType	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.7	NHSNInfluenzaVaccinationSetting	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.8	Codes for Antimicrobial Resistance Option (ARO) Summary Data	active	2020-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.10.20.5.9.9	Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Data	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.1.1	SurgicalOperationNoteDocumentTypeCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.12.1	Personal And Legal Relationship Role Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.4.1	DischargeSummaryDocumentTypeCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.6.1	ProcedureNoteDocumentTypeCodes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.7.1	SupportedFileFormats	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.8.1	ProgressNoteDocumentTypeCode	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.18	MoodCodeEvnInt	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.19	ProblemAct statusCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.20	Telecom Use (US Realm Header)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.21	AgePQ_UCUM	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.22	ProcedureAct statusCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.23	Planned moodCode (Act/Encounter/Procedure)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.24	Planned moodCode (SubstanceAdministration/Supply)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.25	Planned moodCode (Observation)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.26	EntityPersonNamePartQualifier	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.29	DIRQuantityMeasurementTypeCodes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.31	ConsultDocumentType	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.32	DIRDocumentTypeCodes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.33	INDRoleclassCodes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.34	Patient Education	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.35	Pressure Ulcer Stage	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.36	Pressure Point	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.37	TargetSite Qualifiers	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.38	Smoking Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.39	Result Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.41	Tobacco Use	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.44	Mental and Functional Status Response	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.46	Ability	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.47	ADL Result Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.49	Residence and Accommodation Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.50	Sensory Status Problem Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.51	Healthcare Agent Qualifier	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.52	Encounter SCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.54	Planned Intervention moodCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.55	Goal Achievement	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.56	Referral Types	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.58	Wound Characteristic	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.59	DIRSectionTypeCodes	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.60	Priority Level	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.61	Care Model	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.62	Related Document (append/replace)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.65	Physical Exam Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.66	Patient Referral Act moodCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.68	Note Types	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.1.1	Advance Care Planning Services CPT	active	2018-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.1.2	Advance Care Planning Services SCT	active	2018-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.1.3	Advance Care Planning Services Grouping	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.17	Obligation or Prohibition Instruction Type	active	2018-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.4	Advance Healthcare Directive Categories LOINC	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.5	Advance Directives Content Types	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.6	Planned or Completed moodCode	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.69.7	Obligation or Prohibition Instruction Type	active	2017-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.80	Pregnancy Status Determination Method	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.81	Estimated Date of Delivery Including Method	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.82	Estimated Gestational Age Code Including Method	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.84	Other Pregnancy Outcome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.86	Pregnancy Outcome	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.87	Postpartum Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.88	Pregnancy Related Findings	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.89	D(Rh) Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.90	D(Rh) Sensitized	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.91	Rho(D) Immune Globulin	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.1	NHSNEncounterTypeCode	active	2019-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.10	NHSNASAClassCode	active	2019-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.11	NHSNSpinalFusionLevelCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.12	NHSNOccasionOfDetectionCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.13	NHSNDrugSusceptibilityFindingCode	active	2020-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.15	NHSNDrugSusceptibilityTestsCode	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.16	NHSNPathogenCode	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.17	NHSNProcedureCategoryCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.19	NHSNHealthcareServiceLocationCode	active	2019-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.2	NHSNSpinalFusionApproachCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.20	NHSNInfectionTypeCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.3	NHSNHipReplacementCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.4	NHSNKneeReplacementCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.6	NHSNInfectionRiskFactorsCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.7	NHSNBloodStreamInfectionEvidenceTypeCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.13.9	NHSNWoundClassCode	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.2.1017	Closed Head and Facial Trauma	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.2.1018	Closed Head and Facial Trauma	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.1	Major Surgical Procedure	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.134	Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.136	Perforation of Uterus	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.137	Uterine Window	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.138	Uterine Rupture	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.200	Anticoagulant Therapy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.201	Antithrombotic Therapy Anticoagulant	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.202	Atrial Fibrillation or Flutter	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.203	Atrial Ablation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.204	Carotid Intervention	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.205	Direct Thrombin Inhibitor	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.207	Discharged to Health Care Facility for Hospice Care	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.209	Discharged to Home for Hospice Care	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.211	Injectable Factor Xa Inhibitor for VTE Prophylaxis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.212	Hemorrhagic Stroke	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.213	INR	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.214	Intermittent pneumatic compression devices	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.215	LDLc	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.218	Unfractionated Heparin	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.219	Low Molecular Weight Heparin for VTE Prophylaxis	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.222	Intravenous route	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.223	Subcutaneous route	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.226	Thrombolytic tPA Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.230	Venous foot pumps	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.232	Warfarin	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.234	Hemorrhagic Stroke	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.235	Hemorrhagic Stroke	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.238	Carotid Intervention	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.239	Carotid Intervention	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.242	Atrial Ablation	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.243	Atrial Ablation	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.244	Atrial Fibrillation or Flutter	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.245	Atrial Fibrillation or Flutter	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.246	Atrial Fibrillation or Flutter	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.247	Ischemic Stroke	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.25	Single Live Birth	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.251	Ischemic Stroke Embolism	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.252	Ischemic Stroke Embolism	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.255	General Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.256	Graduated compression stockings	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.257	Gynecological Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.258	Hip Fracture Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.259	Hip Replacement Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.26	Single Live Born Newborn Born in Hospital	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.260	Intracranial Neurosurgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.261	Knee Replacement Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.263	Obstetrical or Pregnancy Related Conditions	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.264	Obstetrics VTE	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.27	Dietary Intake Other than Human Milk	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.270	Acute or Persistent Asthma	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.271	Acute or Persistent Asthma	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.272	Urological Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.279	Venous Thromboembolism	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.281	Labor	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.282	Cesarean Birth	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.286	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.288	Medical Induction of Labor	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.292	Emergency Department Visit	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.294	Decision to Admit to Hospital Inpatient	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.295	Decision to Admit to Hospital Inpatient	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.296	Psychiatric/Mental Health Diagnosis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.298	Psychiatric/Mental Health Diagnosis	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.299	Psychiatric/Mental Health Diagnosis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.30	Human Milk	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.308	Left Against Medical Advice	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.309	Patient Expired	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.310	Gynecological Surgery	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.313	Gynecological Surgery	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.315	Knee Replacement Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.317	Knee Replacement Surgery	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.319	Hip Replacement Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.321	Hip Replacement Surgery	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.323	Hip Fracture Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.325	Hip Fracture Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.328	Venous Thromboembolism	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.33	Galactosemia	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.330	Venous Thromboembolism	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.331	Urological Surgery	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.333	Urological Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.335	Obstetrical or Pregnancy Related Conditions	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.337	Obstetrical or Pregnancy Related Conditions	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.338	Obstetrics VTE	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.340	Obstetrics VTE	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.344	Intracranial Neurosurgery	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.346	Intracranial Neurosurgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.348	General or Neuraxial Anesthesia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.35	Galactosemia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.361	General Surgery	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.365	General Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.367	Cesarean Birth	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.369	Cesarean Birth	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.37	Parenteral Nutrition	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.38	Parenteral Nutrition	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.384	Medical Induction of Labor	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.393	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.395	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.400	Low Risk	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.401	Delivery Procedures	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.418	Classical Cesarean Birth	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.419	Classical Cesarean Birth	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.421	Classical Cesarean Birth	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.422	Myomectomy	active	2024-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.423	Statin Allergen	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.424	Nonelective Inpatient Encounter	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.473	Medical Reason For Not Providing Treatment	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.75	Neonatal Intensive Care Unit	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.76	Single Live born Newborn	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.78	Galactosemia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.79	Parenteral Nutrition	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.87	Discharge To Acute Care Facility	active	2021-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.93	Patient Refusal	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1434.1047	Skin Melanoma pT1	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.100	Injectable Fluorouracil	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101	Trastuzumab and Biosimilars	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.102	Breast Cancer	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.103	HER2 Presence in Tissue	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.104	Depression Screening for Adult	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.105	Long Acting Opioids	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.106	High Fiber Supplement or Diet Education	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.107	Standardized Assessment Tools for Dyspnea	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.108	Nausea or Vomiting Assessment	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.109	Pancreatic Cancer	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.110	Pancreatic Cancer	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.111	Audio Visual Telehealth Encounter	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.112	Telephone Encounter	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.113	Telehealth Emergency Department or Initial Inpatient	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.114	Karnofsky Performance Status	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.115	Referral to Hospice Care	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.116	Referral to Palliative Care	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.117	Assessment Scale for Dyspnea	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.118	Nausea or Vomiting Assessment	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.119	Enrollment in Hospice Care	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.120	Palliative Care	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.121	Advance Directive Including Durable Power of Attorney or Instructional	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.122	Carmustine Injectable	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.123	Dacarbazine Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.124	Streptozocin Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.126	Alemtuzumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.127	Azacitidine Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.128	Bendamustine Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.129	Busulfan Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.130	Temozolomide Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.131	Thiotepa Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.132	Oxaliplatin Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.133	Romidepsin Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.134	Trabectedin Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.135	Dolasetron Oral	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.136	Dolasetron Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.137	Granisetron Oral	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.138	Granisetron Transdermal	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.139	Granisetron Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.140	Ondansetron Oral	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.141	Ondansetron Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.142	Ifosfamide Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.143	Arsenic Trioxide Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144	Netupitant Palonosetron Oral	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145	Fosnetupitant Palonosetron Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146	Aprepitant Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147	Rolapitant Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.148	Dexamethasone Oral	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.149	Dexamethasone Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.150	Dexamethasone Drug Implant	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.151	Olanzapine Oral	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.152	Olanzapine Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.153	Idarubicin Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.154	Neurokinin 1 Receptor Antagonist Ingredient	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.155	Serotonin Receptor Antagonist Ingredient	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.156	Clofarabine Injectable	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.157	Belinostat Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.158	Bortezomib Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.159	Cabazitaxel Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.160	Carfilzomib Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.161	Decitabine Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.162	Elotuzumab Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.163	Enfortumab Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.164	Eribulin Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.165	Etoposide Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.166	Inotuzumab Ozogamicin Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.167	Mitoxantrone Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.168	Moxetumomab Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.169	Necitumumab Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.170	Nelarabine Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.171	Temsirolimus Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.172	Tisagenlecleucel Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.173	Topotecan Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.178	Atezolizumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.179	Avelumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.180	Bleomycin Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.181	Cemiplimab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.182	Cladribine Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.183	Daratumumab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.184	Durvalumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.185	Emapalumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.186	Fludarabine Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.187	Ipilimumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.188	Nivolumab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189	Pembrolizumab Injectable	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.190	Polatuzumab Vedotin Injectable	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.191	Pralatrexate Injectable	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.192	Vincristine Injectable	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.193	Methotrexate Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194	Trastuzumab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.195	Mitomycin Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.196	Brentuximab Vedotin Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.197	Doxorubicin Pegylated Liposomal Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.198	Blinatumomab Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.199	Trastuzumab Emtansine Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.200	Gemtuzumab Ozogamicin Injectable	active	2021-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.201	Tagraxofusp Injectable	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.202	Axicabtagene Ciloleucel Injectable	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.203	BRCA1	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.204	BRCA2	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.205	BRCA1 Testing	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.207	Epithelial Ovarian Cancer	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.208	Primary Peritoneal Cancer	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.209	Fallopian Tube Cancer	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.210	Multigene Panel	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.211	BRCA1 and BRCA2	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.212	BRCA1 and BRCA2 Testing	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.213	BRAF V600	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.214	BRAF V600 Testing	active	2023-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.215	Colorectal Cancer	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.216	BRAF V600 Mutation Status	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.217	Cancer Stage I	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.218	Head and Neck Cancer	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.219	Malignant Melanoma of Skin	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.220	Brain Cancer	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.221	Waldenstrom Macroglobulinemia	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.222	High Emetic Risk Intravenous Antineoplastic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223	Moderate Emetic Risk Intravenous Antineoplastic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.224	Docetaxel Injectable	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.225	Cyclophosphamide Injectable	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.226	LAG 3 Inhibitor	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.227	Neoplasm of Brain	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.233	Chemotherapy Administration	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.240	Pathological N Stage N3c	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.241	Audio Visual Telehealth Encounter	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.242	Moderate or High Emetic Risk Oral Antineoplastic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.243	Minimal to Low Emetic Risk Oral Antineoplastic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.244	Copanlisib Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.245	Isatuximab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.246	Loncastuximab tesirine Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.247	Margetuximab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.248	Mirvetuximab soravtansine Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.249	Tafasitamab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.250	Teclistamab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.251	Tisotumab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.252	Asparaginase Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.254	Belantamab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.255	Dostarlimab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.256	Mosunetuzumab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.257	Tremelimumab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.258	Indication for Dexamethasone	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.260	Indication for Olanzapine	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.261	Indication for Dexamethasone	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.263	Indication for Olanzapine	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.264	Prednisone	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.265	As Needed PRN	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.266	Amivantamab Injectable	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.200	Doxorubicin	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.201	Epirubicin	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.202	Capecitabine	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.203	Cyclophosphamide	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.204	Injectable Fluorouracil	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.205	Methotrexate	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206	Trastuzumab and Biosimilars	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.207	HER2 Presence in Tissue	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.208	Carboplatin	active	2020-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.209	Depression Screening for Adult	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.210	Long Acting Opioids	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.211	High Fiber Supplement or Diet Education	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.212	Dexamethasone	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.213	Olanzapine	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.214	Pancreatic Cancer	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.215	Audio Visual Telehealth Encounter	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.216	Telephone Encounter	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.217	Telehealth Emergency Department or Initial Inpatient	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.218	Dyspnea Assessment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.219	Nausea or Vomiting Assessment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.220	Karnofsky Performance Status	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.221	Referral to Hospice Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.222	Referral to Palliative Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.223	Palliative Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.224	Enrollment in Hospice Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.225	Advance Directive Including Durable Power of Attorney or Instructional	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.228	Low Emetic Risk Intravenous Antineoplastic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.229	Minimal Emetic Risk Intravenous Antineoplastic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.232	Epithelial Ovarian Cancer	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.233	Primary Peritoneal Cancer	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.235	BRCA2 Testing	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.236	Multigene Panel	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.237	BRCA1 Testing	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.238	First Line Drug Therapy for Metastatic Colorectal Cancer	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.239	BRAF V600 Testing	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.240	Cancer Stage 4	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.241	Cancer Stage M1	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.242	High Emetic Risk Intravenous Antineoplastic Agent	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.243	Moderate Emetic Risk Intravenous Antineoplastic Agent	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.244	Anthracycline Injectable	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.245	Antiemetic Agent	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.247	Indication for Dexamethasone	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.249	Indication for Olanzapine	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.3	Race Category Excluding Nulls	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1	Abdomen CT without contrast	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.11	Oxycodone	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.12	Oxymorphone	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.70	Morphine	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.71	Methadone Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.72	Meperidine	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.73	Levorphanol	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.74	Hydromorphone	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.75	Hydrocodone	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.76	Fentanyl	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.77	Codeine	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.12	Butorphanol	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.13	Dihydrocodeine	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.14	Nalbuphine	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.15	Opium Combinations	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.16	Pentazocine	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.17	Tapentadol	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.18	Tramadol	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1017	Adrenal Mass	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1019	Diseases of Urinary System	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1020	Hematuria	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1021	Infections of Kidney	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1022	Jaundice	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1023	Liver Lesion (Mass or Neoplasm)	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1024	Malignant Neoplasm of Bladder	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1025	Malignant Neoplasm of Pancreas	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1026	Non Traumatic Aortic Disease	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1028	Unspecified Disorder of Kidney and Ureter	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1301	Surgery Integumentary System Breast	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1302	Surgery Respiratory System Accessory Sinuses	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1303	Surgery Respiratory System Larynx	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1304	Surgery Respiratory System Trachea and Bronchi	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1305	Surgery Respiratory System Lungs and Pleura	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.13064	Surgery Digestive System Esophagus	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1307	Surgery Digestive System Intestines (Except Rectum)	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1308	Surgery Digestive System Rectum	active	2019-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1309	Surgery Digestive System Anus	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1310	Surgery Digestive System Biliary Tract	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1311	Surgery Digestive System Abdomen Peritoneum Omentum	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1312	Surgery Digestive System Kidney	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.13133	Surgery Digestive System Ureter	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1314	Surgery Digestive System Bladder	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1315	Surgery Female Genital System Cervix Uteri	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1316	Surgery Female Genital System Corpus Uteri	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1317	Surgery Female Genital System Oviduct Ovary	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1318	Surgery Eye and Ocular Adnexa Anterior Segment	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.13193	Other Surgeries	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.13202	SPECT MPI	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.13213	Stress Echocardiography	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.13222	Stress MRI	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1323	CCTA	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1329	Diabetes Mellitus	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1330	Renal insufficiency	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1331	Stroke transient ischemic attack	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1332	Prior heart failure	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1333	Ischemic heart disease	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1802	Physical Therapy	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1803	Chiropractic Evaluation	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1804	Claim(s) for evaluation and management > 28 days and <60 days preceding the lumbar spine MRI	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1805	MRI Lumbar Spine Procedures	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1809	Other Deforming Dorsopathies	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1810	Spondylopathies	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1811	Other Dorsopathies	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1812	Biomechanical Lesions (not Elsewhere Classified)	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1813	Dislocation or Sprain of those Joints and Ligaments Located in the Lumbar Spine or Pelvis	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.18143	Patients with lumbar spine surgery in the 90 days prior to MRI	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1832	Cancer	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1833	Congenital spine and spinal cord malformations	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1834	Inflammatory and autoimmune disorders	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1835	Infectious conditions	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1836	Spinal vascular malformations and/or the cause of occult subarachnoid hemorrhage	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1837	Spinal cord infarction	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1838	Neoplastic abnormalities	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1839	Treatment fields for radiation therapy	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1840	Spinal abnormalities associated with scoliosis	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1841	Syringohydromyelia	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1842	Postoperative fluid collections and soft tissue changes	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1843	Trauma	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1844	IV Drug Abuse	active	2022-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1845	Neurological Impairment	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1846	Human Immunodeficiency Virus	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1847	Unspecified Immune Deficiencies	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.190123	Diagnostic Mammography Study	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1902	Ultrasound of the Breast	active	2019-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.190412	Screening Mammography and DBT Studies	active	2018-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.2	Abdomen CT with contrast	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.2000.1	Percutaneous Coronary Intervention ICD10	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.2000.2	Percutaneous Coronary Intervention SNOMEDCT	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.2000.3	Percutaneous Coronary Intervention CPT	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.2000.4	Percutaneous Coronary Intervention HCPCS	active	2018-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.2000.5	Percutaneous Coronary Intervention	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.21	Abdomen CT Without then With Contrast	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4009	Malignant Intracranial Neoplasm	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4010	Malignant Intracranial Neoplasm	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4015	STEMI	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4016	STEMI	active	2019-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4017	STEMI	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4019	Fibrinolytic Therapy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4023	Cerebral Vascular Lesion	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4024	Cerebral Vascular Lesion	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4025	Cerebral Vascular Lesion	active	2019-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4026	Closed Head and Facial Trauma	active	2019-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4028	Aortic Dissection or Ruptured Aortic Aneurysm	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4029	Acute Peptic Ulcer	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4030	Acute Peptic Ulcer	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4031	Acute Peptic Ulcer	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4032	Dementia and Related Intracranial Pathologies	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4033	Dementia and Related Intracranial Pathologies	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4034	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4035	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4036	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4043	Dementia and Related Intracranial Pathologies	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4044	Aortic Dissection or Ruptured Aortic Aneurysm	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4045	Oral Anticoagulant Medications	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4046	Cardiopulmonary Emergency	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4047	Cardiopulmonary Emergency	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4048	Cardiopulmonary Emergency	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4049	Mechanical Circulatory Assist Device	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4050	Mechanical Circulatory Assist Device	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4052	Mechanical Circulatory Assist Device	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4053	Pregnant State	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4054	Pregnant State	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4055	Pregnant State	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4056	Major Surgical Procedure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4057	Emergency Department Encounter	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4066	Diagnostic DBT Study	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3566.2.1005	Chronic Stable Angina	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3566.2.1006	Chronic Stable Angina	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3566.3.1002	Chronic Stable Angina	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1001	Hospice Encounter	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1002	Hospice Encounter	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1003	Hospice Encounter	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1004	Nutrition Services	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1005	Nutrition Services	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1006	Nutrition Services	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1007	Hospice Care Ambulatory	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1008	Hospice Care Ambulatory	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1005	Office Visit	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1020	Initial Hospital Inpatient Visit	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1030	Discharge Services Hospital Inpatient Same Day Discharge	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1035	Discharge Services Hospital Inpatient	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1040	Outpatient Consultation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1050	Emergency Department Evaluation and Management Visit	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1060	Nursing Facility Visit	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1065	Discharge Services Nursing Facility	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1080	Home Healthcare Services	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1110	Preventive Care, Initial Office Visit, 0 to 17	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1115	Preventive Care Services Initial Office Visit, 18 and Up	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1120	Preventive Care, Established Office Visit, 0 to 17	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1125	Preventive Care Services Established Office Visit, 18 and Up	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1130	Preventive Care Services Individual Counseling	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1135	Preventive Care Services Group Counseling	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1215	Referral	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1216	Face-to-Face Interaction	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1221	Behavioral Health Follow up Visit	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1222	Psychotherapy and Pharmacologic Management	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1228	Detoxification Visit	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1232	Audiology Visit	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1233	Medical Disability Exam	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1260	Telephone Visits	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1261	Nursing Facility Visit	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1262	Care Services in Long Term Residential Facility	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1264	Office Visit	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1265	Home Healthcare Services	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1266	Outpatient Consultation	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1276	Frailty Encounter	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1277	Outpatient Encounter	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1278	Outpatient Encounter	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1279	Frailty Encounter	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1281	Virtual Encounter	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1282	Virtual Encounter	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1284	Outpatient Encounter	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1285	Palliative Encounter	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1286	Palliative Encounter	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1287	Telephone Visits	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001	Office Visit	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1004	Initial Hospital Inpatient Visit	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1006	Discharge Services Hospital Inpatient Same Day Discharge	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1007	Discharge Services Hospital Inpatient	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1008	Outpatient Consultation	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1010	Emergency Department Evaluation and Management Visit	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1012	Nursing Facility Visit	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1013	Discharge Services Nursing Facility	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1014	Care Services in Long Term Residential Facility	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1016	Home Healthcare Services	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1022	Preventive Care Services, Initial Office Visit, 0 to 17	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1023	Preventive Care Services Initial Office Visit, 18 and Up	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1024	Preventive Care, Established Office Visit, 0 to 17	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1025	Preventive Care Services Established Office Visit, 18 and Up	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1026	Preventive Care Services Individual Counseling	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1027	Preventive Care Services Group Counseling	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1046	Referral	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1048	Face-to-Face Interaction	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1054	Behavioral Health Follow up Visit	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1055	Psychotherapy and Pharmacologic Management	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1059	Detoxification Visit	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1066	Audiology Visit	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1073	Medical Disability Exam	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1080	Telephone Visits	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1087	Outpatient Encounter	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1088	Frailty Encounter	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1089	Virtual Encounter	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1090	Palliative Care Encounter	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1010	Multiple Myeloma	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1011	Multiple Myeloma	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1012	Premature Menopause	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1013	Premature Menopause	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1014	Multiple Myeloma	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1015	Premature Menopause	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1019	Amenorrhea	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1031	Acute Pharyngitis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1033	Acute Pharyngitis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1034	Acute Tonsillitis	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1036	Acute Tonsillitis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1058	Upper Respiratory Infection	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1059	Upper Respiratory Infection	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1066	Comorbid Conditions for Respiratory Conditions	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.11.1067	Comorbid Conditions for Respiratory Conditions	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.12.1011	Acute Pharyngitis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.12.1012	Acute Tonsillitis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.12.1017	Competing Conditions for Respiratory Conditions	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.12.1022	Upper Respiratory Infection	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.102.12.1025	Comorbid Conditions for Respiratory Conditions	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1021	Amenorrhea	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1022	Amenorrhea	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1025	Bilateral Oophorectomy	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1026	Unilateral Oophorectomy Left	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1028	Unilateral Oophorectomy Left	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1029	Unilateral Oophorectomy Left	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.103.12.1001	Diabetes	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.103.12.1020	Type 1 Diabetes	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1030	Unilateral Oophorectomy Right	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1031	Unilateral Oophorectomy Right	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1032	Unilateral Oophorectomy Right	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1034	Unilateral Oophorectomy, Unspecified Laterality	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1035	Unilateral Oophorectomy, Unspecified Laterality	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1036	Eating Disorders	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1038	Eating Disorders	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1039	Eating Disorders	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.104.11.1029	Essential Hypertension	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.104.11.1031	Essential Hypertension	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.104.12.1011	Essential Hypertension	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1040	Major Transplant	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1042	Major Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1043	Potentially Harmful Antihistamines for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1046	Evidence of Bilateral Oophorectomy	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1048	Evidence of Bilateral Oophorectomy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1049	Potentially Harmful Antiparkinsonian Agents for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1010	Mental Health Diagnoses	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1012	Mental Health Diagnoses	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1017	Major Depression	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1019	Major Depression	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1060	Major Depression In Remission	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1062	Major Depression In Remission	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1161	Schizophrenia or Psychotic Disorder	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1162	Schizophrenia or Psychotic Disorder	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1163	Schizophrenia or Psychotic Disorder	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1178	Pervasive Developmental Disorder	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1180	Pervasive Developmental Disorder	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1206	Mental Behavioral and Neurodevelopmental Disorders	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1207	Mental Behavioral and Neurodevelopmental Disorders	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1210	Schizophrenia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1211	Schizophrenia	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1212	Seizure Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1213	Seizure Disorder	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1214	REM	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1215	REM	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1216	Benzodiazepine Withdrawal	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1217	Benzodiazepine Withdrawal	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1218	Alcohol Withdrawal	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1219	Alcohol Withdrawal	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1220	General Anxiety	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.11.1221	General Anxiety	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1004	Mental Health Diagnoses	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1007	Major Depression	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1104	Schizophrenia or Psychotic Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1152	Pervasive Developmental Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1203	Mental Behavioral and Neurodevelopmental Disorders	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1205	Schizophrenia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1206	Seizure Disorder	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1207	REM Sleep Behavior Disorder	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1208	Benzodiazepine Withdrawal	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1209	Alcohol Withdrawal	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.105.12.1210	Generalized Anxiety Disorder	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050	Potentially Harmful Gastrointestinal Antispasmodics for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1051	Dipyridamole Medications	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1053	Nifedipine Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1054	Potentially Harmful Antidepressants for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1055	Potentially Harmful Barbiturates for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1057	Meprobamate Medications	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1058	Potentially Harmful Estrogens for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1059	Potentially Harmful Sulfonylureas for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1001	Substance Use Disorder	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1003	Substance Use Disorder	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1012	Substance Use Disorder Treatment	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036	Substance Use Disorder Treatment	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.12.1001	Substance Use Disorder	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005	Substance Use Disorder Treatment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1060	Desiccated Thyroid Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1062	Potentially Harmful Skeletal Muscle Relaxants for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1063	Potentially Harmful Pain Medications for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1065	Digoxin Medications	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1066	Digoxin Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1067	Doxepin Medications	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1068	Doxepin Medications	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1001	Malignant Neoplasm of Colon	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1003	Malignant Neoplasm of Colon	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1025	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1027	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1044	Pap Test	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1047	Mammography	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1051	Colonoscopy	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1052	Colonoscopy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1053	Colonoscopy	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.11.1145	sDNA FIT Test	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1001	Malignant Neoplasm of Colon	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1009	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1017	Pap Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1018	Mammography	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1020	Colonoscopy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1038	CT Colonography	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.1039	sDNA FIT Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1024	Kidney Transplant	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1025	Kidney Transplant	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1026	Dialysis Services	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1027	Dialysis Services	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1028	Dialysis Services	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1029	ESRD Monthly Outpatient Services	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1052	Kidney Transplant	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1060	Kidney Transplant Recipient	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.11.1067	Kidney Transplant	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.12.1012	Kidney Transplant	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.12.1013	Dialysis Services	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.12.1014	ESRD Monthly Outpatient Services	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.109.12.1029	Kidney Transplant Recipient	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1065	DTaP Vaccine Administered	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1066	DTaP Vaccine Administered	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1068	Hepatitis A	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1070	Hepatitis A	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1078	Measles	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1080	Measles	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1085	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1087	Mumps	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1089	Mumps	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1098	Rubella	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.110	Rubella	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1104	Varicella Zoster	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1105	Varicella Zoster	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106	Varicella Zoster Vaccine (VZV) Administered	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107	Varicella Zoster Vaccine (VZV) Administered	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1109	Hepatitis A Vaccine Administered	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1110	Hepatitis A Vaccine Administered	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111	Hepatitis B Vaccine Administered	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112	Hepatitis B Vaccine Administered	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115	Child Influenza Vaccine Administered	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116	Child Influenza Vaccine Administered	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117	Inactivated Polio Vaccine (IPV) Administered	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1118	Inactivated Polio Vaccine (IPV) Administered	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1119	Pneumococcal Conjugate Vaccine Administered	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1120	Rotavirus Vaccine (3 dose schedule) Administered	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1121	Rotavirus Vaccine (2 dose schedule) Administered	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1123	Genital Herpes	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1124	Genital Herpes	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1128	Lab Tests for Sexually Transmitted Infections	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1129	Chlamydia Screening	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1133	Pneumococcal Conjugate Vaccine Administered	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1135	HPV Test	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1148	Rotavirus Vaccine (2 Dose Schedule) Administered	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1149	Rotavirus Vaccine (3 Dose Schedule) Administered	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1150	Advanced Illness	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1151	Advanced Illness	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1152	HiB Vaccine (3 dose schedule)	active	2021-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153	HiB Vaccine (3 dose schedule) Administered	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154	HiB Vaccine (4 dose schedule)	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155	HiB Vaccine (4 dose schedule) Administered	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156	HiB Vaccine (3 dose schedule) Administered	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157	HiB Vaccine (4 dose schedule) Administered	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1158	Competing Conditions for Respiratory Conditions	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1159	Competing Conditions for Respiratory Conditions	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1022	DTaP Vaccine Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1024	Hepatitis A	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1032	Mumps	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1037	Rubella	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1039	Varicella Zoster	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040	Varicella Zoster Vaccine (VZV) Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1041	Hepatitis A Vaccine Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042	Hepatitis B Vaccine Administered	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044	Child Influenza Vaccine Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045	Inactivated Polio Vaccine (IPV) Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1046	Pneumococcal Conjugate Vaccine Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1047	Rotavirus Vaccine (3 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1048	Rotavirus Vaccine (2 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1049	Genital Herpes	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1051	Lab Tests for Sexually Transmitted Infections	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1052	Chlamydia Screening	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1053	Measles	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1059	HPV Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1082	Advanced Illness	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1083	Hib Vaccine (3 dose schedule)	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084	Hib Vaccine (3 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1085	Hib Vaccine (4 dose schedule)	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1086	Hib Vaccine (4 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1087	Influenza Virus LAIV Vaccine	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1088	Influenza Virus LAIV Vaccine Administered	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1012	Lab Tests During Pregnancy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1013	Diagnostic Studies During Pregnancy	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1019	Pregnancy Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1022	Complications of Pregnancy, Childbirth and the Puerperium	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1023	Complications of Pregnancy, Childbirth and the Puerperium	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1028	Procedures for Sexual Activity	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1030	Procedures for Sexual Activity	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1031	Diagnosis for Sexual Activity	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1032	Diagnosis for Sexual Activity	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.11.1033	Procedures for Sexual Activity	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1007	Lab Tests During Pregnancy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1008	Diagnostic Studies During Pregnancy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1011	Pregnancy Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1012	Complications of Pregnancy, Childbirth and the Puerperium	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1016	Congenital or Acquired Absence of Cervix	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1017	Procedures Used to Indicate Sexual Activity	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.111.12.1018	Diagnoses Used to Indicate Sexual Activity	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.112.11.1024	Absence of Cervix	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.112.11.1025	Absence of Cervix	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.112.11.1026	Absence of Cervix	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1073	Osteoporosis Without Current Fracture	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1074	Osteoporosis Without Current Fracture	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1078	History of hip fracture in parent	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1080	Rheumatoid Arthritis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1081	Rheumatoid Arthritis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1083	Central DXA of Hip or Spine	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1085	Osteogenesis Imperfecta	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1087	Osteogenesis Imperfecta	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1088	Ankylosing Spondylitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1090	Ankylosing Spondylitis	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1091	Psoriatic Arthritis	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1093	Psoriatic Arthritis	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1094	Ehlers Danlos Syndrome	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1096	Ehlers Danlos Syndrome	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1097	Marfan's Syndrome	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1099	Marfan's Syndrome	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1100	Osteopenia	active	2018-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1102	Osteopenia	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1200	Osteoporosis With Current Fracture	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1201	Osteoporosis With Current Fracture	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1202	DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1308	Frailty Diagnosis	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1309	Frailty Diagnosis	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1310	Frailty Symptom	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.11.1311	Frailty Symptom	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1005	Rheumatoid Arthritis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1038	Osteoporosis Without Current Fracture	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1040	History of hip fracture in parent	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1044	Osteogenesis Imperfecta	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1045	Ankylosing Spondylitis	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1046	Psoriatic Arthritis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1047	Ehlers Danlos Syndrome	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1048	Marfan's Syndrome	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1049	Osteopenia	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1050	Osteoporosis With Current Fracture	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1051	DXA (Dual energy Xray Absorptiometry) Scan	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1074	Frailty Diagnosis	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.113.12.1075	Frailty Symptom	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.11.1021	Narcolepsy	active	2018-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.11.1023	Narcolepsy	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.11.1024	Neurologic impairment	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.11.1025	Neurologic impairment	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.11.1026	Neurologic impairment	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.12.1011	Narcolepsy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.114.12.1012	Neurologic impairment	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1149	Substance Use Disorder Long Acting Medication	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.115.11.1248	Retinal or Dilated Eye Exam	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.115.12.1088	Retinal or Dilated Eye Exam	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150	Substance Use Disorder Short Acting Medication	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1151	Substance Use Disorder Long Acting Medication Administration	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1152	Substance Use Disorder Short Acting Medication Administration	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1155	Substance Use Disorder Short Acting Medication Administration	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1156	Substance Use Disorder Long Acting Medication Administration	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1157	Substance Use Disorder Short Acting Medication Administration	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1163	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1164	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1165	Hospice Diagnosis	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1166	Hospice Diagnosis	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1167	Palliative Care Diagnosis	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1168	Palliative Care Diagnosis	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1169	Palliative Care Diagnosis	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1023	Cushings Syndrome	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1025	Cushings Syndrome	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1026	Lupus	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1028	Lupus	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1031	Hyperthyroidism	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1033	Hyperthyroidism	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1034	Hyperparathyroidism	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.11.1036	Hyperparathyroidism	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.12.1009	Cushings Syndrome	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.12.1010	Lupus	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.12.1015	Hyperthyroidism	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.117.12.1016	Hyperparathyroidism	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1170	Atomoxetine	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1171	Clonidine	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1172	Dexmethylphenidate	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1173	Dextroamphetamine	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1174	Lisdexamfetamine	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1176	Methylphenidate	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1177	Lower Body Fractures Excluding Ankle and Foot	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1178	Lower Body Fractures Excluding Ankle and Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1179	Malignant Neoplasms of Lower and Unspecified Limbs	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.11.1042	Counseling for Physical Activity	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.11.1077	Falls Screening	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.11.1097	CT Colonography	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.11.1220	Frailty Device SNOMED	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.12.1028	Falls Screening	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.12.1035	Counseling for Physical Activity	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.118.12.1300	Frailty Device	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1180	Malignant Neoplasms of Lower and Unspecified Limbs	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1181	Mechanical Complications Excluding Upper Body	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1182	Mechanical Complications Excluding Upper Body	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1183	Partial Arthroplasty of Hip	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1184	Partial Arthroplasty of Hip	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1188	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2022-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1189	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1190	Antibiotic Medications for Upper Respiratory Infection	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1193	Malignant Neoplasms	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1194	Malignant Neoplasms	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1196	Atherosclerosis of the Extremities	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1197	Atherosclerosis of the Extremities	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1198	Atherosclerosis of the Extremities	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1199	Lower Extremity Neurological Assessment Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1001	Disorders of the Immune System	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1003	Disorders of the Immune System	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1004	HIV Viral Load	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1005	HIV 1	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1007	HIV 1	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1008	HIV 2	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1010	HIV 2	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1011	Severe Combined Immunodeficiency	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.11.1012	Severe Combined Immunodeficiency	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1001	Disorders of the Immune System	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1002	HIV Viral Load	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003	HIV	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1007	Severe Combined Immunodeficiency	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1200	Lower Extremity Neurological Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1201	Lower Extremity Visual Inspection Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1202	Lower Extremity Visual Inspection Test	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1203	Monofilament Test Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1204	Monofilament Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1205	Pedal Pulse Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1206	Peripheral Neuropathy	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1207	Peripheral Neuropathy	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1208	Peripheral Neuropathy	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1209	Amputation of Bilateral Feet	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.11.1011	Consultant Report	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.11.1028	BMI percentile	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.11.1030	Height	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.11.1031	Weight	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.12.1006	Consultant Report	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.12.1012	BMI percentile	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.12.1014	Height	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.12.1015	Weight	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1210	Amputation of Bilateral Feet	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1211	Amputation of Bilateral Feet	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1212	Amputation of Left Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1213	Amputation of Left Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1214	Amputation of Left Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1215	Amputation of Right Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1216	Amputation of Right Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1217	Amputation of Right Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1218	Amputation of Unspecified Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1219	Amputation of Unspecified Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.122.11.1003	Ambulatory	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.122.12.1003	Ambulatory	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1220	Foot Assessment With Abnormal Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1221	Foot Assessment With Abnormal Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1222	Acquired Absence of Bilateral feet	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1223	Acquired Absence of Bilateral feet	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1224	Acquired Absence of Left Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1225	Acquired Absence of Left Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1226	Acquired Absence of Left Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1227	Acquired Absence of Right Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1228	Acquired Absence of Right Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1229	Acquired Absence of Right Foot	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1230	Lower Body Fractures Excluding Ankle and Foot	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1231	Malignant Neoplasms of Lower and Unspecified Limbs	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1232	Mechanical Complications Excluding Upper Body	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1233	Partial Arthroplasty of Hip	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1234	Partial Arthroplasty of Hip	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1235	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1236	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1237	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1238	Primary THA Procedure	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1239	Foot Ulcer	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1240	Foot Ulcer	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1241	Foot Ulcer	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1242	Referral for Foot Care	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1243	Therapeutic Footwear	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1244	Foot Deformity	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1245	Foot Deformity	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1246	Foot Deformity	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1247	Megestrol Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1248	Meperidine Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1249	Potentially Harmful Antidepressants for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.11.1004	Fluoride Varnish Application for Children	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.11.1007	Dental Caries	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.11.1009	Dental Caries	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.11.1010	Clinical Oral Evaluation	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.11.1011	Fluoride Varnish Application for Children	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.12.1002	Fluoride Varnish Application for Children	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.12.1003	Clinical Oral Evaluation	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.125.12.1004	Dental Caries	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1250	Potentially Harmful Antihistamines for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1251	Potentially Harmful Antiparkinsonian Agents for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1252	Potentially Harmful Barbiturates for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1253	Potentially Harmful Estrogens for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1254	Potentially Harmful Gastrointestinal Antispasmodics for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1255	Potentially Harmful Pain Medications for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1256	Potentially Harmful Skeletal Muscle Relaxants for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1257	Potentially Harmful Sulfonylureas for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1258	Substance Use Disorder Long Acting Medication	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259	Substance Use Disorder Short Acting Medication	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1260	Viloxazine	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1266	Diabetic Retinopathy Severity Level	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1272	Diabetes	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1273	Diabetes	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.195.11.1003	Counseling for Nutrition	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.195.11.1004	Counseling for Nutrition	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.195.12.1003	Counseling for Nutrition	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1001	Antibiotic Medications for Pharyngitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1078	Nifedipine Medications	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1080	Contraceptive Medications	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1109	Meperidine Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1129	Desiccated Thyroid Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1143	Isotretinoin	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1167	Dipyridamole Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1205	Leucovorin	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1211	Aspirin and Other Antiplatelets	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1212	DTaP Vaccine	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1214	Hepatitis A Vaccine	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1216	Hepatitis B Vaccine	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1220	Child Influenza Vaccine	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1222	Inactivated Polio Vaccine (IPV)	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1228	Pneumococcal Conjugate Vaccine	active	2023-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1232	Rotavirus Vaccine (3 dose schedule)	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1234	Varicella Zoster Vaccine (VZV)	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1235	Measles, Mumps and Rubella (MMR) Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1252	Guanfacine Medications	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1255	Megestrol Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1256	Meprobamate Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1266	Aromatase Inhibitors	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1267	Glucocorticoids (oral only)	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1481	Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1482	Potentially Harmful Antiinfectives for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1517	Dementia Medications	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1530	Antidepressant Medication	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1531	Potentially Harmful Benzodiazepines for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1532	Potentially Harmful Antipsychotics for Older Adults	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1001	Antibiotic Medications for Pharyngitis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1080	Contraceptive Medications	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1143	Isotretinoin	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1170	Varicella Zoster Vaccine (VZV)	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1205	Leucovorin	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1211	Aspirin and Other Antiplatelets	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1213	Antidepressant Medication	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1214	DTaP Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1215	Hepatitis A Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1216	Hepatitis B Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1218	Child Influenza Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219	Inactivated Polio Vaccine (IPV)	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1221	Pneumococcal Conjugate Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1223	Rotavirus Vaccine (3 dose schedule)	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1224	Measles, Mumps and Rubella (MMR) Vaccine	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1265	Aromatase Inhibitors	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1266	Glucocorticoids (oral only)	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1480	Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1481	Potentially Harmful Antiinfectives for Older Adults	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1510	Dementia Medications	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1522	Potentially Harmful Benzodiazepines for Older Adults	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1523	Potentially Harmful Antipsychotics for Older Adults	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1005	Bilateral Mastectomy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1009	Primary THA Procedure	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1015	Flexible Sigmoidoscopy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1016	Flexible Sigmoidoscopy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1017	Flexible Sigmoidoscopy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1020	Fecal Occult Blood Test (FOBT)	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1023	Group A Streptococcus Test	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1024	HbA1c Laboratory Test	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1026	Hysterectomy with No Residual Cervix	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1027	Hysterectomy with No Residual Cervix	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1035	Total Colectomy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1036	Total Colectomy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1055	XRay Study	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1061	Gastric Bypass Surgery	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1062	Gastric Bypass Surgery	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1080	Primary THA Procedure	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1084	History of bilateral mastectomy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1085	History of bilateral mastectomy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1086	Status Post Left Mastectomy	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1087	Status Post Right Mastectomy	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1089	Unilateral Mastectomy, Unspecified Laterality	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1090	Unilateral Mastectomy, Unspecified Laterality	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1091	Status Post Left Mastectomy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1092	Status Post Right Mastectomy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1096	Major Transplant	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1097	Major Transplant	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1132	Unilateral Mastectomy Left	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1133	Unilateral Mastectomy Right	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1134	Hysterectomy with No Residual Cervix	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1135	Hysterectomy with No Residual Cervix	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1140	Bilateral Mastectomy	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1143	Total Colectomy	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1144	Unilateral Mastectomy Left	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1145	Unilateral Mastectomy Right	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1148	Palliative Intervention	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1005	Bilateral Mastectomy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1006	Primary THA Procedure	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1010	Flexible Sigmoidoscopy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1011	Fecal Occult Blood Test (FOBT)	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1012	Group A Streptococcus Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1013	HbA1c Laboratory Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1014	Hysterectomy with No Residual Cervix	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1019	Total Colectomy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1034	XRay Study	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1050	Gastric Bypass Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1068	History of bilateral mastectomy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1069	Status Post Left Mastectomy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1070	Status Post Right Mastectomy	active	2017-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1071	Unilateral Mastectomy, Unspecified Laterality	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1075	Major Transplant	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1133	Unilateral Mastectomy Left	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1134	Unilateral Mastectomy Right	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.12.1135	Palliative Care Intervention	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1064	Anaphylactic Reaction to DTaP Vaccine	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1065	Chronic Liver Disease	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1067	Chronic Liver Disease	active	2022-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1068	Chronic Malnutrition	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1070	Chronic Malnutrition	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1100	Malabsorption Syndromes	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1102	Malabsorption Syndromes	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1105	Intussusception	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1106	Intussusception	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1107	Influenza Virus LAIV Vaccine	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1108	Influenza Virus LAIV Vaccine Administered	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.12.1031	Anaphylactic Reaction to DTaP Vaccine	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.12.1035	Chronic Liver Disease	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.12.1036	Chronic Malnutrition	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.12.1050	Malabsorption Syndromes	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.12.1056	Intussusception	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2446	Lower Extremity Visual Inspection Test	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2447	Pedal Pulse Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2448	Monofilament Test Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2449	Monofilament Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2450	Lower Extremity Neurological Assessment Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2451	Lower Extremity Neurological Tests	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2452	Lower Extremity Visual Inspection Result or Finding	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1004.2616	Autonomous Eye Exam Result or Finding	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.1577	Pharmacologic Therapy for Hypertension	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1036	Chronic Kidney Disease, Stage 5	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1037	Chronic Kidney Disease, Stage 5	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1049	Patient Provider Interaction	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1058	Psych Visit for Family Psychotherapy	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1062	Physical Therapy Evaluation	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1063	Occupational Therapy Evaluation	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1064	Neurobehavioral Status Exam (CPT)	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1067	Dementia and Mental Degenerations	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1068	Dementia and Mental Degenerations	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1069	Standardized Tools for Assessment of Cognition	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1071	Radiation Treatment Management	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1072	Radiation Treatment Management	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1073	Standardized Pain Assessment Tool	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1078	Cancer	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1079	Cancer	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1080	Chemotherapy Administration	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1081	Chemotherapy Administration	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.111	Ophthalmological Services	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.113	Prostate Cancer Treatment	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.118	Initial Myocardial Infarction	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.119	Initial Myocardial Infarction	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.120	Coronary Artery Disease No MI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1238	Ejection Fraction	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1243	Psychoanalysis	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1244	Renal Failure Due to ACE Inhibitor	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1251	Group Psychotherapy	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1256	Allergy to ACE Inhibitor or ARB	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1257	Intolerance to ACE Inhibitor or ARB	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.133	Beta Blocker Therapy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1333	Allergy to Beta Blocker Therapy	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1334	Intolerance to Beta Blocker Therapy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1341	Heart Rate	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1342	Beta Blocker Therapy for LVSD	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1344	Acute and Subacute Iridocyclitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1353	Limited Life Expectancy	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1363	Annual Wellness Visit	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1364	Macular Exam	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1372	Tobacco Use Screening	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1374	Bone Scan	active	2018-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1377	Level of Severity of Retinopathy Findings	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1381	Macular Edema Findings Present	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1401	Cognitive Assessment	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1402	Cup to Disc Ratio	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1403	Optic Disc Exam for Structural Abnormalities	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1509	Acute and Subacute Iridocyclitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1521	Burn Confined to Eye and Adnexa	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1523	Burn Confined to Eye and Adnexa	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1524	Cataract Secondary to Ocular Disorders	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1526	Cataract Secondary to Ocular Disorders	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1527	Cataract Surgery	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1528	Cataract Surgery	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1529	Cataract Congenital	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1530	Cataract Congenital	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1532	Cataract Mature or Hypermature	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1534	Cataract Mature or Hypermature	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1535	Cataract Posterior Polar	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1537	Cataract Posterior Polar	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1538	Certain Types of Iridocyclitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1540	Certain Types of Iridocyclitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1542	Chronic Iridocyclitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1543	Chronic Iridocyclitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1544	Cloudy Cornea	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1546	Cloudy Cornea	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1548	Corneal Edema	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1549	Corneal Edema	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1550	Disorders of Cornea Including Corneal Opacity	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1552	Disorders of Cornea Including Corneal Opacity	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1561	Glaucoma	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1562	Glaucoma	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1564	Hereditary Corneal Dystrophies	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1566	Hereditary Corneal Dystrophies	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1571	Hypotony of Eye	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1572	Hypotony of Eye	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1574	Injury to Optic Nerve and Pathways	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1575	Injury to Optic Nerve and Pathways	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1577	Central Corneal Ulcer	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1578	Central Corneal Ulcer	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1582	Open Wound of Eyeball	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1583	Open Wound of Eyeball	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1587	Pathologic Myopia	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1588	Pathologic Myopia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1590	Posterior Lenticonus	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1591	Posterior Lenticonus	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1601	Retrolental Fibroplasias	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1603	Retrolental Fibroplasias	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1612	Traumatic Cataract	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1613	Traumatic Cataract	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1615	Uveitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1617	Uveitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1618	Vascular Disorders of Iris and Ciliary Body	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1620	Vascular Disorders of Iris and Ciliary Body	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1621	Visual Field Defects	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1623	Visual Field Defects	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1626	Amblyopia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1628	Amblyopia	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1632	Choroidal Degenerations	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1634	Choroidal Degenerations	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1635	Choroidal Detachment	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1637	Choroidal Detachment	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1638	Choroidal Hemorrhage and Rupture	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1640	Choroidal Hemorrhage and Rupture	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1641	Degeneration of Macula and Posterior Pole	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1643	Degeneration of Macula and Posterior Pole	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1644	Degenerative Disorders of Globe	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1646	Degenerative Disorders of Globe	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1647	Diabetic Macular Edema	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1649	Diabetic Macular Edema	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1653	Disorders of Optic Chiasm	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1655	Disorders of Optic Chiasm	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1656	Disorders of Visual Cortex	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1658	Disorders of Visual Cortex	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1659	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1661	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1662	Focal Chorioretinitis and Focal Retinochoroiditis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1664	Focal Chorioretinitis and Focal Retinochoroiditis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1665	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1667	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1668	Hereditary Choroidal Dystrophies	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1670	Hereditary Choroidal Dystrophies	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1671	Hereditary Retinal Dystrophies	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1673	Hereditary Retinal Dystrophies	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1677	Nystagmus and Other Irregular Eye Movements	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1679	Nystagmus and Other Irregular Eye Movements	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.168	Cardiac Surgery	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1680	Optic Atrophy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1682	Optic Atrophy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1683	Optic Neuritis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1685	Optic Neuritis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1686	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1688	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1689	Other Background Retinopathy and Retinal Vascular Changes	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.169	Cardiac Surgery	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1691	Other Background Retinopathy and Retinal Vascular Changes	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1695	Other Disorders of Optic Nerve	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1697	Other Disorders of Optic Nerve	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1701	Other Endophthalmitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1703	Other Endophthalmitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1707	Prior Penetrating Keratoplasty	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1709	Prior Penetrating Keratoplasty	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1713	Purulent Endophthalmitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1715	Purulent Endophthalmitis	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1716	Retinal Detachment with Retinal Defect	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1718	Retinal Detachment with Retinal Defect	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1719	Retinal Vascular Occlusion	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1721	Retinal Vascular Occlusion	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1722	Other Proliferative Retinopathy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1724	Other Proliferative Retinopathy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1728	Separation of Retinal Layers	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1730	Separation of Retinal Layers	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1731	Visual Acuity 20/40 or Better	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.175	Hypotension	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1752	Speech and Hearing Evaluation	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.176	Arrhythmia	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1766	Morgagnian Cataract	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1767	Morgagnian Cataract	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1769	Macular Scar of Posterior Polar	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.177	Atrioventricular Block	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1770	Macular Scar of Posterior Polar	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1771	Ophthalmological Services	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1772	Annual Wellness Visit	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1773	Speech and Hearing Evaluation	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1774	Occupational Therapy Evaluation	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1775	Behavioral Neuropsych Assessment	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1776	Psych Visit Diagnostic Evaluation	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1777	Psych Visit Psychotherapy	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1778	Psychoanalysis	active	2019-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1779	Group Psychotherapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.178	Cardiac Pacer in Situ	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1780	Psych Visit for Family Psychotherapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1781	Best Corrected Visual Acuity Exam Using Snellen Chart	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1782	Physical Therapy Evaluation	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.180	Hypotension	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.181	Arrhythmia	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.183	Cardiac Pacer in Situ	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.185	Hypotension	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.186	Arrhythmia	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.187	Atrioventricular Block	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1912	Major Depressive Disorder Active	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1918	Major Depressive Disorder Active	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1921	Beta Blocker Therapy Ingredient	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1923	Psych Visit Diagnostic Evaluation	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1924	Cardiac Pacer in Situ	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.408	Bradycardia	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.410	Bradycardia	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.411	Bradycardia	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.422	Tobacco User	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.423	Tobacco Use Cessation Pharmacotherapy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.424	Tobacco Use Cessation Counseling	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.425	Tobacco Use Cessation Counseling	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.450	Pain Warranting Further Investigation for Prostate Cancer	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.469	Bilateral Oophorectomy	active	2017-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.470	Bilateral Oophorectomy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.483	Chemotherapy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.484	Chemotherapy	active	2021-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.511	Tobacco Non User	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.532	Pregnancy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.56	Coronary Artery Disease No MI	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.57	Coronary Artery Disease No MI	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.58	Initial Myocardial Infarction	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.589	End Stage Renal Disease	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.59	Asthma	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.590	End Stage Renal Disease	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.60	Asthma	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.61	Asthma	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.73	Primary Open Angle Glaucoma	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.74	Primary Open Angle Glaucoma	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.76	Diabetic Retinopathy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.80	Diabetic Retinopathy	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.859	Left Ventricular Systolic Dysfunction	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.860	Moderate or Severe	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.861	Moderate or Severe LVSD	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.91	Prostate Cancer	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.92	Prostate Cancer	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1002	Chronic Kidney Disease, Stage 5	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1005	Dementia and Mental Degenerations	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1006	Standardized Tools Score for Assessment of Cognition	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1007	Medical Reason	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1008	Patient Reason	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1010	Cancer	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1011	Occupational Therapy Evaluation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1012	Patient Provider Interaction	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1018	Psych Visit for Family Psychotherapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1022	Physical Therapy Evaluation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1023	Behavioral or Neuropsych Assessment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1026	Radiation Treatment Management	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1027	Chemotherapy Administration	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1028	Standardized Pain Assessment Tool	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1090	Moderate or Severe LVSD	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1091	Left Ventricular Systolic Dysfunction	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1092	Moderate or Severe	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1134	Ejection Fraction	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1139	ACE Inhibitor or ARB or ARNI	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1140	Patient Reason for ACE Inhibitor or ARB Decline	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1141	Psychoanalysis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1151	Renal Failure Due to ACE Inhibitor	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1170	Tobacco User	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1174	Beta Blocker Therapy	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1176	Heart Rate	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1177	Allergy to Beta Blocker Therapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1178	Intolerance to Beta Blocker Therapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1184	Beta Blocker Therapy for LVSD	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1187	Group Psychotherapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1189	Tobacco Non User	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1190	Tobacco Use Cessation Pharmacotherapy	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1193	Cardiac Pacer	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1211	Allergy to ACE Inhibitor or ARB	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1212	Intolerance to ACE Inhibitor or ARB	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1240	Annual Wellness Visit	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1241	Acute and Subacute Iridocyclitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1251	Macular Exam	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1259	Limited Life Expectancy	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1278	Tobacco Use Screening	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1283	Level of Severity of Retinopathy Findings	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1285	Ophthalmological Services	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1320	Macular Edema Findings Present	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1332	Cognitive Assessment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1333	Cup to Disc Ratio	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1334	Optic Disc Exam for Structural Abnormalities	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1409	Burn Confined to Eye and Adnexa	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1410	Cataract Secondary to Ocular Disorders	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1411	Cataract Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1412	Cataract Congenital	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1413	Cataract Mature or Hypermature	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1414	Cataract Posterior Polar	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1415	Certain Types of Iridocyclitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1416	Chronic Iridocyclitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1417	Cloudy Cornea	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1418	Corneal Edema	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1419	Disorders of Cornea Including Corneal Opacity	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1423	Glaucoma	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1424	Hereditary Corneal Dystrophies	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1426	Hypotony of Eye	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1427	Injury to Optic Nerve and Pathways	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1428	Central Corneal Ulcer	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1430	Open Wound of Eyeball	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1432	Pathologic Myopia	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1433	Posterior Lenticonus	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1438	Retrolental Fibroplasias	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1443	Traumatic Cataract	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1444	Uveitis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1445	Vascular Disorders of Iris and Ciliary Body	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1446	Visual Field Defects	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1448	Amblyopia	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1450	Choroidal Degenerations	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1451	Choroidal Detachment	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1452	Choroidal Hemorrhage and Rupture	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1453	Degeneration of Macula and Posterior Pole	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1454	Degenerative Disorders of Globe	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1455	Diabetic Macular Edema	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1457	Disorders of Optic Chiasm	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1458	Disorders of Visual Cortex	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1459	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1460	Focal Chorioretinitis and Focal Retinochoroiditis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1461	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1462	Hereditary Choroidal Dystrophies	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1463	Hereditary Retinal Dystrophies	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1465	Nystagmus and Other Irregular Eye Movements	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1466	Optic Atrophy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1467	Optic Neuritis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1468	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1469	Other Background Retinopathy and Retinal Vascular Changes	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1471	Other Disorders of Optic Nerve	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1473	Other Endophthalmitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1475	Prior Penetrating Keratoplasty	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1477	Purulent Endophthalmitis	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1478	Retinal Detachment with Retinal Defect	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1479	Retinal Vascular Occlusion	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1480	Other Proliferative Retinopathy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1482	Separation of Retinal Layers	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1483	Visual Acuity 20/40 or Better	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1489	ACE Inhibitor or ARB or ARNI Ingredient	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1491	Major Depressive Disorder Active	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1492	Psych Visit Diagnostic Evaluation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1493	Beta Blocker Therapy Ingredient	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1496	Psych Visit Psychotherapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1530	Speech and Hearing Evaluation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1558	Morgagnian Cataract	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1559	Macular Scar of Posterior Polar	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1560	Best Corrected Visual Acuity Exam Using Snellen Chart	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1561	Medications for Above Normal BMI	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1562	Medications for Below Normal BMI	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1563	Underweight	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1566	Adult Depression Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1567	Adolescent Depression Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1568	Follow Up for Adult Depression	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1569	Follow Up for Adolescent Depression	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1570	Referral for Adolescent Depression	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1571	Referral for Adult Depression	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1572	High Intensity Statin Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1573	LDL Cholesterol	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1574	Low Intensity Statin Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1575	Moderate Intensity Statin Therapy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1576	Outpatient Encounters for Preventive Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1578	Follow Up Within 4 Weeks	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1580	Referral to Primary Care or Alternate Provider	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1581	Lifestyle Recommendation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1582	Patient Declined	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1583	Referral or Counseling for Alcohol Consumption	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1584	Hospice Care Ambulatory	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.3000	Metformin	active	2019-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.319	Prostate Cancer	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.320	Bone Scan	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.326	Primary Open Angle Glaucoma	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.327	Diabetic Retinopathy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.353	End Stage Renal Disease	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.362	Asthma	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.366	Arrhythmia	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.367	Atrioventricular Block	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.368	Cardiac Pacer in Situ	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.369	Coronary Artery Disease No MI	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.370	Hypotension	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.371	Cardiac Surgery	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.376	Heart Failure	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.378	Pregnancy	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.398	Prostate Cancer Treatment	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.399	Salvage Therapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.401	Prostate Specific Antigen Test	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.403	Initial Myocardial Infarction	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.412	Bradycardia	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.451	Pain Warranting Further Investigation for Prostate Cancer	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.471	Bilateral Oophorectomy	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.485	Chemotherapy	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.509	Tobacco Use Cessation Counseling	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1498	Medications for Above Normal BMI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1499	Medications for Below Normal BMI	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1519	Follow Up for Above Normal BMI	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1523	Follow Up for Above Normal BMI	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1524	Follow Up for BMI Outside Normal Parameters	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1525	Follow Up for Above Normal BMI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1526	Follow Up for Above Normal BMI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1527	Referrals Where Weight Assessment May Occur	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1528	Follow Up for Below Normal BMI	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1549	Follow Up for Below Normal BMI	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1550	Follow Up for Below Normal BMI	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1551	Follow Up for Below Normal BMI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1578	Palliative Care	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1579	Palliative or Hospice Care	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1608	Encounter to Document Medications	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1609	Encounter to Document Medications	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1610	Referrals Where Weight Assessment May Occur	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1751	Encounter to Evaluate BMI	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1834	Encounter to Document Medications	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1917	Encounter to Document Medications	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.695	Encounter to Evaluate BMI	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.885	Encounter to Evaluate BMI	active	2018-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.886	Encounter to Evaluate BMI	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1475	Referral to Primary Care or Alternate Provider	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1476	Pharmacologic Therapy for Hypertension	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1482	Laboratory Tests for Hypertension	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1497	Encounter to Screen for Blood Pressure	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1508	Lifestyle Recommendation	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1509	Weight Reduction Recommended	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1510	Weight Reduction Recommended	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1511	Dietary Recommendations	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1512	Dietary Recommendations	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1514	Dietary Recommendations	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1515	Dietary Recommendations	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1516	Exercise Class	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1518	Recommendation to Increase Physical Activity	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1537	Follow Up Within 4 Weeks	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1538	Encounter to Screen for Depression	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1914	Encounter to Screen for Depression	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1915	Encounter to Screen for Depression	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1916	Encounter to Screen for Depression	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1918	Encounter to Screen for Blood Pressure	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.192	Encounter to Screen for Blood Pressure	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1920	Encounter to Screen for Blood Pressure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2387	Overweight or Obese	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2388	Underweight	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2395	Finding of Hypertension	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2462	Laboratory Tests for Hypertension	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.2466	Dental Tooth Extraction	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.259	Diagnosis of Hypertension	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.261	Diagnosis of Hypertension	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.263	Diagnosis of Hypertension	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.467	Follow Up for Adolescent Depression	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.468	Follow Up for Adult Depression	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.469	Adolescent Depression Medications	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.470	Adult Depression Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.537	Referral for Adolescent Depression	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.538	Referral for Adult Depression	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.791	Patient Declined	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.805	Weight Reduction Recommended	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.810	Recommendation to Increase Physical Activity	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.823	Referral or Counseling for Alcohol Consumption	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.6366.117	Absence of Cervix	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1250	Major Surgical Procedure	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1668	CABG Surgeries	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1743	General or Neuraxial Anesthesia	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1940	Immunocompromised Conditions	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2262	CABG Surgeries	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2328	Immunocompromised Conditions I10	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2343	Immunocompromised Conditions	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2363	Creatinine Lab Test	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.3011	Acute Myocardial Infarction	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.3024	Acute Myocardial Infarction	active	2016-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.307	Encounter Inpatient	active	2020-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.335	Bone Marrow Transplant	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.336	Bone Marrow Transplant	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.404	Bone Marrow Transplant	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.623	Acute Myocardial Infarction	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.694	CABG Surgeries	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.737	PCI	active	2018-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.747	Endotracheal Intubation	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.128	Bipolar Disorder	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.2433	Delivery	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.2435	HBsAg	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.246	Personality Disorder Emotionally Labile	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.247	Personality Disorder Emotionally Labile	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.248	Personality Disorder Emotionally Labile	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.249	Personality Disorder Emotionally Labile	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.254	Dysthymia	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.256	Dysthymia	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.257	Dysthymia	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.262	Deceased	active	2014-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.263	PHQ 9 and PHQ 9M Tools	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.269	Hepatitis B	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.271	Hepatitis B	active	2017-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.272	Hepatitis B	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.273	Live Birth or Delivery	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.274	Live Birth or Delivery I10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.275	Live Birth or Delivery	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.277	Delivery	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.278	Delivery - Diagnosis	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.279	HBsAg	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.281	HBsAg	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.43	Bipolar Disorder	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.44	Bipolar Disorder	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.45	Bipolar Disorder	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.1.82	Delivery	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.11.721	Deceased	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.67.1.101.11.723	PHQ-9 Tool	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.6929.2.1000	Estimated Glomerular Filtration Rate	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.6929.2.1002	Urine Albumin Creatinine Ratio	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.6929.3.1000	Estimated Glomerular Filtration Rate	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.6929.3.1007	Urine Albumin Creatinine Ratio	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1000	Strabismic Amblyopia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1001	Strabismic Amblyopia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1002	Refractive Amblyopia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1003	Refractive Amblyopia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1004	Routine Ophthalmological Examination	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1005	Pediatric Best Corrected Visual Acuity Exam	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1006	LogMAR Visual Acuity Exam	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1007	Aphakia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1008	Aphakia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1009	Infantile and Juvenile Cataract	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1010	Infantile and Juvenile Cataract	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1011	Congenital Corneal or Anterior Segment Conditions	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1012	Congenital Corneal or Anterior Segment Conditions	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1013	Eyelid or Orbital Conditions	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1014	Eyelid or Orbital Conditions	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1015	Coloboma of Optic Disc	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1016	Coloboma of Optic Disc	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1017	Hemorrhage of Optic Nerve Sheath	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1018	Hemorrhage of Optic Nerve Sheath	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1019	Optic Nerve Hypoplasia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1020	Optic Nerve Hypoplasia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1021	Disorder of Visual Cortex Due to Underlying Condition	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1022	Disorder of Visual Cortex Due to Underlying Condition	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1023	Cortical Blindness	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1024	Cortical Blindness	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1025	Congenital Condition of Retina	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.2.1026	Congenital Condition of Retina	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1000	Strabismic Amblyopia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1001	Refractive Amblyopia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1002	Routine Ophthalmological Examination	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1003	Pediatric Best Corrected Visual Acuity Exam	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1004	LogMAR Visual Acuity Exam	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1005	Aphakia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1006	Infantile and Juvenile Cataract	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1007	Congenital Corneal or Anterior Segment Conditions	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1008	Eyelid or Orbital Conditions	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1009	Coloboma of Optic Disc	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1010	Hemorrhage of Optic Nerve Sheath	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1011	Optic Nerve Hypoplasia	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1012	Disorder of Visual Cortex Due to Underlying Condition	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1013	Cortical Blindness	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.1014	Congenital Condition of Retina	active	2019-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2	Allergy and Intolerance Type	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8	Severity	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2	Problem Type (SNOMEDCT)	active	2025-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4	Problem	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.11	Medication Product Form	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.7	SPL Drug Route of Administration Terminology	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9	Body Site Value Set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.16	Medication Brand Name	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.17	Medication Clinical General Drug	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.18	Medication Drug Class	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.22	CVX Vaccines Administered Complete Set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.28	Procedure	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60	Social History Type (SCT)	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.62	Vital Sign Result Type	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.64	Medication Fill Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68	Problem Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.4.642.2.575	Race Categories	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.4.642.3.155	Care Team Category	active	2024-06
us.nlm.vsac	R4	http://hl7.org/fhir/ValueSet/event-timing	EventTiming	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.4.642.40.2.48.1	Detailed Ethnicity Including Absence Reasons	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.4.642.40.2.48.3	Ethnicity Categories	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.24.7.14	Clinically Important Bacteria and Fungi	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.24.7.280	NHSNGenotypicTests	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.24.7.281	Bacterial Skin Commensals	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1066	Healthcare Provider Taxonomy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3180	NHSNInsertionSiteCode	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3181	NHSNRoleOfPerformerCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3182	NHSNReasonForInsertionCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3183	NHSNSkinPreparationCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3184	NHSNSterileBarrierCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3185	NHSNCatheterTypeCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3194	NHSNSignificantPathogenCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3195	NHSNCriterionOfDiagnosisCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3196	NHSNInfectionConditionCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3234	NHSNPopulationCategoryCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3247	NHSNTimingCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3248	NHSNEligibilityCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3249	NHSNSpecimenTypeCode	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3283	NHSNOrganismASTCode	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3360	NHSNAntimicrobialAgentAURPCode	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3361	NHSNRouteOfAdministrationAURPCode	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591	Payer Type	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3595	NHSNPopulationSummaryReportTypeCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6007	NHSNVascularAccessTypeCode	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6008	NHSNSuspectedSourceTypeCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6042	NHSNVascularAccessSiteCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6051	NHSNClosureTechniqueCode	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6074	NHSNStaphAureusTestResults	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7160	NHSNStaphAureusSpecificTest	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7214	NHSNSameDayOutcomeMeasure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7215	NHSNInfectionFirstReportedSource	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7232	NHSNRaceCategory	active	2020-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7233	NHSNPreviousPatientLocation	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7237	NHSNBloodCollectionLocation	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7238	NHSNPreviousFacility	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239	NHSNContraindicationType	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7240	NHSNCarbaTestMethod	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7241	NHSNCarbaDetectType	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7242	NHSNCdiffTestMethod	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7338	NHSNStartOrContinuation	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7353	NHSNSummaryBloodProductUsage	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.836	Race	active	2012-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.837	Ethnicity	active	2012-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.877	Detailed Ethnicity	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.13883.3.3157.4067	MRI of the Breast	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.13883.3.3157.4068	MRI of the Breast	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.13883.3.3157.4069	Intraspinal Abscess	active	2022-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.113883.3.67.1.101.3.2444	Major Depression Including Remission	active	2021-02
fhir.argonaut.questionnaire	R3	CapabilityStatement/adaptive-questionnaire-service	Argonaut Adaptive Questionnaire Service CapabilityStatement	active	2019-02
fhir.argonaut.questionnaire	R3	CapabilityStatement/answerbank	Argonaut Answerbank CapabilityStatement	active	2019-02
fhir.argonaut.questionnaire	R3	CapabilityStatement/argo-questionnaire-provider-ehr	Argonaut Argo Questionnaire Provider Ehr CapabilityStatement	active	2019-02
fhir.argonaut.questionnaire	R3	CapabilityStatement/assessmentbank	Argonaut Assessmentbank CapabilityStatement	active	2019-02
fhir.argonaut.questionnaire	R3	ImplementationGuide/argonaut.us.questionnaire-1.0.0	Argonaut Questionnaire	draft
fhir.argonaut.questionnaire	R3	OperationDefinition/next-question	Argonaut Next Question Operation	draft	2018-08
fhir.argonaut.questionnaire	R3	Questionnaire/questionnaire-example-audit-c	Alcohol Use Disorder Identification Test - Consumption [AUDIT-C]	draft	2019-02
fhir.argonaut.questionnaire	R3	Questionnaire/questionnaire-example-dast	Drug Abuse Screening Test-10 [DAST-10]	draft	2018-07
fhir.argonaut.questionnaire	R3	Questionnaire/questionnaire-example-housing	Housing Questions	draft	2018-07
fhir.argonaut.questionnaire	R3	Questionnaire/questionnaire-example-phq9	Patient Health Questionnaire (PHQ-9)	draft	2018-07
fhir.argonaut.questionnaire	R3	Questionnaire/questionnaire-example-sampler	Argonaut Questionnaire Sampler	draft	2018-07
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-context-type-value	context-type-value	draft	2018-12
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-context-type	context-type	active	2018-12
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-context	context	draft	2018-12
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-publisher	questionnaire_publisher	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-status	questionnaire_status	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-title	questionnaire_title	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/Questionnaire-version	questionnaire_version	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/QuestionnaireResponse-author	questionnaireresponse_author	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/QuestionnaireResponse-context	questionnaireresponse_context	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/QuestionnaireResponse-patient	questionnaireresponse_patient	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/QuestionnaireResponse-questionnaire	questionnaireresponse_questionnaire	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/QuestionnaireResponse-source	questionnaireresponse_source	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/QuestionnaireResponse-status	questionnaireresponse_status	active	2019-02
fhir.argonaut.questionnaire	R3	SearchParameter/patient-birthdate	patient_birthdate	active	2019-02
fhir.argonaut.questionnaire	R3	StructureDefinition/argo-adap-questionnaireresponse	Argonaut Adaptive QuestionnaireResponse Profile	active	2019-02
fhir.argonaut.questionnaire	R3	StructureDefinition/argo-questionnaire-valueset	Argonaut Questionnaire Contained ValueSet Profile	active	2018-05
fhir.argonaut.questionnaire	R3	StructureDefinition/argo-questionnaire	Argonaut Questionnaire Profile	active	2018-04
fhir.argonaut.questionnaire	R3	StructureDefinition/argo-questionnaireresponse	Argonaut QuestionnaireResponse Profile	active	2018-04
fhir.argonaut.questionnaire	R3	StructureDefinition/extension-itemOrder	Argonaut Questionnaire Item Order Extension	active	2019-02
fhir.argonaut.questionnaire	R3	StructureDefinition/extension-multipleAnd	Argonaut SearchParameter Multiple AND Extension	active	2018-04
fhir.argonaut.questionnaire	R3	StructureDefinition/extension-multipleOr	Argonaut SearchParameter Multiple OR Extension	active	2018-04
fhir.argonaut.questionnaire	R3	StructureDefinition/extension-responsePeriod	Argonaut QuestionnaireResponse Response Period Extension	active	2018-04
fhir.argonaut.questionnaire	R3	StructureDefinition/extension-timeLimit	Argonaut Questionnaire Time Limit Extension	active	2018-02